Noninvasive evaluation of patients with coronary artery disease and heart failure by Van De Veire, N
 
FACULTY OF MEDICINE AND HEALTH SCIENCES 
 
 
 
NONINVASIVE EVALUATION OF PATIENTS  
WITH CORONARY ARTERY DISEASE AND HEART FAILURE 
 
NICO R.L. VAN DE VEIRE 
 
 
PROMOTORS: 
PROF. DR. J. DE SUTTER 
 PROF. DR. T.C. GILLEBERT 
 
 
THESIS SUBMITTED IN FULFILLMENT OF THE REQUIREMENTS FOR  
THE DEGREE OF ‘DOCTOR IN MEDICAL SCIENCES’ (PHD) 
 
 
 
 
D/2006/11.061/1 
ISBN-10: 90-9021224-8 
ISBN-13: 978-90-9021224-1 
2006 
Department of Cardiovascular Diseases 
Ghent University Hospital 
De Pintelaan 185 
9000 GENT 
BELGIUM 
 
 
 
 
 
 
Logistic support by Roche Belgium for the publication of this thesis is gratefully 
acknowledged 
 
 
 
 
 
 
 
 
 
 
 
Painting on the cover: 
“Twee overlieden van het chirurgijnsgilde te Amsterdam” 
by Jurriaen Pool, 1699, Amsterdams Historisch Museum,  
exhibited at Boerhaave Museum, Leiden, The Netherlands 
  
Promotors 
Prof. dr. J. De Sutter     Ghent University 
Prof. dr. T.C. Gillebert     Ghent University 
 
 Begeleidingscommissie 
Prof. dr. J. De Sutter     Ghent University 
Prof. dr. T.C. Gillebert     Ghent University 
Prof. dr. J. Phillippé      Ghent University 
Lic. M. De Buyzere      Ghent University 
 
Examination board 
        Prof. dr. V. Conraads     University of Antwerp 
Prof. dr. G. De Backer     Ghent University 
                         Prof. dr. G. Derumeaux     Université de Lyon
  Prof. dr. J. De Sutter     Ghent University 
Prof. dr. T.C. Gillebert     Ghent University 
Prof. dr. M. Petrovic     Ghent University 
Prof. dr. R. Tavernier     Ghent University 
      Prof. dr. G. Van Camp    Free University of Brussels 
Prof. dr. J. Van de Voorde (Chairman)      Ghent University  
                 
 
Dean of the Faculty of Medicine and Health Sciences 
Prof. dr. J.-L. Pannier 
 
Rector Ghent University 
Prof. dr. P. Van Cauwenberge 
 
 
 
 
 
 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
 
 
 
 
 
 
 
 
 
 
DULCIA NON MERUIT QUI NON GUSTAVIT AMARA 
 
Ovidius 
 
 
 
 
 
 
 
 
 
 
 
Dankzij mijn ouders 
 
 
 
TABLE OF CONTENTS 
_________________________________________________________________ 
 
 
TABLE OF CONTENTS 
 
 
 
General introduction and outline of the thesis………………….…………11 
 
 
Part 1: Application of Tissue Doppler Imaging techniques for the 
noninvasive assessment of filling pressures 
 
1.1 Echocardiographically estimated left ventricular end-diastolic and right ventricular 
systolic pressure in normotensive healthy individuals.  
N. Van de Veire, J. De Backer, A-K. Ascoop, B. Middernacht, A. Velghe, J. De Sutter 
Intern J Cardiovasc Imaging 2006; in press …………………………………………….31 
 
1.2 Effects of age, gender and left ventricular mass on septal mitral annulus velocity 
(E’) and the ratio of transmitral early peak velocity to E’ (E/E’).  
J. De Sutter, J. De Backer, N. Van de Veire, A. Velghe, M. De Buyzere, T.C. Gillebert 
Am J Cardiol 2005; 95:1020-1023 …………………………………………………….....53 
 
1.3 Effect of ischemic mitral regurgitation on the ratio of early transmitral flow velocity 
to mitral annulus early diastolic velocity in patients with stable coronary artery 
disease.  
N. Van de Veire and J. De Sutter 
Am J Cardiol 2006; 97: 1449-1451.………………………………………………………67 
 
 
 
 
 
 7
TABLE OF CONTENTS 
___________________________________________________________________ 
Part 2: Noninvasive evaluation of potential candidates for cardiac 
resynchronization therapy 
 
 
2.1 Global and regional parameters of dyssynchrony in ischemic and non-ischemic 
cardiomyopathy. 
N. Van de Veire, J. De Sutter, G. Van Camp, P. Vandervoort, P. Lancellotti, B. 
Cosyns, P. Unger, T.C. Gillebert 
Am J Cardiol 2005; 95: 421-423 ………………………………………………………….79 
 
2.2 Prevalence of mechanical dyssynchrony in patients with heart failure and 
preserved left ventricular function. (a report from the Belgian Multicenter Registry on 
Dyssynchrony) 
J. De Sutter, N. Van de Veire, L. Muyldermans, T. De Backer, E. Hoffer, M. 
Vaerenberg, B. Paelinck, P. Decoodt, L. Gabriel, T.C. Gillebert, G. Van Camp 
Am J Cardiol 2005; 96: 1543-1548 ………..……………………………………………..91 
 
2.3 Relationship between QRS duration, left ventricular volumes and prevalence of 
nonviability in patients with coronary artery disease and severe left ventricular 
dysfunction. 
O. De Winter, N. Van de Veire, F. Van Heuverswijn, G. Van Pottelberge, T.C. 
Gillebert, R.A. Dierckx, J. De Sutter 
Eur J Heart Fail 2006; 8: 275-277 ………………………………………………………109 
 
2.4 Noninvasive evaluation of the cardiac venous system in coronary artery disease 
patients using 64-slice Computed Tomography 
N. Van de Veire, J. Schuijf, J. De Sutter, D. Devos, A. de Roos, E. van der Wall, M 
Schalij, J. Bax 
J Am Coll Cardiol 2006; in press  …………………………………………………….…119 
 
 
 
 
 8 
TABLE OF CONTENTS 
_________________________________________________________________ 
Part 3: Noninvasive markers of prognosis in heart failure patients 
 
3.1 Diabetes and impaired fasting glucose as predictors of morbidity and mortality in 
male coronary artery disease patients with reduced left ventricular function. 
N. Van de Veire, O. De Winter, T.C. Gillebert, J. De Sutter 
Acta Cardiol 2006; 61: 137-143 …………………………………………………………145 
 
3.2 Maximum oxygen uptake at peak exercise in elderly patients with coronary artery 
disease and preserved left ventricular function: The role of inflammation on top of 
tissue Doppler-derived systolic and diastolic function. 
N. Van de Veire, O. De Winter, J. Philippé, M. De Buyzere, D. Bernard, M. Langlois, 
T.C. Gillebert, J. De Sutter 
Am Heart J 2006; 152: 297.e1-297.e7………………………………………………….165 
 
General discussion and future perspectives ………………………….…185 
 
Summary ………………………………………………...……………………………. 197 
 
Samenvatting …………………………………………………………………………201 
 
List of publications …………………………………………………………………205 
 
Dankwoord…………………………………….…………………………………….....211 
 
Curriculum vitae……………………………………………………………………...217 
 
 
 
 
 
 
 9
TABLE OF CONTENTS 
___________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 10 
  
 
 
General Introduction and Outline of the Thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENERAL INTRODUCTION AND OUTLINE OF THE THESIS 
___________________________________________________________________ 
General Introduction 
Over the past 50 years, the cardiologic landscape underwent a fundamental 
transformation. Before the Second World War, acute myocardial infarction, 
secondary to acute thrombotic coronary occlusion was regarded as a rare condition 
not compatible with survival. In the fifties and sixties an alarming rise in coronary 
artery disease (CAD) mortality was observed in the industrialised world. At that time, 
therapeutic modalities for patients presenting with myocardial infarction provided little 
benefit, other than relieving pain. Consequently mortality rates, even in hospital 
setting, were high. (1) The introduction of coronary care units in the sixties, providing 
a better control of life threatening arrhythmias, was the first step to improve survival. 
(1) In most Western European countries the age standardised CAD death rates 
started to decline since the seventies. (2-5) This encouraging decline of – 
predominantly in-hospital - death rate can be explained by an improved treatment of 
patients with myocardial infarction and unstable angina through the use of both 
cardiac medication and coronary reperfusion strategies. (2) In many countries, efforts 
to improve primary prevention of CAD, by reducing traditional risk factors such as 
smoking, hypertension, hypercholesterolemia, diabetes mellitus and obesity, have 
made an important contribution to declining CAD death rates. (6) Also changes in 
diet and lifestyle modifications play a central role in this positive evolution. (5) 
 
Anno 2006, CAD is still an important cause of death in Flanders, Belgium, accounting 
for almost 14 percent of total mortality; ischemic heart disease is one of the main 
causes of potential life years lost and is the first cause of death in the age category 
between 70 and 80 years. (7) Among CAD patients, acute myocardial infarctions are 
responsible for two thirds of all deaths, followed by ischemic cardiomyopathy. (7)  In-
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hospital mortality rates of acute myocardial infarction have declined, but data from 
the MONICA project show that a large group of patients die from myocardial 
infarction, before reaching the hospital. (8)   
 
Moreover, despite a slow but significant decrease in age-standardized mortality due 
to acute coronary syndromes, the (absolute) mortality due to chronic heart failure 
continues to increase worldwide. (9) The decrease in cardiovascular mortality and 
the increase in admission rates for chronic conditions such as heart failure, chronic 
coronary syndromes, and diseases of the arteries, support the hypothesis that longer 
survival of many patients with heart diseases is leading to a growing pool of patients 
at increased risk for subsequent cardiovascular complications in Western countries. 
(10) In Flanders, chronic ischemic heart disease is the most important reason for 
hospitalization for men between 50 and 79 years and the second most important 
reason for women between 70 and 79 years old. (7) For men, aged 85 or more, heart 
failure is the most important hospital admission reason; for women aged 80 years or 
more, heart failure is the second most important hospitalization reason. (7) 
 
As a result, general practitioners and cardiologists are facing increasingly frail, mostly 
elderly CAD patients who survived myocardial infarction but developed a chronic 
ischemic cardiomyopathy, often causing signs and symptoms of heart failure. (11) 
Several treatment options, both medical and non-pharmacologic, are available for 
these patients. (12) Large, randomized trials have proven the efficacy of new and old 
drugs such as ACE-inhibitors, AT2-receptor blockers, aldosteron antagonists and 
beta-blockers. (13) Cardiac rehabilitation therapy, first introduced in post myocardial 
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infarction patients, is now successfully applied in heart failure patients. (14) Device 
therapy, including implantable defibrillators and biventricular pacemakers is also 
being increasingly used. (15) 
 
Heart failure is not the sole privilege of patients with a poor left ventricular ejection 
fraction. Recent reports show that a large proportion of patients admitted to the 
hospital with a diagnosis of heart failure have a preserved ejection fraction. (16,17) 
Moreover the proportion of patients with the diagnosis of heart failure with preserved 
ejection fraction increased over a period of 15 years. (16) The survival of patients 
with heart failure with preserved ejection fraction was similar to that of patients with 
reduced ejection fraction. (17) In this thesis, several chapters are devoted to this 
important group of patients. 
 
In order to select the best therapeutic option for a specific patient, the cardiologist 
needs additional information concerning the present status and prognosis of the 
patient. As we are dealing with elderly, less mobile and fragile patients, these 
techniques should be easily accessible, noninvasive and if possible, bedside.  
 
The goal of the clinical research projects presented in this thesis is to investigate the 
potential value of some recently introduced noninvasive techniques, including tissue 
Doppler imaging, nuclear imaging, multi slice computed tomography and biomarkers 
to provide diagnostic, therapeutic and decision-making information in CAD patients 
with heart failure. The patients studied in this thesis are mainly elderly patients with a 
documented history of coronary artery disease, recruited from the outpatient clinics 
and wards of the University Hospital Ghent and Leiden University Medical Center. 
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Both patients with heart failure and poor left ventricular systolic function and patients 
with heart failure and preserved left ventricular systolic function were included. 
 
The most recent guidelines of the European Society of Cardiology emphasize the 
role of several noninvasive techniques in the diagnostic work-out of heart failure 
patients. (18) These guidelines explicitly mention the use of echocardiography and 
more specifically tissue Doppler imaging to evaluate diastolic function and left 
ventricular filling pressures.  In the first part of the thesis we study the effects of aging 
on these parameters and try to provide age-specific reference values. Furthermore 
we will apply these parameters in a population of CAD patients with a wide range of 
left ventricular ejection fraction,  that developed ischemic mitral regurgitation.  
 
As already mentioned previously, cardiac resynchronization therapy (CRT) is an 
exciting new treatment option for heart failure patients. The CARE-HF trial showed 
that CRT improves symptoms and the quality of life and reduces complications and 
the risk of death. (19) Not all patients however respond favorably to this invasive and 
expensive treatment. (20) An improved selection of potential responders is 
mandatory. The second chapter will integrate multi modality imaging to address 
several issues related to the selection of CRT candidates. 
 
When dealing with a potentially fatal disease such as heart failure, it becomes 
extremely important for patient management and decision making, to determine the 
prognosis of an individual patient. Several prognosticators and prognostic models 
have been proposed to stratify patients. (21) In the last chapter we will investigate the 
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prognostic value of a simple biochemical marker: fasting blood glucose in patients 
with poor left ventricular systolic function. Since the landmark publication by Mancini 
et al (22), exercise capacity, as evaluated with spiroergometry has become a widely 
accepted prognosticator. The underlying mechanisms, contributing to or limiting 
functional capacity, are not completely understood. In the last part of this thesis we 
will investigate the association between echocardiographic tissue Doppler imaging 
parameters, novel biomarkers and maximal oxygen uptake during a bicycle exercise 
test in CAD patients with heart failure and a preserved left ventricular systolic 
function. 
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Outline of the thesis 
 
Part 1: Echocardiography and filling pressures 
 
History taking and clinical examination are the cornerstones of diagnostic work-up. 
Advanced technology is increasingly used by physicians to confirm or revoke the 
clinicians’ original hypothesis and findings. Echocardiography is a fine example of a 
bedside diagnostic technique used daily by cardiologists. (23) Novel technological 
advances developed within the last decade have expanded the accuracy and 
potential applications of echocardiography. Even the art of measuring filling 
pressures, previously a privilege of the invasive techniques, nowadays belongs to the 
diagnostic array of the cardiac sonographer. (24) The advantages of 
echocardiographic evaluation of filling pressure are numerous: it can be performed 
bedside, it is safe and noninvasive, is available at every time in every part of the 
hospital and it is nonexpensive. 
 
The first part of this thesis is entirely devoted to the echocardiographic assessment of 
filling pressures. In the mid eighties several authors validated the estimation of right 
ventricular end-systolic pressure by measuring the peak systolic pressure gradient 
across a regurgitant tricuspid valve and assessing inferior caval size and its 
respiratory variation. (25,26,27) A clinical example of this measurement is depicted in 
Figure 1. 
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Figure 1: Example of estimation of right ventricular systolic pressure in a patient with an ischemic 
cardiomyopathy. Left panel: The peak systolic pressure gradient across the regurgitant tricuspid valve 
in this patient is 40 mmHg. Right panel: the right atrial pressure is estimated at 10 mmHg (inferior 
vena cava diameter between 1.5 and 2 cm). Right ventricular pressure estimation: 40 mmHg + 10 
mmHg = 50 mmHg; 
 
More recently the E/E’ value was introduced. This simple value, derived from the 
early mitral inflow and early diastolic mitral annulus velocity was validated almost a 
decade ago and has become a reliable estimation of left ventricular end-diastolic 
pressure. (28,29)  
       
Figure 2: Example of assessment of the E/E’ value in a patient with ischemic cardiomyopathy. Left 
panel: Transmitral flow is evaluated by placing the sample volume of the pulsed wave Doppler at the 
tips of the mitral valve leaflets. E: 108. Right panel: The E’ value is evaluated by placing the sample 
volume of the pulsed wave Tissue Doppler Imaging modality at the septal side of the mitral valve 
annulus. E’: 4. E/E’: 27, indicating elevated left ventricular end-systolic pressures. 
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As aging is accompanied with several structural and functional cardiac changes, it 
was our hypothesis that these changes are reflected by echocardiographic 
parameters including estimated right and left ventricular filling pressures. This 
hypothesis was tested in healthy individuals without a history of hypertension and 
with normotensive blood pressure during the echocardiographic examination.   
 
In the second chapter of Part 1 we studied effects of age and gender on E/E’ and the 
effect of increased left ventricular mass as many CAD patients develop hypertrophy 
as a result of arterial hypertension. 
 
The last chapter of Part 1 is devoted to the noninvasive assessment of left ventricular 
end-diastolic pressure and its relation with severity of mitral regurgitation. Many CAD 
patients develop some degree of mitral regurgitation, that is not related to primary 
structural valvular abnormalities. Among CAD patients, changes in ventricular 
structure and function related to ischemia and remodelling can lead to mitral 
regurgitation. (30) In this part of the thesis we investigated the prevalence of 
ischemic mitral regurgitation in patients with established CAD referred for 
echocardiography. In the same population we investigated the relation between 
severity of ischemic mitral regurgitation and E/E’.  
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Part 2: Selection of potential candidates for Cardiac 
Resynchronization Therapy.  
 
Although the treatment of heart failure patients improved tremendously over the last 
decade (12), following the introduction of drugs such as ACE-inhibitors, AT2-receptor 
blockers, aldosteron antagonists and beta-blockers, clinical trials involving novel 
medical treatments focusing on the immune system produced rather disappointing 
results. As a consequence non-medical treatment options such as cardiac 
rehabilitation, surgery and device therapy gained interest. (18) In highly symptomatic 
heart failure patients on optimal medical treatment, with a left bundle branch block on 
the surface electrocardiogram and poor left ventricular systolic function, the 
implantation of a biventricular pacemaker has become an attractive treatment option. 
(31,32,33) The rationale behind Cardiac Resynchronization Therapy (CRT) is that 
these patients have an inefficient coordination of the contraction between the left and 
right ventricle (interventricular dyssynchrony) and/or between the various segments 
of the left ventricle (intraventricular dyssynchrony). (34) Stimulating both right 
ventricle and left ventricle has acute hemodynamic effects reducing mitral 
regurgitation and improving systolic function. On the long run it will lead to reverse 
remodeling, improvement of symptoms and exercise capacity. The CARE-HF trial 
has even shown beneficial effects on morbidity and mortality. (19) However, 30 % of 
patients treated with CRT do not respond favorably to this expensive and invasive 
therapy. (20,35,36) The reasons for failure of biventricular pacing are numerous: 
infection, lead dislodgment, programming errors, … A better selection of potential 
candidates for biventricular pacing is imperative and the second part of this thesis is 
devoted to patient selection by means of noninvasive imaging modalities. 
 20 
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Cardiologists have always evaluated time intervals, intrinsically related to the cardiac 
cyclus, either by auscultating the heart with a stethoscope or by interpreting the 
surface electrocardiogram. In the early years of echocardiography M-mode and 
Doppler were used to quantify intervals and they are still used today to evaluate left 
ventricular function or to measure interventricular delay. The difference in activation 
between the right and left ventricular activation – interventricular dyssynchrony – can 
be measured by evaluating the difference between onset QRS – Doppler flow in the 
aorta and onset QRS – Doppler flow in the pulmonary artery.  
 
 
Figure 3: Interventricular delay. Start with measuring the time interval between onset of QRS and 
onset aortic flow (A). Than the time interval between the onset of QRS and the pulmonary flow is 
measured (B). Interventricular delay is the difference between A and B 
 
Recently Tissue Doppler Imaging (TDI) expanded the clinical applications of 
measuring time intervals. Colour TDI graphically depicts myocardial velocities, 
measured at a specific sampling position, in function of time.  Using the QRS-
complex as a reference it becomes possible to measure the time interval between 
the onset of QRS and the time to peak systolic myocardial velocity.  
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Figure 4: Example of a Colour Tissue Doppler Imaging myocardial velocity curve at the basal left 
ventricular lateral segment. The time interval between the onset of QRS and peak systolic myocardial 
velocity is measured and expressed in ms.  
 
If sample volumes are placed at different left ventricular segments it is possible to 
identify the area of latest mechanical activation and to quantify differences in 
activation delays between these left ventricular segments. Several authors have 
proposed different parameters to quantify the degree of dyssynchrony. (37) Several 
observational studies have shown that the larger the intraventricular dyssynchrony  
the more likely that these patients will respond favorably to biventricular pacemaker 
implantation.  
 
During 2003, the Belgian Working Group on Echocardiography and Cardiac Doppler 
set up a Multicenter Registry on Dyssynchrony and the results are presented in the 
first and second chapters of Part 2.  First we studied potential differences between 
patients with ischemic cardiomyopathy and patients with idiopathic dilated 
cardiomyopathy. We used Colour TDI to assess global and regional mechanical 
dyssynchrony in these patients groups. We particularly focused on potential 
differences regarding the area of latest activation as this could have practical  
 22 
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implications regarding left ventricular lead implantation. The second paper of the 
Belgian Multicenter Registry on Dyssynchrony describes the prevalence of 
dyssynchrony, using conventional Doppler and TDI, in patients with heart failure but 
with a preserved left ventricular systolic function.  
 
In the 3th chapter of Part 2 we investigated another important issue in patient 
selection of CRT candidates: viability. We used myocardial perfusion imaging to 
assess viability of the different LV segments in patients with a poor left ventricular 
systolic function and broad QRS complex. 
 
Finally, in the fourth chapter of Part 2 we focused on the cardiac venous system. The 
left ventricular lead of a biventricular pacemaker should ideally be positioned in a 
tributary of the coronary sinus that is draining the area of latest mechanical activation 
(evaluated with TDI) and containing viable myocardial tissue. Knowledge on the 
anatomy of the cardiac veins before the CRT implantation would add to the success 
ratio of this procedure. We retrospectively analysed 100 patients with a noninvasive 
imaging technique: 64 slice Computed Tomography. The study aims were to 
evaluate the feasibility of analysing the cardiac venous system with CT and to study 
possible differences in coronary venous anatomy between patients without CAD, 
patients with significant CAD and patients with a history of myocardial infarction. 
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Part 3: Noninvasive markers of prognosis in heart failure patients 
 
Exercise testing is being used in daily practice to detect myocardial ischemia. (38) 
The treadmill (USA) and the bicycle (Europe), in combination with a 12 lead standard 
electrocardiogram and blood pressure measurements, have been used for decades 
for this purpose. The sensitivity and specificity of exercise testing to detect 
myocardial ischemia can be enhanced if combined with myocardial perfusion 
imaging. (38) Exercise testing also provides information on the physical condition of a 
patient: the watts reached at peak exercise are a measurement of physical status. 
More objective information is available for the physician if the exercise test is 
combined with spiroergometry. Using this technique, the minute ventilation, carbon 
dioxide production and oxygen consumption are measured on a breath by breath 
basis. By analyzing these curves it is possible to conclude if the patients really 
reached a maximal effort. The oxygen consumption at peak exercise offers important 
prognostic information, especially in patients with heart failure. (39) 
 
Exercise capacity is the resultant of a complex interaction between the circulatory, 
respiratory and musculoskeletal system. Many factors contributing to exercise 
capacity are not fully understood. In the last chapter of Part 3 we studied the possible 
role of Brain Natriuretic Peptide, blood fasting glucose (also a prognosticator) and 
inflammatory markers on top of longitudinal myocardial function and diastolic 
function, evaluated with TDI.  
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ABSTRACT 
 
 
Aim 
To study the effect of aging on and the relationship between echocardiographically 
estimated left ventricular (LV) filling pressure and estimated right ventricular (RV) 
systolic pressure among healthy normotensive individuals. 
 
Methods 
We analyzed 249 healthy individuals (aged 18-82 years, 52% men) with normal 
echocardiographic findings and reliably measurable tricuspid regurgitation gradients. 
Subjects with blood pressure > 140/90 mmHg and/or LV hypertrophy were excluded. 
LV & RV dimensions and LV mass were measured with M-mode echocardiography. 
Atrial (A) volumes were determined with the area-length method. Diastolic function 
was assessed with transmitral Doppler and mitral annulus tissue Doppler. The ratio 
of transmitral early peak velocity to early diastolic mitral annulus velocity (E/E’) was 
used as estimation of LV filling pressure. The transtricuspid Doppler gradient was 
used to estimate RV end-systolic pressure.  
 
Results 
Even in normotensive individuals aging was accompanied by an increase in LV mass 
and LA dimensions and an increase in relaxation abnormalities. E/E’ increased with 
every decade:  from 7.8 for age 18-35 years to 10.9 for age ≥ 75 years (p<0.0001) as 
did the transtricuspid gradient: from 18.3 mmHg for age 18-35 years to 25.8 mmHg 
for age ≥75 years (p<0.0001). Linear regression showed that estimated RV systolic 
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pressure was independently predicted by age, LA volume, LV systolic function and 
E/E’. 
 
 
Conclusion 
Among normotensive healthy individuals both E/E’ and tricuspid regurgitation 
gradients increase significantly with aging. Moreover the E/E’ ratio was independently 
predicting the tricuspid regurgitation gradient. These findings support the need for 
further studies defining age specific normal values. 
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ABBREVIATIONS 
 
A: late transmitral flow velocity 
DT: deceleration time 
E:  transmitral early peak velocity 
E’: early diastolic mitral annulus velocity 
FS: fractional shortening 
IVSD: end-diastolic interventricular septum wall thickness 
L: left 
LA: left atrial 
LAD: left atrial diameter 
LAV: left atrial volume 
LV: left ventricular 
LVEDD: left ventricular end-diastolic diameter 
LVESD: left ventricular end-systolic diameter 
PWD: end-diastolic posterior wall thickness 
R: right 
RA: right atrial 
RAV: right atrial volume 
RV: right ventricular 
RVEDD: right ventricular end-diastolic diameter 
TAPSE: tricuspid annular plane systolic excursion 
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INTRODUCTION 
 
In daily clinical practice transthoracic echocardiography is frequently used as a 
noninvasive tool to evaluate left (L) and right (R) ventricular (V) pressures. (1) The 
first papers demonstrating that RV systolic pressure could be accurately estimated by 
measuring the peak systolic pressure gradient across a regurgitant tricuspid valve 
were published in the mid eighties. (2-4) This method became a standard part of any 
routine echocardiographic study.  More recently a novel echocardiographic 
parameter was introduced, allowing physicians to evaluate LV filling pressures 
noninvasively: the ratio of transmitral early peak velocity (E) over early diastolic mitral 
annulus velocity (E’) or E/E’.  In order to identify patients with elevated left ventricular 
end-diastolic pressures different cut-off values have been proposed for E/E’.  Nagueh 
et al suggested a cut-off of 10 (5) and this value was used in a large epidemiologic 
study evaluating the prevalence of systolic and diastolic LV dysfunction (6). Ommen 
et al suggested a higher cut-off of 15 for E/E’ which is now increasingly used (7).  
 
Increased LV wall thickness and alterations in diastolic filling patterns are the most 
dramatic changes in cardiac function that occur with aging in healthy adults (8). It is 
therefore logical to assume that physiological aging of the heart is reflected by 
changes in echocardiographic parameters such as estimated filling pressures. 
Published normal values, including individuals of all ages, for RV and LV pressures, 
as estimated by echocardiography, are however scarce. Some earlier studies 
suggested that age should be taken into account when interpreting RV systolic 
pressure values but these reports were limited by the small number of included 
subjects (9,10,11).  
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McQuillan et al evaluated 3790 echocardiographic normal subjects and established 
an age-adjusted reference range for pulmonary artery systolic pressure (12). 
McQuillan et al also report a correlation between LV wall thickness and pulmonary 
artery systolic pressure, even within the normal range of wall thickness considered in 
their study (12). The authors suggest that LV wall thickness may relate to pulmonary 
artery systolic pressure through diastolic dysfunction and the effects of decreased LV 
compliance and increased LV end-diastolic pressure with aging and in conditions as 
systemic hypertension. In that study however no data were available regarding 
diastolic function including estimated LV filling pressures (E/E’). 
 
The aims of the present study were 1) to evaluate estimated LV filling pressure (E/E’) 
and estimated RV systolic pressure (tricuspid regurgitation gradient) among 
apparently healthy individuals with a broad age range; 2) to evaluate whether RV 
systolic pressure is independently predicted by E/E’ in a healthy normotensive 
population without echocardiographic evidence of LV hypertrophy. 
 
METHODS 
 
Between January and June 2004 we prospectively screened all presumed healthy 
individuals, referred to our institution for a cardiovascular check-up, who underwent a 
transthoracic echocardiography.  For analysis we selected individuals, aged 18 years 
or older, without a cardiovascular history and in sinus rhythm, with a normal 
transthoracic echocardiogram, without structural heart disease and with a reliably 
measurable tricuspid regurgitation gradient. Excluded were subjects in whom 
abnormalities, such as significant valvular disease, hypertrophic cardiomyopathy, LV 
wall motion abnormalities or pericardial effusion were found during the 
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echocardiographic examination.  Also subjects with echocardiographic evidence of 
LV hypertrophy, defined as a LV mass index > 134 g/m² for men and a LV mass 
index > 110 g/m² for women, were excluded (13, 14).  Individuals with a history of 
hypertension or with resting systolic blood pressure > 140 mmHg and/or diastolic 
blood pressure > 90 mmHg were excluded. Subjects with a history of pulmonary 
hypertension, echocardiographic evidence of pulmonary hypertension, chronic 
obstructive pulmonary disease or pulmonary embolism were also excluded. The 249 
healthy individuals (130 men and 119 woman) who met the strict inclusion criteria 
and had a reliably measurable tricuspid regurgitation gradient were divided in 6 age 
categories: 67 subjects between 18 and 34 years, 45 individuals between 35 and 44 
years, 53 subjects between 45 and 54 years, 46 between 55 and 64 years, 27 
between 65 and 74 years and finally 11 subjects aged 75 years or more. 
 
Echocardiographic examination 
 
After 5 minutes resting, arterial blood pressure was measured at the right brachial 
artery. All patients underwent a standard echocardiographic examination with a 
VIVID 7 (Vingmed Ultrasound, GE, Horten, Norway) commercially available scanner. 
The examinations were performed by cardiologists or cardiologists in training. All 
studies were supervised by an experienced echocardiographist (level III, American 
Society of Echocardiography). Patients were examined in the left lateral recumbent 
position using standard parasternal short- and long-axis and apical views. Left 
ventricular dimensions were measured by 2-dimensional guided M-mode in the 
parasternal long-axis view. LV end-diastolic and end-systolic diameters (LVEDD and 
LVESD) as well as interventricular septum (IVSD) and posterior (PWD) end-diastolic 
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wall thickness were measured from leading edge to leading edge using the ASE 
convention (13). To assess global left ventricular systolic function the fractional 
shortening (FS) was calculated using the formula: (LVEDD-LVESD)/LVEDD * 100. 
RV end-diastolic diameter (RVEDD) was measured in parasternal long axis. Left 
atrial diameter (LAD) was measured in M-mode at the end of systole as the largest 
distance between the posterior aortic wall and the centre of the line denoting the 
posterior LA wall. Left and right atrial (RA) volumes were measured using the single 
plane area-length method in the apical 4 chamber view.  Average LV wall thickness 
was calculated as the sum of IVSD and PWD divided by 2. LV mass was calculated 
using the Penn formula: (1.04 [(LVEDD + posterior wall thickness + septal wall 
thickness)³ - (LVEDD)³]) – 14 g and was indexed for body surface (13, 14). LVEDD, 
LVESD, IVSD, PWD, RVEDD, LAD, LA and RA volumes were also indexed for body 
surface. RV function was evaluated by measuring the systolic displacement of the 
lateral portion of the tricuspid annular plane systolic excursion (TAPSE). TAPSE was 
recorded on the M-mode format under 2-dimensional echocardiographic guidance 
(15).   
 
Tricuspid regurgitation was graded as trace (grade 1) or mild (grade 2) by 
assessment of the colour-flow jet in relation to the RA in multiple orthogonal views. 
With continuous-wave Doppler, the maximum peak tricuspid regurgitation recorded 
from any view was used to determine the RV systolic pressure with the simplified 
Bernoulli equation (RV systolic pressure = 4V² + RA pressure). Pulmonary artery 
systolic pressure was assumed to equate the RV systolic pressure in the absence of 
pulmonic stenosis and RV outflow tract obstruction.  
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A 2-mm sized sample volume of the pulsed wave Doppler was placed between the 
tips of the mitral leaflets in the apical 4-chamber view. Early (E) and late (A) 
transmitral flow velocities, the ratio of early to late flow velocities (E/A), and 
deceleration time (DT) of E velocity were obtained. Pulse-wave tissue Doppler 
imaging was performed by activating the Doppler tissue imaging function in the same 
machine. Sample volume was located at the medial side of the mitral annulus. Early 
(E’) diastolic mitral annulus velocities and the ratio of E/E’ were obtained. The mean 
values of ≥2 different cycles were obtained.  
 
Statistical analysis 
 
Data were analyzed with the software program SPSS 11.5 (SPSS Inc, Chicago, Il, 
USA). Data in the tables are presented as mean ± standard deviation. Differences 
between age categories were studied with Analysis of Variance (ANOVA).  
Determinants of LV dimensions, LA diameters and E/E’ were evaluated with linear 
regression analysis. Spearman correlations were used to test the association of 
continuous variables with mean tricuspid regurgitation gradient. Multiple linear 
regression analysis was used to determine the slope of the association between 
tricuspid regurgitation gradients and continuous variables. Significance level p was 
set at 0.05. 
 
RESULTS 
 
The 249 included healthy individuals had mean systolic and diastolic blood pressure 
values of 123 ± 11 and 66 ± 12 mmHg; blood pressures were comparable between  
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Table 1: Ventricular and atrial dimensions according to age category 
  
AGE (years)  
Dimension 18-34 
N= 67 
35-44 
N = 45 
45-54 
N = 53 
55-64 
N = 46 
65-74 
N = 27 
≥ 75 
N = 11 
 
Overall   
P 
SBP (mmHg) 
DBP (mmHg) 
123 ± 11 
68 ± 9 
123 ± 10 
69 ± 9 
122 ± 10 
67 ± 10 
123 ± 14 
68 ± 11 
124 ± 10 
68 ± 9 
125 ± 8 
66 ± 12 
NS 
NS 
LVEDD (mm) 44.3 ± 4.2 45.0 ± 4.7 44.9 ± 4.7 44.4 ± 5.0 42.7 ± 5.2 43.4 ± 5.9 NS 
LVEDDind 
(mm/m²) 
24.9 ± 2.8 25.0 ± 2.4 24.1 ± 2.9 24.4 ± 3.0 23.7 ± 1.6 24.4 ± 2.9 NS 
LVESD (mm) 28.8 ± 4.1 28.6 ± 5.3 28.4 ± 4.0 28.4 ± 5.3 26.8 ± 4.9 27.1 ± 6.7 NS 
LVESDind 
(mm/m²) 
16.2 ± 2.4 15.9 ± 2.7 15.2 ± 2.4 15.6 ± 3.1 14.9 ± 2.5 15.3 ± 3.8 NS 
FS (%) 35 ± 7 37 ± 9 37 ± 7 36 ± 8 37 ± 9 38 ± 9 NS 
IVSD (mm) 8.3 ± 1.5 9.1 ± 1.3 9.5 ± 1.6 9.8 ± 1.3 10.0 ± 1.3 9.6 ± 1.3 < 0.0001 
IVSDind (mm/m²) 4.6 ± 0.8 5.0 ± 0.7 5.1 ± 0.8 5.3 ± 0.7 5.6 ± 1 5.5 ± 0.9 < 0.0001 
PWD  (mm) 8.6 ± 1.6 9.0 ± 1.4 9.6 ± 1.4 9.4 ± 1.3 9.8 ± 1.2 10.2 ± 1.5 < 0.0001 
PWDind (mm/m²) 4.8 ± 0.8 5.0 ± 0.7 5.1 ± 0.8 5.1 ± 0.6 5.5 ± 0.8 5.7 ± 0.7 < 0.0001 
RVEDD1 (mm) 28.2 ± 4.9 30.4 ± 5.2 30.2 ± 5.3 31.3 ± 5.2 31 ± 5.8 34.0 ± 2.7 0.04 
RVEDDind1
(mm/m²) 
15.6 ± 2.6 16.5 ± 2.3 15.9 ± 2.6 17.2 ± 2.4 17.2 ± 3.7 18.9 ± 3.1 0.01 
TAPSE (mm) 25.1 ± 4.1 24.6 ± 4.6 25.9 ± 4.7 25.6 ± 4.0 25.3 ± 3.0 22.7 ± 4.7 NS 
LAD (mm) 31.3 ± 4.2 32.8 ± 4.9 34.9 ± 6.0 37.0 ± 4.8 36.0 ± 4.2 37.5 ± 5.5 < 0.0001 
LADind  (mm) 17.4 ± 2.3 18.1 ± 1.9 18.5 ± 2.7 20.3 ± 2.8 20.1 ± 2.5 21.0 ± 2.7 < 0.0001 
LA vol² (ml) 37 ± 14 40 ± 14 43 ± 17 49 ± 20 50 ± 39 58 ± 39 0.004 
LA vol² ind 
(ml/m²) 
20 ± 7 22 ± 7 23 ± 7 27 ± 9 26 ± 11 32 ± 18 < 0.0001 
RA vol1 (ml) 37 ± 13 36 ± 12 43 ± 16 40 ± 16 42 ± 17 43 ± 24 NS 
RA vol1 ind 
(ml/m²) 
20 ± 7 20 ± 6 22 ± 7 22 ± 8 22 ± 7 24 ± 12 NS 
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Data are presented as mean ± standard deviation. 1Data available in 185 subjects. ²Data available in 
186 subjects. 
Abbreviations: SBP: systolic blood pressure, DBP: diastolic blood pressure, LVEDD: left ventricular 
end-diastolic diameter, LVESD: left ventricular end-systolic diameter, FS: fractional shortening, IVSD: 
interventricular septum end-diastolic thickness, PWD: posterior wall end-diastolic thickness, ind: 
indexed for body surface, RVEDD: right ventricular end-diastolic diameter. TAPSE: tricuspid annulus 
plane systolic excursion, LAD: left atrium diameter, LA vol: left atrium volume, RA vol: right atrial 
volume. 
 
the age categories (table 1). The mean BMI was 24 ± 3 kg/m² and mean body 
surface area 1.82 ± 0.20 m². The percentage male participants was slightly higher 
(52%) but with an even distribution over the age categories.  
 
LV and LA dimensions and LV mass according to age categories 
 
Mean LVEDD was 44 ± 5 mm, mean LVESD was 28 ± 5 mm and all subjects had a 
normal global LV systolic function (mean FS: 36 ± 8 %). Table 1 shows no significant 
differences between the age categories regarding LV dimensions and this holds true 
when the dimensions are indexed for body surface. With linear regression analysis 
LV diameters were predicted by body surface but not by age or gender.  
 
Mean IVSD was 9 ± 2 mm, mean PWD was 9 ± 1 mm and mean LV mass index was 
92 ± 17 g/m². In multivariate linear regression analysis LV mass index was predicted 
by age and gender. Table 1 shows that IVSD and PWD increased as subjects got 
older resulting in an increased average wall thickness and LV mass index (Figure 1). 
It is also apparent from table 1 that the LA diameters and LA volumes (available in 
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186 subjects) increased with age. With linear regression analysis LA dimensions 
were predicted by age and body surface but not by gender. 
 
Figure 1  
Mean values ± 95 % confidence intervals according to age categories of average wall 
thickness (left panel) and left ventricular mass indexed for body surface (right panel) 
 
 
 
RV and RA dimensions according to age categories 
 
RV end-diastolic diameters (available in 185 subjects) were higher in older subjects 
(table 1) and this was confirmed after indexation for body surface. Age, gender and 
body surface were independent predictors of RVEDD in multivariate linear regression 
analysis. RV function as assessed with TAPSE was normal and comparable between 
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the age categories.  No significant differences were observed between the age 
categories regarding RA volumes.  RA volumes were independently predicted by 
body surface area but not by age or gender. 
 
Diastolic parameters and estimated left ventricular end-diastolic pressure 
according to age categories (table 2) 
 
Mean E was 75 ± 17 cm/s, mean A 64 ± 17 cm/s, mean DT 202 ± 54 ms and mean 
E/A 1.3 ± 0.4. All these parameters were predicted by age (linear regression 
analysis); when subjects became older E decreased, A increased, DT prolonged and 
E/A decreased. Mitral annulus velocities (E’) measured at the medial annulus   
decreased with age (table 2). In multivariate analysis E/E’ was predicted by age 
(Table 2, Fig 2) and gender. 
 
Table 2: Diastolic function, and estimated left and right ventricular pressures 
 
AGE (years)  
Dimension < 35 
N = 67 
35-44 
N = 45 
45-54 
N = 53 
55-64 
N = 46 
65-74 
N = 27 
≥ 75 
N = 11 
 
Overall 
P 
 
E (cm/s) 
 
84 ± 14 
 
77 ± 16 
 
74 ± 20 
 
73 ± 13 
 
65 ± 17 
 
62 ± 16 
 
< 0.0001 
A (cm/s) 56 ± 10 56 ± 11 63 ± 16 75 ± 20 76 ± 18 76 ± 19 < 0.0001 
DT (ms) 186 ± 39 187 ± 45 210 ± 57 201 ± 50 232 ± 63 251 ± 87 < 0.0001 
E/A 1.5 ± 0.3 1.4 ± 0.3 1.2 ± 0.3 1.0 ± 0.3 0.9 ± 0.3 0.9 ± 0.4 < 0.0001 
E’ (cm/s) 11 ± 2 10 ± 2 9 ± 2 8 ± 3 7 ± 2 6 ± 1 < 0.0001 
E/E’ 7.8 ± 1.8 8.0 ± 2.0 9.0 ± 2.3 10.4 ± 3.2 10.5 ± 3.2 10.9 ± 2.0 < 0.0001 
TR grad 
(mmHg) 
18.3 ± 4.1 19.3 ± 5 20.8 ± 5.6 22.9 ± 4.7 23.5 ± 6.1 25.8 ± 9.3 < 0.0001 
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Data are presented as mean ± standard deviation.  
Abbreviations: E: early peak mitral flow velocity, A: late mitral flow velocity, DT: deceleration time, 
E/A: ratio of early and late mitral flow velocity, E’: early mitral annulus diastolic velocity, medial: E’ 
measured at the medial side of the mitral annulus,  E/E’: ratio of early mitral flow velocity and mitral 
annulus velocity, TR grad: tricuspid regurgitation gradient. 
 
 
Figure 2  
Mean values ± 95% confidence intervals according to age categories of the ratio of 
early peak mitral flow velocity E and early diastolic mitral annulus velocity E’  (E/E’) 
(left panel) and  maximum peak tricuspid regurgitation gradient (right panel). Overall 
p was derived with analysis of variance (ANOVA). 
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Tricuspid regurgitation according to age categories 
 
The mean tricuspid regurgitation gradient was 20.8 ± 6 mmHg (range 4 to 44 mmHg). 
The transvalvular gradient increased according to age (table 2, Figure 2). The 
parameters that correlated significantly with the tricuspid regurgitation gradients were 
age, BMI, systolic blood pressure, diastolic blood pressure, LA volume, IVSD, PWD, 
average wall thickness, LV mass index, FS, A, E’ (inverse correlation), E/A (inverse 
correlation) and E/E’ with r values ranging from 0.15 to 0.36 (p ranging from < 0.0001 
to < 0.05). The following variables were entered into a multiple linear regression 
model to predict tricuspid regurgitation gradients: age, BMI, systolic blood pressure, 
LA volume, LV mass index, fractional shortening and E/E’. Age (ß=0.1, p=0.003), LA 
volume (ß=0.05, p=0.01), fractional shortening (ß=0.22, p<0.0001) and E/E’ (ß=0.32, 
p=0.04) independently predicted right ventricular systolic pressure as estimated by 
the tricuspid regurgitation gradient (model R²= 0.32, p<0.0001).   
 
 
DISCUSSION 
 
 
This study shows that among carefully selected normotensive healthy individuals with 
a broad age range, both E/E’ and tricuspid regurgitation gradients increase 
significantly with aging. Moreover the E/E’ ratio was independently predicting the 
tricuspid regurgitation gradient.  
 
Aging is associated with several changes and adaptations in the cardiovascular 
system.  There is controversy, however, about to what extent these adaptations are 
part of a natural aging process, or a response to environmental factors. (16) Many of 
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these age related structural and functional changes in the heart are reflected by 
changes in echocardiographic parameters.  LV wall thickness, measured via M-mode 
echocardiography, increases progressively with age. (17) This is most likely caused 
by increased vascular loading on the heart. An age dependent increase in LV mass 
increases the stiffness of the left ventricle and promotes an increase in end-diastolic 
filling pressure. (8) Structural and functional changes within the LV myocardium are 
responsible for a reduced early diastolic LV filling rate reflected by smaller E waves 
on the transmitral flow pattern. Despite the slowing of LV filling early in diastole, more 
filling occurs in late diastole, due to a more vigorous atrial contraction, which 
produces an exaggerated A wave. (8) The augmented atrial contraction and the 
increased diastolic filling pressure result in left atrial enlargement which is reflected 
by increased LA dimensions. The prolonged DT slope reflects decreased LV 
compliance, as it takes longer for LA and LV pressures to equilibrate.  
 
All of these changes can also occur in hypertensive subjects. In the present study we 
did not only exclude subjects with a history of hypertension but blood pressure was 
actually measured, thereby guaranteeing that non-detected hypertensive subjects 
were also excluded. Even when applying these strict inclusion criteria, the present 
study confirms the findings of previous reports (18,19, 20):  LA dimensions, LV wall 
thickness and LV mass index increased with aging;  E decreased, A increased, DT 
prolonged,  E/A decreased and the E/E’ ratio increased. The upper limit of LA 
diameter was 25 mm/m² in our study. One study reports an upper limit of 24 mm/m² 
(based on a reference population aged 18-60 years) but this likely ignores age-
related increases in LA dimensions. (21) 
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Right ventricular systolic pressure can be assessed noninvasively by measuring the 
tricuspid regurgitation gradient plus right atrial pressure. Unfortunately various 
studies have used various estimates for the right atrial pressure, ranging from 5 (22, 
23) to 10 mmHg (10, 12). However, since 10 mmHg may be an overestimation in 
healthy individuals, we report tricuspid regurgitation gradients without adding an 
estimation of right atrial pressure. In clinical practice evaluation of the jugular vein or 
respiratory echographic changes of the inferior vena cava diameter can be used for 
the estimation of right atrial pressure.  
 
Tricuspid regurgitation gradients increased with age as reported in previous studies.  
Dib et al studied 134 echocardiographic normals (including 37 hypertensive patients), 
aged 20 to 85 years and found systolic pulmonary artery pressure increasing 
progressively with age with values up to 32±6 mmHg in 80 years old or more. (10) 
Aessopos et al studied 53 healthy persons; the tricuspid gradient ranged from 12.6 to 
29.3 mmHg. (11) They found no correlation with age but had deliberately excluded 
individuals aged 55 or more. Gradients ≥ 20 mmHg were found in 36% and they 
considered a gradient of 30 mmHg as the upper normal limit. (11) Dokainish et al 
studied 33 echocardiographically normal individuals, aged 90 to 100 years. (23) 
Mean pulmonary artery pressure was 31 mmHg ± 6. The authors concluded that, in 
the elderly, a pulmonary artery pressure ≤ 40 mmHg by echocardiography could be 
considered normal. McQuillan et al determined pulmonary artery systolic pressure 
(PASP) in 3790 echocardiographically normal subjects. (12) To calculate PASP the 
authors assumed that right atrial pressure was 10 mmHg in all cases. The mean 
tricuspid regurgitation gradient in their study was 18.3 ± 4.9 mmHg. This is 2.5 mmHg 
lower than the mean gradient in the present study but this could be explained by the 
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lower mean age in McQuillan’s study: 33 years versus 47 years in the present study. 
Age was found to be the strongest predictor of pulmonary artery pressure with an 
increase of approximately 1 mmHg per decade.   
 
Interestingly, McQuillan and co-workers found LV PWD and IVSD to be 
independently associated with pulmonary artery systolic pressure. They suggested 
that LV wall thickness might relate to pulmonary artery systolic pressure through 
diastolic dysfunction and the effects of decreased LV compliance and increased LV 
end-diastolic pressure with aging and in such conditions as systemic hypertension. 
However, McQuillan et al had no information available on diastolic function or left 
ventricular filling pressures, 3% of their patients had a history of arterial hypertension, 
blood pressure was not measured and it was not detailed whether increased LVMI 
was an exclusion criterion.  McQuillan et al report significant univariate correlations 
between tricuspid regurgitation gradient and age, BMI, LV wall thickness, LA 
dimension and LV systolic function. All of these correlations were also found in the 
present study next to LV mass index, diastolic function parameters (A, E/A, E/E’) and 
blood pressure. In multivariate linear regression analysis the tricuspid regurgitation 
gradient was independently predicted by age, LA volume, LV function and E/E’. This 
suggests but does not prove that the age related LV changes with increased wall 
thickness, diastolic dysfunction and increased left ventricular filling pressures could, 
at least in part, be responsible for the equivalent increase of the right ventricular 
systolic pressure at older age.  Other factors could be a decrease in the pulmonary 
blood flow, an increase in the mean pulmonary pressure and an increase in 
pulmonary resistance, presumed related to reduced compliance of the pulmonary 
vascular bed. (22) Moreover, not only the cardiovascular but also the pulmonary 
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system, is subject to aging and these structural and functional changes of the lungs 
could also explain higher right ventricular systolic pressures at older age. (25) 
 
Our findings support the need for age adjusted cut-off values for echocardiographic 
estimated ventricular pressures. As E/E’ ratios and tricuspid regurgitation gradients 
are increasingly used in clinical decision making and patient follow-up, age specific 
normal values of these parameters should be available, especially in the old and very 
old. 
 
LIMITATIONS 
 
The reported data are limited to adults, aged 18 years or more. The subjects included 
in this study were “presumed healthy” individuals undergoing a check-up. Although 
we took great care in selecting these normals it is possible that some of the subjects 
could have occult cardiovascular disease. However, all subjects had normal cavity 
dimensions and normal wall motion making severe coronary artery disease less 
likely.  Doppler measurement of tricuspid systolic pressure gradient is applicable only 
in a proportion of healthy subjects, characterized by a clearly definable tricuspid 
regurgitation Doppler signal. Persons with mild to moderate tricuspid regurgitation 
were considered healthy, though the presence of tricuspid regurgitation might be 
related to mild pulmonary abnormalities. Although patients with a history of  
pulmonary disease were excluded, the lack of objective evaluation of pulmonary 
status with spirometry is an important limitation of this study. The early diastolic mitral 
annulus velocities were recorded at the medial mitral annulus; values recorded at the 
lateral side are mostly higher resulting in a lower E/E’.  (23) 
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CONCLUSION 
 
 
The present study demonstrates in 249 healthy, normotensive individuals, aged 18 to 
82 years that aging is accompanied by an increase of LV wall thickness and LV mass 
index. These changes probably reduce LV compliance which induces elevated LV 
filling pressures as reflected by higher E/E’ values. The equivalent elevation of right 
ventricular systolic pressure as reflected by the increased tricuspid regurgitation 
gradient might be related to the increased LVMI through diastolic dysfunction. These 
data support the need for age adjusted normal values for echocardiographic 
estimated ventricular pressures, especially in the old and very old. 
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AIMS 
 
The aims of this study are to evaluate the effects of age, gender and left ventricular 
(LV) hypertrophy on the early diastolic mitral annulus velocity (E’) evaluated by tissue 
Doppler imaging and the ratio of the transmitral early peak velocity (E) evaluated by 
conventional Doppler over E’ (E/E’) in a wide age range of normal individuals and in 
patients with LV hypertrophy due to hypertension (1-6).  
 
METHODS 
Study population 
 
From January 2002 until December 2002 we evaluated all asymptomatic individuals 
without a history of cardiovascular or pulmonary disease who were referred for 
routine echocardiography at our department.  Subjects with atrial fibrillation as well 
as subjects in whom significant abnormalities (such as significant valvular disease, 
hypertrophic cardiomyopathy, LV systolic dysfunction, pericardial effusion, LV 
hypertrophy or pulmonary hypertension) were found during the echocardiographic 
examination were excluded.  In total, 174 individuals were included in the study. This 
study population represents 3% of all transthoracic echocardiographies performed 
during the study period at our department. 
 
To study the effect of LV mass on annular velocities, an additional 86 patients with a 
history of hypertension (defined as a blood pressure > 140/90 mmHg or taking 
antihypertensive medication) and previously documented LV hypertrophy on 
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echocardiography were evaluated.  All these patients were asymptomatic and 
exclusion criteria were similar as for the normal individuals. 
 
Echocardiographic examination 
 
All patients underwent a standard echocardiographic examination, using a VIVID 7 
(Vingmed, GE, Horten, Norway) scanner.  Patients were examined in the left lateral 
recumbent position using standard parasternal short- and long-axis and apical views.  
The LV dimensions and ejection fraction were measured by two-dimension guided M-
mode in the parasternal long-axis view.  Left ventricular end diastolic and end systolic 
diameters (LVEDD and LVESD) as well as septal and posterior enddiastolic wall 
thickness were measured using the Penn convention.  Left ventricular mass was 
calculated using the Penn formula: 1.04 ((LVEDD + posterior wall thickness + septal 
wall thickness) ³ - (LVEDD) ³) –14 g and was indexed for body surface area.  LV 
hypertrophy was defined as a LV mass index > 134 g/m² for men and a LV mass 
index > 110 g/m² for women (7,8).  
 
Sample volume (size 2 mm) of the pulsed wave Doppler was placed between the tips 
of the mitral leaflets in the apical four-chamber view.  Early (E) and late (A) 
transmitral flow velocities, the ratio of early to late peak velocities (E/A) and 
deceleration time of E velocity were obtained.  Pulsed wave tissue Doppler imaging 
was performed by activating the Doppler tissue imaging function in the same 
machine.  Sample volume was located at the septal side of the mitral annulus.  Early 
(E’) mitral annulus velocities and the ratio of E/E’ were obtained.  The mean values of 
at least two different cycles were obtained. 
 55
CHAPTER 1.2 
___________________________________________________________________ 
 
Statistical analysis 
 
Data are expressed as mean ± standard deviation.  Differences between the normal 
individuals and patients with LV hypertrophy were evaluated with the unpaired 
Student’s t test.  Determinants of E’ and E/E’ were evaluated by multiple linear 
regression analysis.  Differences across age groups were assessed by analysis of 
variance (ANOVA).  A p-value < 0.05 was considered as statistically significant. 
 
 
RESULTS 
 
In total 174 normal individuals were included (age 56±14 years, range 21-87 years, 
108 men).  Mean LVEDD was 47±6 mm and mean LVESD 30±6 mm with a 
calculated mean LV ejection fraction of 59±10% and mean LV mass index of 98±20 
g/m².  Mean E was 77±19 cm/s, mean A 69±19 cm/s, mean E/A 1.2±0.5, mean 
deceleration time 204±51 ms, mean E’ 8.2±2.5 cm/s and mean E/E’ 10.0±3.2. Table 
1 shows the results of the different diastolic parameters in the normal population 
according to 5 age groups: < 45 years (n=39, age 36±7 years), age 45-54 years 
(n=43, age 50±3 years), 55-64 years (n=40, age 59±3 years), 65-74 years (n=35, age 
69±3 years) and age > 74 years (n=17, age 78±4 years). 
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Multiple linear regression analysis, including age, gender and LV mass index, 
showed that E’ was only predicted by age (β= -0.54, p<0.001).  Figure 1 shows the 
values for E’ in the 5 age groups.  It can be noticed that E’ shows a steep decrease 
with age (p<0.005 in ANOVA).   
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In contrast, E/E’ was predicted by age (β=0.44, p<0.001) and gender (β=-0.22, 
p<0.01) but not by LV mass index.  Figure 2 shows the values for E/E’ in the different 
age groups according to gender. For both men and women, E/E’ showed a significant 
increase with age (p<0.001 in ANOVA).  Moreover, women had in general slightly 
higher values (p<0.05) for E/E’ compared to men. 
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In total 86 patients with hypertension and previously documented LV hypertrophy 
were included (age 62±14 years, range 24-88 years, 50 men).  Mean LVEDD was 
52±5 mm and mean LVESD 31±6 mm with a calculated mean LVEF of 62±10% and 
mean LV mass index of 151±22 g/m² (p<0.01 compared to normal individuals).  
Mean E was 81±18 cm/s, mean A 72±20 cm/s, mean E/A 1.2±0.5, mean deceleration 
time 203±53 ms, mean E’ 7.5±2.5 cm/s (p<0.01 compared to normal individuals) and 
mean E/E’11.7±3.5 (p<0.01 compared to normal individuals).  Table 1 shows the 
results of the different diastolic parameters in this population according to 5 age 
groups: < 45 years (n=11, age 37±6 years), age 45-54 years (n=13, age 52±3 years), 
55-64 years (n=22, age 60±3 years), 65-74 years (n=23, age 69±3 years and age > 
74 years (n=17, age 80±4 years). Stepwise multiple linear regression analysis, 
including age, gender and LV mass index, showed that E’ was only predicted by age 
(β= -0.41, p<0.001). Also E/E’ was only predicted by age (β=0.35, p<0.001) and not 
by gender or LV mass index.  
 
 
Figure 3 shows the values for E/E’ in normal individuals and patients with 
hypertension and LV hypertrophy.  E/E’ showed a significant increase with age in 
patients with hypertension and LV hypertrophy (p<0.001 in ANOVA).  Furthermore, 
for each age category patients with LV hypertrophy had slightly higher E/E’ values 
compared to normal individuals. 
 
 
 
 
 59
CHAPTER 1.2 
___________________________________________________________________ 
 
 
According to Nagueh et al (5), a ratio of E/E’>10 is a marker of elevated LV filling 
pressures.  The total number of normal individuals with E/E’ > 10 in the present study 
was 6/39 (15%) in the group < 45 years, 11/43 (26%) in the group 45-54 years, 19/40 
(48%) in the group 55-64 years, 22/35 (63%) in the group 65-74 years and 12/17 
(71%) in the group > 74 years.  The total number of patients with LVH and E/E’ > 10 
was 5/11 (45%) in patients < 45 years, 8/13 (62%) in patients 45-54 years, 14/22 
(64%) in patients 55-64 years, 15/23 (65%) in patients 65-74 years and 14/17 (82%) 
in patients > 74 years. 
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Ommen et al (6) suggested a cutoff value for E/E’ of 15 as a marker for elevated LV 
filling pressures.  Figure 4 shows the prevalence of normal individuals and patients 
with LV hypertrophy with E/E’ > 15 in the different age groups.  In normal 
asymptomatic individuals < 65 years, E/E’ > 15 was rarely noticed.  In contrast, in 
normal asymptomatic individuals ≥ 65 years, a significant proportion showed E/E’ 
values > 15. (14% in the group 65-74 years and 24% in the group older then 74 
years). 
 
 
 
DISCUSSION 
 
In this study we evaluated the effects of age, gender and LV hypertrophy on E’ and 
E/E’ in normals and in patients with LV hypertrophy due to hypertension. Age 
appeared to be the strongest determinant of E’ and E/E’ suggesting that both in 
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normals and patients with LV hypertrophy age dependent cut-off values should be 
taken into consideration. 
 
We documented across a wide age range a decrease of E’ of approximately 1 cm/s 
per decade and an increase of E/E’ of approximately 1 unit per decade both in 
normal individuals and in patients with LV hypertrophy due to hypertension.  This age 
dependency has important implications for the diagnosis of diastolic dysfunction or 
elevated LV filling pressures, especially in the elderly.  Nagueh et al (5) showed 
previously that the E/E’ ratio correlated well to pulmonary capillary wedge pressure 
measured invasively in 60 patients evaluated in the intensive care unit or in the 
catheterization laboratory.  An E/E’ ratio>10 detected a mean pulmonary capillary 
wedge pressure  > 15 mmHg with as sensitivity of 97% and a specificity of 78% while 
a ratio of 12 resulted in a higher specificity (88%) but a lower sensitivity (68%).  
Based on these and other studies a cut-off value for E/E’ of 10 has been increasingly 
used as one of the parameters to evaluate diastolic function and LV filling pressures 
(2).  Recently this cut-off value was also used in large epidemiological studies that 
evaluated the prevalence of systolic and diastolic LV dysfunction in the community 
(9,10).  In our normal individuals however, an E/E’ ratio > 10 was frequently 
encountered in individuals < 65 years (15% in the group < 45 years, 26% in the 
group 45-54 years, and 48% in the group 55-64 years).  Moreover, most 
asymptomatic individuals ≥ 65 years showed a ratio > 10 (63% in the group 65-74 
years and 71% in the group > 74 years) suggesting that this cut-off is probably to low 
for the evaluation of elderly subjects. 
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In a study of 100 consecutive patients referred for cardiac catheterization, Ommen et 
al (6) showed that E/E’> 15 identified an increased mean LV diastolic pressure (>12 
mmHg, measured by high-fidelity micro manometer-tipped catheters) with a 
predictive accuracy of 76% which was higher than the accuracies of parameters 
derived from transmitral or pulmonary venous flow signals.  The mean age of this 
population was 63 years and 61% were men.  In our study of normal asymptomatic 
individuals an E/E’ ratio > 15 was rarely found in individuals < 65 years (figure 4).  
However, in individuals ≥ 65 years, an E/E’ ratio > 15 was more frequently 
encountered (14% in the group 65-74 years and 24% in the group older then 74 
years).  Especially in women older then 74 years the normal data suggest that 
possibly an even higher cut-off for E/E’ should be used (figure 2).  This hypothesis 
needs however confirmation in further comparative studies in the elderly.   
 
Our multivariate regression analysis shows a relationship between gender and 
values of E/E’ in the normal population.  Women had indeed higher values than man 
across all age groups but the differences were small with wide confidence intervals.  
Comparable with these findings, Nikitin et al (11) reported recently in a smaller group 
of middle-aged normal individuals slight but significant sex-related differences for 
systolic and early diastolic velocities at different myocardial regions determined with 
colour TDI.  This age and gender dependency of E/E’ in normal individuals is very 
similar to the age and gender dependency that has been described for brain 
natriuretic peptides (12).  Normal values for these neurohormones that are 
increasingly used for the diagnosis and prognosis of heart failure and estimation of 
LV filling pressures are also higher in women and increase with age.   
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CONCLUSION 
 
In summary, our results strongly suggest that a single cut-off value for E/E’ for the 
evaluation of diastolic function or elevated LV filling pressures should not be used in 
clinical practice.  Instead age dependent normal values should be taken into 
consideration.  Also, women appear to have slightly higher normal values of E/E’ but 
differences are small.  Finally, the effect of left ventricular mass is only modest after 
correction for age and gender. 
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ABSTRACT 
 
The aims of the present study were 1) to evaluate the prevalence of ischemic mitral 
regurgitation (MR) in a large population of patients with documented coronary artery 
disease referred for echocardiography and 2) to assess whether IMR is an 
independent determinant of echocardiographically estimated left ventricular (LV) 
filling pressures. We studied 849 consecutive CAD patients (67±10 years, 76% men) 
without organic valvular disease.  Ischemic MR was semi quantitatively graded as 
absent or trace, grade I, grade II and grade III-IV by assessment of the colour-flow jet 
in relation to the left atrium in multiple orthogonal views. The ratio of early transmitral 
flow velocity (E) over mitral annulus early diastolic velocity (E’), E/E’,  was determined 
to estimate LV filling pressures. Ischemic MR was absent in 25% of the patients and 
28% had a grade II or more ischemic MR. Only 18% of the patients with preserved 
LV function  had a significant ischemic MR but up to 66% of the patients with poor LV 
function had a grade II or more MR. The E/E’ was independently predicted by age, 
gender,  LV ejection fraction but also by ischemic MR severity. Even mild ischemic 
MR was associated with an increase of this non-invasive marker of LV filling 
pressures.  
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INTRODUCTION 
 
The ratio of early transmitral flow velocity (E) over mitral annulus early diastolic 
velocity (E’) is a widely used non-invasive tool to estimate left ventricular (LV) filling 
pressures. (1,2)  The E/E’ value has also been shown to be a powerful predictor of 
survival in patients with coronary artery disease (CAD). (3) Bruch et al validated the 
use of E/E’ for estimation of filling pressures in patients with ischemic mitral 
regurgitation (MR). (4) Among CAD patients, changes in ventricular structure and 
function related to ischemia and remodelling can lead to MR. (5) A higher degree of 
ischemic MR is associated with a worse prognosis. (6,7,8) The present study 
evaluates the prevalence of ischemic MR in a large series of consecutive CAD 
patients and assesses whether ischemic MR is a determinant of E/E’ in CAD 
patients. 
 
METHODS 
 
We retrospectively analyzed 849 consecutive patients with a documented history of 
CAD (myocardial infarction, significant coronary stenosis and/or revascularisation), 
referred for transthoracic echocardiography. Patients with organic mitral or aortic 
valve disease such as prolaps, rheumatic valve disease or endocarditis were 
excluded. Patients with ischemic MR had as underlying mechanism a Carpentier type 
IIIb dysfunction correlating to restricted leaflet motion during systole secondary to 
papillary muscle displacement.  
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Echocardiography 
 
LV diameters were determined with 2D echocardiography (VIVID 7, GE, Horten, 
Norway).  LV mass was calculated using the Penn formula: 1.04 ((LV end-diastolic 
diameter + posterior wall + interventricular septum)³ - (LV end-diastolic diameter)³) –
14 g and was indexed for body surface area. LV systolic function was visually scored 
in 4 categories: LV ejection fraction >55%, 41-55%, 26-40%, and < 26%. Using 
pulsed wave Doppler the sample volume was placed at the mitral leaflets tips to 
assess the E value. E’ was determined at the medial mitral annulus using pulsed 
wave tissue Doppler and the E/E’ was calculated. Ischemic MR was semi 
quantitatively graded as absent or trace, grade I, grade II and grade III-IV by 
assessment of the colour-flow jet in relation to the left atrium in multiple orthogonal 
views.  
 
Statistical analysis 
 
Patients were divided in 4 categories according to MR severity and statistical 
comparisons were made with analysis of variance (ANOVA) using SPSS statistical 
software version 11.5 (SPSS Inc, Chicago, Il., USA). 
 
RESULTS 
 
The 849 included patients (76% men) had a mean age of 67±10 years ranging 
between 24 and 92 years. Mean LV end-diastolic diameter was 48±8 mm (range 24-
87 mm), mean LV end-systolic diameter was 34±10 mm (range 11-81 mm) and mean 
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LV mass index was 124±39 g/m² (range 51-302 g/m²). A preserved LV systolic 
function (EF>55%) was present in 53%, 24% had LVEF between 41-55%, 15% 
between 26-40% and 8% had a poor LV function (EF < 26%). 
 
 
Table 1 shows the distribution of ischemic MR severity. Figure 1 illustrates that in 
patients with a preserved LV function only 18% have a significant ischemic MR; this 
percentage increased as LV function became worse and up to 66% of the patients 
with poor LV function had a significant ischemic MR.  
 
Table 1: Left ventricular dimensions and filling pressures according to ischemic mitral 
regurgitation severity 
Ischemic Mitral Regurgitation  
Variable Absent 
(n=212) (25%) 
Grade I 
(n=395) (47%) 
Grade II 
(n=207) (24%) 
Grade III-IV 
(n=35) (4%) 
 
p value 
Left ventricular end-diastolic 
diameter (mm/m²) 
 
24 ± 4 
 
25 ± 4 
 
27 ± 4 
 
32 ± 6 
 
< 0.001 
Left ventricular end-systolic 
diameter (mm/m²) 
 
16 ± 4 
 
17 ± 5 
 
19 ± 5 
 
26 ± 8 
 
< 0.001 
Early transmitral flow velocity: E 
(cm/s) 
 
66 ± 24 
 
68 ± 25 
 
70 ± 30 
 
75 ± 42 
 
< 0.001 
Early diastolic medial mitral 
annulus velocity: E’ (cm/s) 
 
5.9 ± 2.0 
 
5.7 ± 2.2 
 
5.0 ± 1.8 
 
4.7 ± 1.9 
 
< 0.001 
 
E/E’ 
 
11.9 ± 4.8 
 
12.8 ± 5.6 
 
15.1 ± 7.0 
 
16.7 ± 9.3 
 
< 0.001 
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Figure 1: Distribution of ischemic mitral regurgitation (IMR) severity according to left 
ventricular ejection fraction (LVEF) 
 
 
 
 
As ischemic MR increased, LV dimensions increased (table 1). The E value 
increased and the E’ decreased as ischemic MR became more prominent resulting in 
higher E/E’ values in patients with MR grade III-IV. The E/E’ ratio was also 
determined by LV systolic function: in patients with preserved function the mean E/E’ 
was 13.4±4.8, in patients with LVEF between 41-55% 14.0±5.5, in patients with LVEF 
between 26-40% 15.7±.5.6 and in patients with poor LVEF it was 19.5±6.8 (overall p 
value < 0.001).  
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Figure 2 illustrates that E/E’ is determined both by LV systolic function and ischemic 
MR severity. Within each ischemic MR category patients with a worse LV function 
had a higher E/E’ value. Patients without MR and with preserved LV function had the 
lowest E/E’ value, patients with poor LV function and grade III-IV MR had the highest 
E/E’ ratio. Multiple linear regression analysis was used to fit a model to predict the 
E/E’ ratio. The following parameters predicted independently E/E’: mitral regurgitation 
severity (β=0.68, p<0.0001), left ventricular ejection fraction (β=0.68, p<0.0001), 
gender (β=-2.2, p< 0.0001), LV mass index (β=0.003, p=0.008), LV end-diastolic 
diameter (β=0.023, p=0.02) and age (β=0.059, p<0.0001). 
 
Figure 2: The early transmitral flow velocity (E) over mitral  annulus early diastolic 
velocity (E’) according to severity of ischemic mitral regurgitation (IMR) and according 
to left ventricular ejection fraction (LVEF) 
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DISCUSSION 
 
Bursi et al showed in 773 patients who underwent echocardiography within 39 days 
after myocardial infarction that the overall prevalence of MR was 40%. (8) In the 
present study including CAD patients with and without previous myocardial infarction 
the overall prevalence of ischemic MR was 53%; 28% of the patients had a 
significant MR and this increased up to 66% in patients with poor LV function.   
 
In the first validation studies on E/E’ by Nagueh and Ommen (1,2) patients with MR 
were excluded or not separately evaluated. Bruch et al (4) demonstrated that the E/E’ 
ratio also correlated significantly with LV end-diastolic pressure in patients with 
ischemic MR and showed that E/E’ > 15 had a 80% sensitivity and 100% specificity 
for prediction of LV end-diastolic pressure ≥ 15 mmHg. If we implement this cut-off in 
the present study,  a large proportion of the patients with IMR grade II or more have 
elevated LV end-diastolic pressures but also patients with a grade I ischemic MR and 
poor LV systolic function have E/E’ values ≥ 15. The poor prognosis of patients with 
more severe IMR could be related to the development of heart failure and higher LV 
filling pressures. 
 
It would also be interesting to investigate if patients with elevated E/E’ ratio at rest 
develop more severe MR during exercise. Recently, Lancellotti et al have extensively 
shown the importance of evaluating MR echocardiographically during semi-supine 
exercise. (9,10) Their results indicate that patients with a large increase in the degree 
of MR during exercise have a worse outcome. 
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ABSTRACT 
 
In this study we used Colour Tissue Doppler Imaging to assess global and regional 
mechanical dyssynchrony in patients with ischemic (IC) and idiopathic dilated 
cardiomyopathy (IDC). Potential differences in the area of latest mechanical 
activation could have practical implications regarding lead positioning and success 
rate of biventricular pacemaker implantation. 
 
INTRODUCTION 
 
Cardiac resynchronization therapy is a recent therapeutic option for patients with 
symptomatic heart failure, an impaired left ventricular systolic function and a broad 
QRS on the surface electrocardiogram (1-3). In order to avoid non-responders 
several novel echocardiographic tools have been introduced. These parameters 
should improve patient selection by identifying individuals with mechanical 
dyssynchrony (4). We used Colour Tissue Doppler Imaging to assess  
intraventricular dyssynchrony in patients with IC and in patients with IDC.  
 
The aim of the present study was to evaluate potential differences between patients 
with IC and IDC in global and regional parameters of dyssynchrony. We neutralized 
the confounding effect of severity of heart failure by comparing groups matched for 
New York Heart Association class and N-terminal prohormone Brain Natriuretic 
Peptide (NT-proBNP). To study the effect of QRS duration we included both small 
and broad QRS groups.   
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METHODS 
 
Study population 
 
From an ongoing registry for dyssynchrony we selected 4 groups of patients: Group 
1: IC & QRS < 120 ms, Group 2: IDC & QRS  < 120 ms, Group 3:  IC & QRS  ≥ 120 
ms, Group 4:  IDC & QRS ≥ 120 ms. Patients with IC had either evidence of previous 
(> 3 months) myocardial infarction or angiographic evidence of significant coronary 
artery disease with our without previous revascularization procedures. Groups 1 and 
2, as well as groups 3 and 4 were matched for left ventricular ejection fraction and 
severity of heart failure. Patients in atrial fibrillation were excluded.  
 
To assess the severity of heart failure, patients were classified by an experienced 
cardiologist according to the New York Heart Association. In addition blood samples 
were taken after overnight fasting and NT-proBNP levels were measured in 10 
microL of serum with an automated electrochemiluminescence immunoassay using 
an Elecsys 2010 (Roche Diagnostics).  
 
Echocardiography 
 
The echocardiographic studies were performed with a commercially available 
ultrasonographic system, equipped with a 2.5 to 3.5 MHZ transducer (VIVID 7, GE 
Vingmed Ultrasound). All subjects were examined in the left lateral recumbent 
position using standard parasternal short- and long-axis and apical views. Two-
dimensional and M-mode echocardiograms were obtained according to the American 
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Society of Echocardiography guidelines. Global left ventricular function was 
assessed by measuring left ventricular end-diastolic and end-systolic volume and left 
ventricular ejection fraction  using the modified biplane Simpson rule.  
 
Colour Tissue Doppler Imaging was performed using the apical 4, 2 and 3 chamber 
views to assess longitudinal myocardial regional function. Gain settings, filters and 
pulse repetition frequency were adjusted to optimize colour saturation. Sector size 
and depth were optimized for the highest possible frame rate. Three consecutive 
beats were recorded from each view and the images were digitally stored for offline 
analysis (EchoPac 3.1.0, GE Vingmed Ultrasound). From the 3 apical views a 6-
basal and 6-mid segmental model was obtained, namely the septal, lateral, inferior, 
anterior, anteroseptal and posterior segments at both basal and mid levels. In each 
segment the time from the beginning of the QRS complex to peak systolic motion 
(Ts) was measured.  The individual segmental Ts values were corrected for heart 
rate by dividing them by the square root of the RR interval; these values represent 
regional dyssynchrony.  
 
The following parameters of global dyssynchrony were calculated: The dispersion 
defined as the difference between the longest and shortest Ts of the basal septal, 
lateral, inferior and anterior segments and the standard deviation of Ts intervals 
measured at all 12 segments (SD 12) according to Yu et al (5) (6).  
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Statistical analysis 
 
Categorical variables were compared with a Pearson Chi Square test and group 
comparisons of continuous variables were made with an Independent Samples T-test 
making use of  statistical software (SPSS 11.5).  
 
RESULTS 
 
The clinical characteristics and global parameters of dyssynchrony of the 4 groups 
are shown in table 1. The larger number of IC patients is a reflection of daily clinical 
practice. As intended there were no significant differences between groups 1 and 2 
or between groups 3 and 4 concerning functional classification or NT-proBNP levels. 
No major differences where observed regarding medical treatment (Table 1).  
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The two parameters representing global intraventricular dyssynchrony (dispersion 
and SD12) were higher in the broad QRS groups compared to the small QRS groups 
(table 1).  In the small QRS groups an SD 12 higher than 32.5 ms (upper limit of 
normality according to ref 7) was noted in 34 % of the IC and 39% of the IDC 
patients. In the broad QRS groups 49 % of the IC and 65% of the ICD patients 
exceeded this limit. No significant differences in global mechanical dyssynchrony 
could be observed between IDC and IC patient groups. Regional mechanical 
dyssynchrony parameters did not differ significantly between IC patients with a small 
QRS and IDC pts with a small QRS.  The regional mechanical dyssynchrony within 
the broad QRS groups (groups 3 and 4) is graphically depicted in Figure 1.  
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For nearly all individual left ventricular segments a significant or highly significant 
difference could be observed between the IC and IDC broad QRS patient groups. 
The time to peak systolic motion was consistently later among the IDC patients with 
broad QRS compared to IC patients with broad QRS. In figure 2 the area of latest 
activation is shown for the 17 patients with IDC and a broad QRS (panel A) and the 
35 patients with IC and a broad QRS (panel B). The area of latest mechanical 
activation was predominantly located in the lateral segment for IDC patients whereas 
in IC patients it was more spread over all segments with the majority of latest 
activation situated in the inferior (26%) and lateral segment (37%). 
 
 
DISCUSSION 
 
Our results confirm previous reports concerning global parameters of intraventricular  
dyssynchrony (8) : the amount of dyssynchrony tends to be more pronounced in 
patients with heart failure and a broad QRS (49% & 65%) then in patients with heart 
failure and a narrow QRS (34% & 39%) interval. Ghio et al reported prevalences of 
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30 % in a narrow QRS group, 57% in patients with QRS between 120-150 ms & 71% 
in patients with QRS ≥ 150 ms. (9)  
 
We were not able to demonstrate a difference between IC and IDC patients 
regarding global mechanical dyssynchrony, nor could we demonstrate a difference in 
regional dyssynchrony parameters between IC and IDC patients with a small QRS 
interval. We do, however, report for the first time a significant difference in regional 
mechanical dyssynchrony between IC and IDC patients with broad QRS intervals. 
The time to systolic peak motion was significantly longer in the IDC group and this for 
nearly all LV segments (Fig. 1).   
 
Despite similar QRS width and heart failure severity patients may present with a 
different location of mechanical dyssynchrony, which seems to be related to the 
underlying etiology: the area of latest mechanical activation was mainly located in the 
lateral wall of the left ventricle for IDC patients. This is in accordance with previous 
publications based on other techniques to evaluate mechanical dyssynchrony. 
Sogaard et al used 3D echocardiography and tissue tracking to show in a small 
number of subjects that in patients with IDC the myocardium with delayed 
longitudinal contraction was tended to be located in the lateral and posterior walls of 
the left ventricle (10). In contrast they found that delayed longitudinal contraction was 
more frequent in the septum and in the inferior wall in patients with IC. Ansalone et al 
used Pulsed Wave Tissue Doppler Imaging to assess dyssynchrony in 31 patients 
with non-ischemic heart failure and left bundle branch block by measuring time 
between closure and re-opening of mitral valve (11).  The most delayed site in their 
study was the lateral site (35%).   
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The localisation of the area of latest mechanical activation could have practical 
implications towards the succes rate of biventricular pacing.  Standard coronary sinus 
lead positioning in biventricular pacing has mainly an effect on the activation of the 
lateral wall and its precisely here that latest activation is predominantly located in IDC 
patients whereas in IC patients the area of latest activation is not necessarily the 
lateral wall. Sogaard proved that individual tailoring of the interventricular delay with 
preactivation of regions showing mechanical asynchrony produced a further 
significant reduction in the extent of delayed contraction (10). Mehra pointed out that 
the definition of a successful implant should not be narrowed to merely accepting 
device implantation, but must include demonstration and identification of the precise 
area of ventricular asynchrony, followed by positioning the coronary sinus catheter in 
the optimal location to tackle the mechanical dyssynchronous contractility (12). We 
believe that colour TDI assessment of mechanical dyssynchrony offers a non-
invasive approach to resolve this problem.  
 
CONCLUSION 
 
In conclusion we have shown with colour TDI echocardiography that broad QRS 
patients with idiopathic dilated cardiomyopathy have a longer regional time to peak 
contraction compared to broad QRS patients with ischemic cardiomyopathy. Also 
their area of latest activation is more frequently located in the lateral wall. Regional 
dyssynchrony in small QRS patients and global calculated parameters of 
dyssynchrony are however not different between ischemic and non-ischemic 
cardiomyopathy patients. 
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ABSTRACT 
 
Aim 
The present study evaluates the prevalence of mechanical inter- and intraventricular 
dyssynchrony in heart failure patients with preserved left ventricular (LV) ejection 
fraction (EF).  
 
Methods 
We studied 138 heart failure patients (age 67±11 years, 76% men); 60 patients had a 
preserved LVEF (>40%). Using conventional Doppler echocardiography, 
interventricular mechanical delay (IVMD) ≥40ms was defined as interventricular 
dyssynchrony.  Using pulsed wave Tissue Doppler Imaging (TDI), time from 
beginning of QRS complex to onset of systolic motion was measured in 4 basal LV 
segments and a dispersion ≥60ms, was defined as intraventricular dyssynchrony.  
 
Results 
Prevalence of inter- and intraventricular dyssynchrony was lower in patients with 
preserved as compared to patients with reduced LVEF (17% vs 41%, p<0.01 for 
interventricular dyssynchrony, 18% vs 36%, p<0.01 for intraventricular 
dyssynchrony).  However, patients with preserved LVEF and QRS width  ≥120ms 
showed higher values for parameters for inter- and intraventricular dyssynchrony 
compared to patients with QRS width <120ms (IVMD 33±20 ms vs 20±16 ms, p<0.05 
and TDI dispersion 42±26 ms vs 33±22 ms, p<0.05).  In patients with QRS width ≥ 
120ms, prevalence of inter- and intraventricular dyssynchrony was comparable for 
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patients with preserved and reduced LVEF (42% vs 55%, p=ns for interventricular 
dyssynchrony and 45% vs 46%, p=ns for intraventricular dyssynchrony).   
 
Conclusion 
In conclusion, the prevalence of inter- and intraventricular dyssynchrony is low (17 
and 18% respectively) in heart failure patients with preserved LVEF.  However, in the 
presence of QRS width ≥120 ms, this prevalence raises to almost 50%, which is 
comparable to heart failure patients with reduced LVEF and QRS width ≥120 ms.  
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INTRODUCTION 
Cardiac resynchronization therapy is increasingly used in heart failure patients with 
reduced left ventricular (LV) ejection fraction (EF) (1-4).  However, as many as 30-
40% of all heart failure patients have a (nearly) normal LVEF.  Although mortality 
rates are lower, their hospitalisation rates are comparable to those of patients with 
reduced LVEF (5-7).  No studies have assessed the potential effect of biventricular 
pacing in these patients. Data on mechanical dyssynchrony assessed by 
echocardiography including Tissue Doppler Imaging (TDI) in these patients are 
scarce (8).  The aim of the present study was to evaluate the prevalence of inter- and 
intraventricular dyssynchrony in heart failure patients with preserved LVEF and 
compare the findings to heart failure patients with reduced LVEF.  In this multicenter 
study we used previously validated and more widely available conventional 
echocardiographic (9-12) and Pulsed Wave TDI (13,14) techniques to assess 
mechanical  dyssynchrony. 
 
METHODS 
 
Study population 
 
During the 6 months study period, controls and patients were enrolled in 12 centers.  
Controls were in sinus rhythm without cardiovascular disease, systemic disease or 
diabetes mellitus, with normal physical examination, electrocardiogram and 
echocardiography.  Individuals with hypertension (blood pressure ≥ 140/90mmHg or 
antihypertensive treatment) were excluded. Patients had ischemic or nonischemic 
cardiomyopathy with a broad range of LVEF and QRS duration. They were in New 
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York Heart Association class II or more.   Heart failure patients were divided into 
patients with preserved LVEF (> 40 %) and patients with reduced LVEF (≤ 40 %).  
Exclusion criteria were primary valvular heart disease or hypertrophic 
cardiomyopathy, atrial flutter or fibrillation and pacing.   
 
Echocardiography 
 
Studies were performed with the same ultrasonographic system (VIVID 7, GE 
Vingmed Ultrasound, Horten, Norway).  A training session was organized to 
standardize image acquisition. In each center images were recorded by the same 
level III echocardiographer. Subjects were examined in the left lateral recumbent 
position using standard parasternal short- and long-axis and apical views.  Two-
dimensional and M-mode echocardiograms were obtained according to the American 
Society of Echocardiography guidelines.  Global LV function was assessed by 
measuring LV end-diastolic and end-systolic volume and LVEF, using the modified 
biplane Simpson rule. 
 
Pulsed wave Doppler recordings across aortic and pulmonary valve were obtained 
from the apical 5-chamber view and the parasternal short-axis view.  Aortic and 
pulmonary preejection times were defined as time intervals between onset of the 
QRS complex and onset of aortic and pulmonary flow, respectively.  Interventricular 
mechanical delay (IVMD) was defined as the difference between aortic and 
pulmonary preejection times (9,10). M-mode tracings were recorded from the 
parasternal short axis at the papillary level of the mitral valve. Septal to posterior wall 
motion delay (SPWMD) was calculated as the shortest interval between the maximal 
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posterior displacement of the septum and the maximal displacement of the left 
posterior wall as described by Pitzalis et al (11,12).  
 
For the pulsed wave TDI recordings, velocities of long-axis wall motion were 
assessed in apical 4 and 2 chamber views during end-expiration, with a sample 
volume of 5 mm positioned at the basal septum, lateral, inferior and anterior 
segments. Three consecutive beats were recorded from each view and images were 
digitally stored for offline analysis (EchoPac PC version 3.1.0, GE Vingmed 
Ultrasound, Horten, Norway).  Time from beginning of QRS to onset of systolic 
motion was measured in the 4 basal segments of the left ventricle and the dispersion 
was defined as the difference between the longest and shortest time interval in these 
4 segments (13,14). Dyssynchrony analyses were performed centrally (Ghent 
University, Belgium) by 2 observers (JDS and NVDV).  The average value from 3 
consecutive beats was taken for each measurement.  Inter- and intraobserver 
variabilities were calculated from 10 subjects. 
 
Statistical analysis 
 
SPSS 11.5.1 (SPPS Inc, Chicago, USA) was used for statistical analysis.  Data are 
presented as mean ± SD or total number (%).  Also 75th and 95th percentile for the 
values in the normal subjects are given.  Paired and unpaired t test, Fisher’s exact 
test, and Pearson test were used when appropriate.  Analysis of variance (ANOVA) 
with post hoc testing was performed for group comparisons.  Intra and interobserver 
variability was determined by the coefficients of variance by comparing the SD of the 
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test differences as percentage of the average in both series.  Statistical significance 
was defined at p<0.05. 
 
 
RESULTS 
 
Characteristics of normal subjects and heart failure patients 
 
A total of 192 subjects were prospectively enrolled: 54 controls and  138 heart failure 
patients.  Controls (63% men) had an average age of 48±16 years, a mean LVEF of 
63±8% and a mean QRS width of 89±10 ms.  Table 1 shows the clinical 
characteristics of the heart failure patients divided in 4 groups according to LVEF and 
QRS width.  
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Feasibility and reproducibility of conventional and Pulsed Wave TDI 
measurements  
 
Aortic preejection time measurements were feasible in all subjects. Pulmonary 
preejection time could not be measured in only 2 normals (4%) and 2 patients (1%) 
because of poor visualization of the right ventricular outflow tract. SPWMD 
measurements were only possible in 39/54 normals (72%) and in 61/138 heart failure 
patients (44%). Pulsed wave TDI measurements were feasible in 97% of all 
segments in controls and in 93% of all segments in heart failure patients. 
Intraobserver variability was 3.5% for aortic preejection time, 4.7% for pulmonary 
preejection time, 18.7% for SPMWD and 3.8% for the intraventricular dispersion.  
Interobserver variability was 7.2% for aortic preejection time, 6.5% for pulmonary 
preejection time, 37.7% for SPWMD and 9.3% for the intraventricular dispersion 
measured by pulsed wave TDI.  
 
 
Measurements of inter- and intraventricular mechanical dyssynchrony 
 
Normal values are shown in table 2. For the conventional as well as the pulsed wave 
TDI parameters no significant correlations were found with age, LVEF or QRS width.  
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Results for heart failure patients according to LVEF and QRS width are shown in 
table 3.   
 
 
Echocardiographic dyssynchrony parameters were not related to age. There were 
significant positive correlations with QRS width (r=0.48, p<0.01 for aortic preejection 
time, r=0.50, p<0.01 for IVMD, r=0.36, p<0.01 for SPWMD and r=0.48, p<0.01 for 
pulsed wave TDI dispersion). Also, significant negative correlations were noted with 
LVEF (r=-0.38, p<0.01 for aortic preejection time, r=-0.30, p<0.01 for IVMD, r=-0.22, 
p=0.09 for SPWMD and r=-0.30 (p<0.01) for pulsed wave TDI dispersion).  Heart 
failure patients with a QRS width ≥ 120 ms had a longer aortic preejection time, IVMD 
and pulsed wave TDI dispersion as compared to patients with QRS width < 120 ms.  
This difference was present both in patients with preserved and reduced LVEF.  
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Similar trends were found for SPWMD although differences were not statistically 
significant. 
 
 
Prevalence of inter and intraventricular dyssynchrony  
 
The prevalence of interventricular mechanical dyssynchrony (defined as IVMD ≥ 40 
ms) was significantly lower in patients with preserved LVEF (10/60 patients, 17%) as 
compared to patients with reduced LVEF (32/78 patients, 41%, p<0.01).  Also the 
prevalence of intraventricular dyssynchrony (defined as a dispersion ≥ 60 ms 
assessed by pulsed wave TDI) was significantly lower in patients with preserved 
LVEF (11/60 patients, 18%) as compared to patients with reduced LVEF (28/78 
patients, 36%, p<0.01). However, in the presence of a QRS width ≥ 120ms, the 
prevalence of inter- and intraventricular dyssynchrony was higher and even 
comparable to heart failure patients with reduced LVEF and a QRS width ≥ 120ms 
(42% vs 55%, p=ns for interventricular dyssynchrony and 45% vs 46%, p=ns for 
intraventricular dyssynchrony). 
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Figure 1 shows the prevalence of interventricular mechanical dyssynchrony,  
assessed by conventional Doppler measurements, according to LVEF and QRS 
width.   
 
 
Figure 2 shows the prevalence of intraventricular dyssynchrony, assessed by Pulsed 
Wave TDI, according to LVEF and QRS width.   
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DISCUSSION 
 
The main findings of our study are the following: 1) the overall prevalence of inter- 
and intraventricular dyssynchrony is low in heart failure patients with preserved LVEF 
(17% for interventricular dyssynchrony and 18% for intraventricular dyssynchrony) 
but 2) in the presence of a QRS width ≥120 ms, this prevalence raises to almost 
50%, which is comparable to heart failure patients with reduced LVEF and QRS 
width ≥120 ms.   
 
As many as 30-40% of all patients with heart failure symptoms have a normal or 
slightly reduced LVEF. Also, in our study, the prevalence of heart failure with 
preserved LVEF was high (43%). Although the mortality rate of these patients is 
lower, their hospitalization rate for heart failure is comparable to that of heart failure 
patients with reduced LVEF (5-7). To the best of our knowledge no larger studies are 
published on the prevalence of inter- and intramechanical dyssynchrony in these 
patients. 
 
The prevalence of interventricular dyssynchrony was 17% in heart failure patients 
with preserved LVEF and this prevalence increased to 42% in patients with 
preserved LVEF and QRS duration ≥120 ms. This was similar to the prevalence of 
55% in patients with reduced LVEF and increased QRS width. Other studies reported 
similar interventricular dyssynchrony prevalence in patients with reduced LVEF.  
Bader et al (13), using a cutoff of 38 ms, reported a prevalence of 12% in small QRS 
and 34% in broad QRS patients.   Ghio et al (15), using a cutoff of 40 ms, found a 
prevalence of 12.5% in small QRS patients, 52% in patients with QRS between 120-
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150 ms and 72% in patients with a QRS width > 150 ms. In view of these similar 
results in patients with reduced LVEF, we believe that our findings in patients with 
preserved LVEF are valid and that interventricular dyssynchrony is mainly present in 
heart failure patients with preserved LVEF in the presence of an increased QRS 
width. It remains however to be proven, even in patients with an accepted indication 
for cardiac resynchronization, whether it is necessary to achieve interventricular 
synchronization or whether it is sufficient to correct LV intraventricular dyssynchrony 
(16,17).   
 
Using pulsed wave TDI, we report a prevalence of intraventricular dyssynchrony of 
18% in heart failure patients with preserved LVEF and this prevalence increased to 
45% in patients with preserved LVEF and QRS duration ≥120 ms. This was again 
similar to the prevalence of 46% in patients with reduced LVEF and increased QRS 
width. Salo et al (8) reported on the prevalence of mechanical dyssynchrony in 8 
patients with LVEF≥50% and NYHA class II-III heart failure.  They found arguments 
for dyssynchrony in 6 of the 8 patients (75%).   In the present study we found a 
clearly lower prevalence of intraventricular dyssynchrony which could be related to 
the larger sample size and different methodology. Already in 2002, Ansalone et al 
(18) showed the potential of pulsed wave TDI for selecting patients for biventricular 
pacing. More recently, measurements of electromechanical delays using pulsed 
wave TDI in 4 basal segments with calculation of the dispersion has been proposed 
as a marker of intraventricular dyssynchrony.  Penicka et al (14) showed that this 
parameter was the best predictive parameter of reverse remodeling in 49 heart 
failure patients with wide QRS treated with biventricular pacing.  Our 95th percentile 
in normals of 63 ms using pulsed wave TDI is very close to the suggested cut-off of 
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60 ms for therapy prediction (14).  Using a cutoff of 60 ms, our prevalence of 
intraventricular dyssynchrony in heart failure with reduced LVEF and increased QRS 
was 46% which is similar to the prevalence of 57% in the study by Penicka et al (14). 
Bader et al (21) reported a higher prevalence of 84% but these authors used a lower 
cutoff of 40 ms in a population of heart failure patients without myocardial infarction.  
Using colour TDI, different authors reported prevalences of intraventricular 
dyssynchrony in heart failure patients with reduced LVEF and increased QRS similar 
to our findings: 57% by Yu et al (19), 61% by Bax et al (20) and 57% in patients with 
a QRS width between 120-150 ms by Ghio et al (15).    
 
Finally, Pitzalis et al (11) proposed a simple M-mode parameter, the SPWMD as a 
marker for intraventricular asynchrony.  A prolonged SPWMD (> 130ms) was a 
predictor for clinical benefit and remodeling with biventricular pacing (11,12).  Our 
95th upper limit of normality of 137ms is close to the suggested cutoff of 130ms, but 
we were unable to measure SPWMD correctly in 28% of the normals and in 56% of 
the heart failure patients. Inter- and intraobserver variability was poorer as compared 
to the other echocardiographic parameters.  Although both patients with preserved 
and reduced LVEF and a QRS ≥ 120 ms showed higher mean values of SPWMD as 
compared to the other groups, differences did not reach statistical significance due to 
the larger standard deviations.   
 
STUDY LIMITATIONS 
 
Our study has some limitations. First, no evaluation of tissue tracking, strain or strain 
rate parameters was performed. It has been suggested that timing of myocardial 
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motion could underestimate the degree of asynchrony, in particular in the presence 
of ischemic heart disease. Noninvasive identification of specific abnormal but 
reversible strain and strain rate patterns could help to further improve patient 
selection for biventricular pacing compared to velocity imaging (22, 23).  However 
strain and strain rate analysis are not yet widely available and technical 
improvements are required to make data analysis easy applicable for routine clinical 
use. Secondly, as in most studies on dyssynchrony and cardiac resynchronization 
therapy, we did not evaluate patients in atrial fibrillation.  Further studies are needed 
in this specific group of heart failure patients. Finally, although heart failure patients 
with preserved LV function were selected with great care it is theoretically possible 
that a small percentage of these patients could in fact be heart failure patients with 
an impaired LVEF that improved under therapy. 
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ABSTRACT 
 
Background 
 
Patients with coronary artery disease (CAD), a QRS duration ≥120 ms and left 
ventricular ejection fraction (LVEF) ≤30% are potential candidates for cardiac 
resynchronization therapy (CRT). Our aim was to investigate the relationship 
between QRS duration, left ventricular volumes and prevalence of nonviable tissue in 
this patient population. 
 
Methods 
 
We studied 132 patients (118 men, age 68±5 years) with CAD and LVEF ≤30% 
(mean LVEF 24±6 %).  LV volumes and myocardial viability were determined by 
gated myocardial perfusion imaging. 
 
Results 
 
A QRS duration ≥ 120 ms was present in 91 patients (69%).  Although there were no 
differences in LVEF, patients with longer QRS durations had significant larger end-
diastolic and end-systolic volumes (p<0.01). Substantial non-viable tissue in the 
inferior or lateral wall was present in 29% of patients with a QRS duration ≥120 ms 
versus 7% of those with a QRS duration <120 ms (p<0.01).  
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Conclusions 
 
An increased QRS duration is associated with more advanced remodeling in patients 
with CAD and poor LV function. Almost one third of these patients with a prolonged 
QRS duration have no viable tissue in the inferolateral wall, an area that is usually 
stimulated with CRT.  
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BACKGROUND 
 
Cardiac resynchronization therapy (CRT) is considered as a potential therapeutic 
option in patients with heart failure, reduced left ventricular ejection fraction (LVEF) 
and an increased QRS duration.  Although functional improvements and effects on 
morbidity and mortality have been reported, up to 30 % of CRT patients do not 
respond to this therapy and this percentage could be even higher in patients with 
underlying coronary artery disease (CAD) (1-3).  One of the reasons could be the 
presence of non-viable tissue in the inferolateral wall which is usually paced when 
the LV lead is placed transvenously via the coronary sinus.  
 
AIMS 
 
Our study aims were to assess the relationship between QRS duration on the surface 
ECG, left ventricular volumes and the prevalence of nonviable tissue in patients with 
CAD and poor LV function.   
 
METHODS 
 
Study population 
 
We studied 132 consecutive patients with CAD and a resting LVEF ≤ 30 %.  The 
diagnosis of CAD was based on a history of myocardial infarction, coronary 
revascularisation or angiographic significant CAD (at least one vessel with ≥ 75 % 
stenosis).  All patients were studied more than 3 months after myocardial infarction or 
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revascularisation and patients with ventricular pacing on the resting ECG were 
excluded.  QRS duration was measured on a 12-lead surface ECG, at a speed of 25 
mm/s, from the resting ECG. 
 
Gated SPECT 
 
All patients underwent a resting gated myocardial perfusion SPECT study using 
technetium-99m tetrofosmin as described previously (4).  Quantified Gated SPECT 
software (QGS®, Cedars-Sinai, Los Angeles, CA, USA) was used to obtain resting LV 
ejection fraction and volumes. For viability scoring, the myocardium was divided in 5 
regions, anterior wall, lateral wall, inferior wall, septal wall and apex. The anterior, 
lateral, inferior and septal wall were subdivided in 3 regions (apical, mid and basal 
region), the apex was subdivided in 2 regions (5). A myocardial wall was considered 
to contain substantial non-viable tissue if none of the segments had a mean 
myocardial uptake higher than 55% of the maximum uptake in the myocardium on 
the resting perfusion images (6). 
 
 
Statistical Analysis 
 
Statistical analyses were performed using SPSS 11.0.1 statistical software (SPSS 
Inc., Chicago, USA). Spearman rank correlations, Mann-Whitney U and Kruskall-
Wallis testing were used to investigate relations between QRS duration and LV 
volumes and prevalences of nonviable myocardium according to QRS duration. 
 
 113
CHAPTER 2.3 
___________________________________________________________________ 
Ethics 
 
The study was approved by the local Ethics Committee of the Ghent University 
Hospital.  
 
RESULTS 
 
Mean age of the 132 patients was 68±5 years and mean LVEF was 24±6 %.    
Previous myocardial infarction was present in 86 (65%) and previous coronary 
revascularisation in 63 (48%) patients.  
 
According to the SPECT findings, the anterior wall was infarcted in 21 (16 %), the 
septal wall in 19 (14 %) and the inferolateral in 73 (55 %) patients.   
 
Patients were treated with ACE-inhibitors or AT-2 receptor blockers (n=98, 74%), 
beta-blockers (n=59, 45%) and diuretics (n=48, 36%).  
 
Mean QRS duration was 131±32 ms and a QRS duration ≥ 120 ms was present in 91 
patients (69%).  For the whole group QRS duration correlated significantly with LV 
enddiastolic volumes (r=0.31, p<0.001) and LV endsystolic volumes (r=0.30, 
p<0.001).  As compared to patients with small QRS, patients with QRS duration > 
120 ms had significantly higher LV enddiastolic volumes (248±77 vs 205±73 ml, 
p<0.01) and LV endsystolic volumes (193±68 vs 159±60 ml, p<0.01).  Figure 1 
shows the mean LV enddiastolic and endsystolic volumes according to four classes 
of QRS duration. No significant relation was found between LVEF and QRS duration. 
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The inferior or lateral wall was nonviable in 26 patients with a QRS duration ≥ 120 ms 
(29%).  This frequency was significantly higher than in patients with QRS duration < 
120 ms (29% vs 7%, p<0.01).  Prevalences of nonviable tissue in different regions for 
patients with QRS < 120 ms and QRS ≥ 120 ms are shown in figure 2. 
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CONCLUSION 
 
Our results indicate that a prolonged QRS duration (≥120 ms) is frequent in patients 
with CAD and LVEF ≤ 30% with a prevalence of almost 70%.  Similar to previous 
studies in patients with idiopathic dilated cardiomyopathy (7-9), this increase in QRS 
duration is clearly related to an increase in LV enddiastolic and endsystolic volumes, 
indicating more advanced remodeling in these patients.  More importantly, absence 
of viable tissue in the inferolateral wall in CAD patients with poor LV function is 
frequent, with a prevalence of 29% when QRS duration is increased as compared to 
only 7% when QRS duration is < 120 ms. This implicates that almost 30% of potential 
candidates for CRT with CAD have non-viable tissue in the inferolateral wall.  Since 
non-viable tissue is electromechanically non-functional (10) placement of the lead in 
the inferolateral region could lead to ineffective pacing in these patients (11). This 
could therefore be one of the explanations why CRT is ineffective in a substantial 
number of patients with CAD.  Further studies are however needed to determine 
whether viability assessment can help in the selection of candidates for CRT and in 
the determination of optimal lead localization. 
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ABSTRACT 
 
Objectives 
To evaluate the value of 64-slice computed tomography (CT) to visualise the cardiac 
veins and evaluate the relation between variations in venous anatomy and history of 
infarction. 
 
Background 
Cardiac resynchronization therapy (CRT) is an attractive treatment for selected heart 
failure patients. Knowledge on venous anatomy may help identifying candidates for 
successful left ventricular lead implantation. 
 
Methods 
The 64-slice CT of 100 individuals (age 61±11 years, 68% men) was studied. 
Subjects were divided in 3 groups: 28 controls, 38 patients with significant coronary 
artery disease (CAD), 34 patients with a history of infarction. Presence of the 
following coronary sinus (CS) tributaries was evaluated: posterior interventricular vein 
(PIV), posterior vein of the left ventricle (PVLV) and left marginal vein (LMV). Vessel 
diameters were also measured. 
 
Results 
CS and PIV were identified in all individuals. PVLV was observed in 96% of controls, 
84% of CAD and 82% of infarction patients. In patients with a history of infarction, a 
LMV was significantly less observed as compared to controls and CAD patients (27% 
versus 71% and 61% respectively, p<0.001). None of the patients with lateral 
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infarction and only 22% of patients with anterior infarction had a LMV. Regarding 
quantitative data no significant differences were observed between the groups. 
 
Conclusion 
Non-invasive evaluation of cardiac veins with 64-slice CT is feasible. There is 
considerable variation in venous anatomy. Patients with a history of infarction were 
less likely to have a LMV which may hamper optimal left ventricular lead positioning 
in CRT implantation. 
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INTRODUCTION 
 
Cardiac resynchronization therapy (CRT) has become an attractive treatment option 
for highly symptomatic heart failure patients with a broad QRS complex on the 
surface ECG and poor left ventricular (LV) systolic function. (1-3) In selected patients 
CRT reduces symptoms and improves exercise capacity. The CARE-HF trial also 
reported a significant reduction of morbidity and mortality, compared to optimized 
medical treatment. (4) However, in large randomized trials, up to 30% of the patients 
undergoing CRT do not respond favourably to this invasive treatment. (5) In order to 
improve the success rate, several issues including echocardiographic evaluation of 
mechanical dyssynchrony and the evaluation of viability in the target region for the 
LV pacing lead, should be addressed during the selection of potential candidates. (6) 
Another important pre-implantation issue is knowledge on the cardiac venous 
anatomy of the candidate. Even if viable tissue is identified in the region with the 
latest mechanical activation, endocardial CRT implantation will only be successful if 
the LV lead can be positioned in a vein draining this region. Ideally, venous anatomy 
should be assessed before implantation, non-invasively in the outpatient clinic, to 
determine whether a transvenous approach is feasible. The feasibility of multi-slice 
computed tomography (MSCT) to visualize the venous anatomy was recently 
demonstrated in a study with 16-detector row CT. (7) The authors described a 
marked variability in venous anatomy, confirming previous invasive studies. (8) The 
absence of coronary sinus tributaries may be related to scar formation secondary to 
previous myocardial infarction in the region drained by these specific veins. In the 
present study, the cardiac venous anatomy of 100 subjects undergoing non-invasive 
coronary angiography with 64-slice MSCT was retrospectively evaluated. The study 
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aims were 1) to evaluate the feasibility of 64-slice MSCT to depict the cardiac venous 
system and 2) to evaluate the relationship between variations in cardiac venous 
anatomy and previous myocardial infarction. 
 
METHODS 
 
Study population 
The anatomy of the cardiac venous system was retrospectively studied in 100 
consecutive subjects (68 men, age 61 ± 11 years) in whom MSCT was performed for 
non-invasive evaluation of the coronary arteries. The population was divided in three 
groups. Twenty-eight subjects had normal coronary arteries (controls). Thirty-eight 
patients had significant coronary artery disease (CAD) without a history of previous 
infarction. Thirty-four patients had CAD and a history of myocardial infarction; mean 
time between occurrence of the myocardial infarction and CT acquisition was 49 ± 7 
months. 
 
Multi-slice computed tomography 
Imaging was performed with a 64-detector row Toshiba Multislice Aquilion 64 system 
(Toshiba Medical Systems, Otawara, Japan). Between 80 and 110 ml of contrast 
material (Iomeron 400, Bracco Altana Pharma GmbH, Konstanz, Germany) at an 
injection rate of 5 ml/minute was used. Scanning was performed using simultaneous 
acquisition of 64 sections with a collimated slice thickness of 0.5 mm. Rotation time 
ranged from 400 to 500 ms depending on heart-rate and tube voltage was 120 kV at 
300 mA. A segmental reconstruction algorithm allowed inclusion of patients with a 
range of heart rates without the need for pre-oxygenation or beta-blocking agents. 
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Retrospective ECG gating was performed to eliminate cardiac motion artefacts. Data 
reconstruction was performed on a Vitrea post-processing workstation (Vital Images, 
Plymouth, Minnesota). 
 
Anatomic observations 
The tributaries of the cardiac venous system (Figure 1) were identified on volume-
rendered reconstructions. Thereafter, the course of the veins was evaluated in three 
orthogonal planes using multiplanar reformatting. The presence of the following 
cardiac veins was evaluated: CS, Anterior Interventricular Vein, Posterior 
Interventricular Vein (PIV), Posterior Vein of the Left Ventricle (PVLV) and Left 
Marginal Vein (LMV). The number of side branches of these tributaries was also 
evaluated.  
Figure 1. Volume-rendered reconstruction of the heart, posterolateral view. The first tributary of the 
Coronary Sinus (CS) is the Posterior Interventricular Vein (PIV), running in the posterior 
interventricular groove. The second tributary of the CS is the Posterior Vein of the Left Ventricle 
(PVLV) with several side branches (asterix). The next tributary is the Left Marginal Vein (LMV). The 
Great Cardiac Vein (GCV) will then continue as Anterior Cardiac Vein in the anterior interventricular 
groove. Also note the Circumflex Coronary Artery (CX) and Right Coronary Artery (RCA) 
. 
 
 124 
NONINVASIVE VISUALISATION OF CARDIAC VEINS IN CAD PATIENTS USING 64 SLICE CT 
_________________________________________________________________ 
Quantitative data 
The ostium of the CS was defined as the site where the CS makes an angle with the 
right atrium in the crux cordis area. Multiplanar reformatting was used to determine 
the size of the ostium in two directions (Figure 2). The diameters of the proximal 
parts of the PIV, PVLV and LMV were measured. The proximal diameter of the Great 
Cardiac Vein (GCV) and the distal diameter of the GCV before continuing its course 
in the anterior interventricular groove as Anterior Cardiac Vein were also evaluated. 
Finally, the distance between the origins of the various venous tributaries was 
measured on volume-rendered reconstructions (Figure 3). 
Figure 2. Measurement of the diameter of the Coronary Sinus in the antero-posterior 
direction, transverse plane (Panel A) and in the supero-inferior direction, coronal 
plane (Panel B). RA: right atrium, LA: left atrium, RV: right ventricle.  
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Figure 3. Example of measurement of the distance between the origins of the 
tributaries of the Coronary Sinus. (PIV: Posterior Interventricular Vein, PVLV: 
Posterior Vein of the Left Ventricle, LMV: Left Marginal Vein). 
 
 
 
Statistical analysis 
A statistical software program SPSS 12.0 (SPSS Inc, Chicago,Il, USA) was used for 
statistical analysis. Continuous variables are presented as mean ± standard 
deviation. Categorical variables are presented as absolute number (percentage). 
Analysis of variance (ANOVA) was used to study differences between the groups 
regarding continuous variables; Chi-square testing was used to study differences 
regarding categorical data. A p-value <0.05 was considered statistically significant. 
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RESULTS 
 
Baseline characteristics 
In Table 1, baseline characteristics of the individuals are summarized. Compared to 
controls, patients with significant CAD or a history of infarction were older and were 
more frequently male. They also had a higher frequency of cardiac risk factors 
including hypercholesterolemia, smoking and diabetes mellitus.  
 
Table 1. Baseline characteristics of the study population 
 Controls 
n = 28 
CAD 
n = 38 
Infarction 
n = 34 
p-value 
Age (yrs) 56 ± 11 64 ± 10 62 ± 11 0.02 
Male gender 14 (50%) 26 (68%) 28 (82%) 0.03 
LV ejection fraction 64 ± 9 % 58 ± 14 % 50 ± 13 % 0.0001 
Cardiac risk factors     
Hypertension 10 (40%) 17 (50%) 11(37%) NS 
Hypercholesterolemia 11 (44%) 24 (71%) 22 (73%) 0.047 
Smoking 4 (16%) 10 (29%) 14 (47%) 0.048 
Diabetes mellitus 9 (35%) 14 (40%) 3 (10%) 0.02 
Familial history CAD 7 (28%) 7 (21%) 12 (39%) NS 
CAD: coronary artery disease; LV: left ventricular. 
 
Left ventricular ejection fraction was significantly lower in patients with a history of 
infarction. Regarding the coronary artery lesions: none of the controls had significant 
coronary stenosis (by definition). In the CAD group, 10 patients had lesions occluding 
± 50% of the coronary lumen, 25 patients had lesions occluding ≥75% of the lumen. 
A significant stenosis was present in the left anterior descending coronary artery in 
78%, in the left circumflex coronary artery in 38% and in the right coronary artery in 
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30%. For patients with a history of infarction, these percentages were 88%, 46% and 
42% respectively. Regarding the location of the infarction, 23 patients (68%) had a 
previous anterior infarction, 4 (12%) a lateral infarction and 7 (21%) an inferior 
infarction. Twelve of the 34 infarction (35%) patients had a non-Q wave infarction, 22 
(65%) had a Q wave infarction. 
 
Anatomic observations 
No patients had to be excluded because of suboptimal study quality. The CS, 
Anterior Interventricular Vein and PIV were observed in nearly all patients (100%, 
100% and 99% respectively). The PVLV was observed in 96% of the controls, in 84% 
of the CAD patients and in 82% of the patients with previous infarction (p=NS). LMV 
was significantly less often identified in patients with a previous infarction as 
compared to CAD patients and controls (27% vs 61% vs 71%, p<0.001, Figure 4). An 
example of a patient with a previous infarction and absence of the LMV is presented 
in Figure 5. None of the patients with a history of a lateral infarction had a LMV, only 
22% of the patients with a history of an anterior infarction had a LMV whereas 43% of 
the patients with a previous inferior infarction had a LMV.  
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Figure 4. Presence of the Coronary Sinus (CS) and its main tributaries: Posterior Interventricular Vein 
(PIV), Posterior Vein of the Left Ventricle (PVLV) and Left Marginal Vein (LMV) in the three subsets 
(controls, patients with coronary artery disease (CAD) and patients with CAD and history of myocardial 
infarction).  
 
 
 
Figure 5. Example of absence of the Posterior and Left Marginal Vein in a patient with a history of an 
anterolateral infarction. Panel A: posterior view, Panel B: left lateral view. The only tributary of the 
Coronary Sinus (CS) and Great Cardiac Vein (GCV) is the Posterior Interventricular Vein (PIV). Also 
note the Obtuse Marginal (MO) branch of the Circumflex Coronary Artery and the Right Coronary 
Artery (RCA). 
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In the 12 non-Q wave infarction patients the PVLV was present in 11 patients (92%) 
and the LMV was present in 5 patients (42%). In the 24 Q-wave infarction patients 
the PVLV was only present in 17 patients (77%) and the LMV in 4 (18%) patients.In 
patients with a previous infarction, the presence of both a PVLV and LMV was 
significantly less often observed as compared to CAD patients and normals (26% vs 
61% vs 71%, p<0.01, Figure 6). Patients with a PIV exhibited one side branch in 7%, 
two side branches in 28% and three side branches in 2% of patients; 63% of these 
patients had no side branches. In the patients in whom a PVLV was identified, one 
side branch was observed in 2%, 2 side branches in 16% and 3 side branches in 1% 
of patients; 81% had no side branches. In patients with a LMV, one side branch was 
present in 4% and two side branches in 23% of patients, 73% of these patients had 
no side branches. No significant differences were observed between controls, 
patients with CAD with or without previous infarction regarding the number of side 
branches.  
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Figure 6. Prevalence of both the Posterior Vein of the Left Ventricle (PVLV) and the Left Marginal 
Vein (LMV), only the PVLV and neither PVLV and LMV according to subject category: controls, 
coronary artery disease (CAD) and myocardial infarction patients. 
 
 
 
Quantitative measurements from MSCT 
The quantitative measurements are presented in Table 2. Inter- and intra-observer 
agreement were assessed in 10 patients and were 94% and 97%. For all patients, 
the diameter of the CS in the supero-inferior direction was significantly larger as 
compared to the antero-posterior direction: 12.2 ± 3.3 mm versus 11.3 ± 3 mm (p = 
0.002). The more distant tributaries of the CS had smaller diameters. Within the three 
groups (controls, CAD patients or patients with previous infarction) no significant 
differences were noted. The distances between the origins of the different vessels 
were also comparable between the three groups. 
 
 
 131
CHAPTER 2.4 
___________________________________________________________________ 
Table 2. Quantitative measurements in venous anatomy from MSCT 
 
 Controls 
n = 28 
CAD 
n = 38 
Infarction 
n = 34 
p-value
Diameters      
CS antero-posterior (mm) 11.5 ± 2.4 11.2 ± 3.7 11.2 ± 2.9 NS 
CS supero-inferior (mm) 12.6 ± 3.2 11.7 ± 3.3 12.5 ± 3.3 NS 
GCV proximal (mm) 7.2 ± 1.4 7.0 ± 1.8 7.4 ± 1.4 NS 
GCV distal (mm) 4.9 ± 1.1 5.0 ± 1.0 5.1 ± 1.3 NS 
PIV (mm) 5.0 ± 0.7 5.2 ± 1.3 5.2 ± 1.3 NS 
PVLV (mm) 3.8 ± 0.7 3.9 ± 1.0 4.1 ± 1.1 NS 
LMV (mm) 3.1 ± 0.8 3.6 ± 1.5 5.3 ± 5.8 NS 
 
Distance between origin of  
    
PIV and PVLV (mm) 32 ± 17 27 ± 14 36 ± 22 NS 
PVLV and LMV (mm) 41 ± 13 39 ± 15 38 ± 17 NS 
PVLV and AIV (mm) 51 ± 16  55 ± 17 57 ± 10 NS 
LMV and AIV (mm)          45 ± 9 44 ± 14 46 ± 13 NS 
 
AIV: Anterior Interventricular Vein; CS: Coronary Sinus; GCV: Great Cardiac Vein; 
LMV: Left Marginal Vein; PIV: Posterior Interventricular Vein; PVLV: Posterior Vein. 
 
DISCUSSION 
 
The main findings in the current study are two-fold. First, non-invasive evaluation of 
the cardiac venous system in CAD patients is feasible using 64-slice MSCT. Second, 
variation of the cardiac venous anatomy in CAD patients appears related to a history 
of previous myocardial infarction; patients with previous infarction have significantly 
less left marginal veins. These observations may have important implications for 
selection of potential CRT candidates with a history of myocardial infarction. 
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Non-invasive evaluation of the cardiac venous system 
Until recently, the cardiac venous system could only be evaluated invasively using 
retrograde venography, either by direct manual contrast injection or after occlusion of 
the coronary sinus. (8,9) In 2000, few studies reported on the use of non-invasive 
imaging with electron beam CT to depict the cardiac venous system. (10,11) 
Recently, Mao et al analyzed the electron beam CT of 231 patients and 
demonstrated that this technique provides 3-D visualization of most components of 
the coronary venous system. (12) In 2003, Tada et al reported the feasibility of MSCT 
to obtain high quality three-dimensional images of the cardiac venous system in one 
patient. (13) Recently, preliminary studies were published on the value of 16-slice 
MSCT to evaluate the cardiac veins. (7,14,15) Since then, 16-slice MSCT is 
gradually being replaced by 64-slice MSCT, offering a higher spatial resolution with a 
decreased acquisition time. Abbara et al suggested that due to the shorter scanning 
time, venous opacification might be insufficient using scanning protocols tailored for 
imaging the coronary artery system. (14) However, the feasibility of depicting the 
cardiac venous system with 64-slice MSCT was clearly demonstrated in the present 
study. Despite a shorter scanning time, the CS and its tributaries could be evaluated 
in all individuals. Prominent side branches - suitable for insertion of pacemaker leads 
- were adequately visualized but the distal parts of side branches with a smaller 
diameter could not be detected in all patients. 
 
Variations in cardiac venous anatomy 
In the current report the accepted terminology for the CS and its tributaries of the 
Nomina Anatomica (English version) as described by von Lüdinghausen was used to 
permit comparison with previous studies. (16) Of note, in various studies the PIV is 
often described as the Middle Cardiac Vein. Both in anatomical series and imaging 
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series, either invasive venography or non-invasive evaluation with CT, a substantial 
variation in anatomy was reported.  
 
First, the CS was analyzed. The CS is the most constant component of the cardiac 
venous system and was detected in all patients. The diameter of the CS was larger in 
the supero-inferior direction as compared to the antero-posterior direction, indicating 
an oval shape of the ostium, confirming the 16 slice MSCT observations of 
Jongbloed et al. (7) and MRI observations by Wittkampf et al. (17). 
 
Secondly, the tributaries of the CS were evaluated. The PIV was observed in (nearly) 
all patients. The highest variability was observed in the number of tributaries between 
the PIV and the Anterior Interventricular Vein. In anatomical series the PVLV existed 
as a single large vessel in 63% of the cases (diameter ranging from 1.0 – 5.5 mm) 
and the prevalence of the LMV was between 73% and 88% of cases (diameter 
varying from 1.0 – 3.0 mm). (15) Meisel et al studied 129 patients referred for 
cardioverter-defibrillator implantation with invasive venography and noted a PVLV in 
55% and a LMV in 83%. (8) In studies using  noninvasive modality (Electron Beam 
CT or 16 slice MSCT), the prevalence of the PVLV varied between 13% and 80 % 
and the prevalence of the LMV between 38% and 93%. (11-14) The number of 
patients with CAD was not  specified in every study and data on the prevalence and 
site of infarction were frequently lacking. Mao and co-workers, analyzed 231 patients 
and found the CS in 100%, the PIV in 100%, the Posterior Vein in 78% and the 
Marginal Vein in 81%. (12) Abbara et al (14) included 54 patients with suspected 
CAD, referred for 16-slice MSCT. In 4 patients (7.4%) no LMV could be identified and 
in 11 (20.4%) patients no Posterior Vein could be found; however none of the 
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patients had a definite diagnosis of acute myocardial infarction. (14) Jongbloed et al 
studied 38 patients including 18 CAD patients. (7) The CS and PIV were observed in 
all patients, the PVLV was found in 95% and the LMV in 60% of patients. 
 
A novelty of the current study is the demonstration of an association between these 
anatomic variations and the history of a previous myocardial infarction. None of the 
patients with a previous lateral infarction had a LMV and patients with anterolateral 
myocardial infarctions and especially Q-wave infarctions were lacking the LMV. Post-
mortem studies on cardiac veins in ischemic heart disease are scarce. Hansen 
studied several series of patients who died from ischemic heart disease and detected 
thrombosis of the epicardial veins in large transmural infarctions. (18) In all cases the 
thrombosed veins were those draining the infarcted myocardium. (19) Indirect 
evidence supporting the association between previous infarction and absent cardiac 
veins is provided by Komamura et al who used thermodilution meaurements of great 
cardiac vein flow after reperfusion and demonstrated that salvaged myocardium after 
successful thrombolysis was not observed in patients demonstrating a progressive 
decrease in great cardiac vein flow. (20)  
 
Clinical implications 
The observation that patients with previous infarction are frequently lacking the LMV 
has important implications for the selection of potential candidates for CRT. 
Positioning the LV lead is the most challenging part of CRT implantation. Before 
referring the patient with previous infarction for CRT implantation, a triad of questions 
(Figure 7) has to be answered. First: where is the area of latest activation located? 
As shown by Ansalone et al, the best clinical response occurs in patients who had 
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their LV lead placed in or near the site of latest activation. (21)  Echocardiography 
with tissue Doppler imaging is an adequate non-invasive imaging modality to answer 
this question. (22,23) Second: does the area of latest mechanical activation not 
contain transmural scar tissue? Recently, Bleeker et al observed that patients with 
transmural posterolateral scar tissue on contrast-enhanced MRI failed to respond to 
CRT. (24) This observation underscored that assessment of LV dyssynchrony in 
patients with ischemic cardiomyopathy should be combined with assessment of scar 
tissue, to verify whether the region that will be targeted for LV pacing does not 
contain transmural scar tissue. After having identified the region of latest activation 
without scar tissue a final and third question has to be answered: are their cardiac 
veins, draining this target region, suitable for LV lead placement? MSCT can provide 
an answer to this question that appears important in patients with a history of 
myocardial infarction. If suitable cardiac veins are absent, a surgical approach is 
preferred over transvenous LV lead positioning. MSCT is a reliable technique to 
depict the cardiac venous system and the 3D reconstruction will also allow segmental 
classification to map the cardiac veins and tributaries in relation to the left ventricular 
wall in a manner comparable to that of echocardiography. (25) MSCT is able to 
detect anatomic and quantitative differences that may occur in CS and venous 
anatomy of heart failure patients who are candidates for CRT. MSCT will not only 
confirm the presence of a specific CS tributary but will also provide information on the 
course of the vessel, side-branches, the diameter, the distance from the CS and the 
relation with adjacent structures. Depending on the experience of the implanting 
cardiologist, no invasive venography at all or only selected venography of the target 
cardiac vein may be sufficient to implant the lead successfully, based on the MSCT 
data. In addition, information on cardiac venous anatomy acquired with MSCT could 
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possibly also be used during CRT implantation for 3-D navigation into the heart 
cavities and veins. (25) 
Figure 7. 
To improve the response rate to CRT, the left ventricular lead has to be positioned in the area of latest 
mechanical as can be identified with tissue Doppler imaging (TDI). The myocardium in this area 
should not contain transmural scar tissue, which can be evaluated with contrast-enhanced MRI. A 
transvenous approach will only be possible if a suitable vein draining this region is present, which can 
be detected by MSCT. 
 
 
 
LIMITATIONS 
 
The 64-slice MSCT scans were tailored for optimal visualisation of the coronary 
arteries. This could have caused suboptimal enhancement of the coronary veins, 
particularly of second and third degree side branches with a small diameter. Since 
atrial fibrillation is considered a contraindication for MSCT of the coronary arteries 
only patients in sinus rhythm were included. Prospective confirmation of the current 
findings, comparing venography and MSCT,  is needed in patients referred for CRT. 
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CONCLUSION 
 
Non-invasive evaluation of the cardiac venous anatomy with 64-slice MSCT is 
feasible. There is considerable variation in cardiac venous anatomy. Patients with a 
history of myocardial infarction were less likely to have a LMV possibly limiting 
optimal LV lead positioning for CRT. 
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 ADDENDUM 
 
Heart Failure patients with CAD and impaired LV function 
Flow Chart for the selection of potential CRT candidates 
 
 
1. Optimize medical treatment, consider cardiac rehabilitation and reevaluate 
 
2. Evaluate if the patient is elegible for CRT according to the classic criteria 
- NYHA class III/IV ? 
- QRS width > 120 ms? 
- LV ejection fraction < 35 %? 
 
3. Perform transthoracic echocardiography, including Tissue Doppler Imaging 
- evaluate ventricular dimensions and function 
- evaluate cardiac valves with emphasis on mitral regurgitation 
- consider semi-supine bicycle echocardiography in case of mild mitral regurgitation 
- evaluate dyssynchrony, identify area of latest activation  
 
4. Evaluate ischemia and viability with nuclear techniques or MRI 
 
a) If reversible ischemia is present consider revascularization. If CABG is 
scheduled, consider mitral valve plasty and epicardial LV lead positioning at 
the site of latest activation. Reevaluate the need for CRT post 
revascularization. 
 
b) If reversible ischemia is absent and the amount of scar tissue is limited 
perform a MSCT to visualize the cardiac venous system. If a suitable cardiac 
vein is identified refer the patient for transvenous CRT implantation. If not 
consider epicardial LV lead positioning. 
 
 
5. Check AICD indications  
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ABSTRACT 
 
Objectives 
 
To evaluate the prognostic value of impaired fasting glucose and diabetes mellitus 
(DM) in male patients (pts) with coronary artery disease (CAD) and a poor left 
ventricular function. 
 
Methods and results 
 
From a prospective database on patients referred for gated myocardial perfusion 
imaging between 1998 & 2002 all male pts with a history of CAD and poor left 
ventricular function were selected. Poor function was defined as left ventricular 
ejection fraction (LVEF) ≤ 40%. Subjects were categorized as nondiabetics with 
fasting blood glucose levels < 110 mg/dL, nondiabetics with impaired fasting glucose 
(fasting blood glucose between 110 and 125 mg/dL) and diabetics. Median follow-up 
was 2.7 years. End points were all cause mortality, cardiac death and hospitalization 
for heart failure. One hundred and sixty patients were selected (age 65±9 years & 
LVEF  29±8 %). In univariate analysis atrial fibrillation, NYHA class, glycemia and DM 
discriminated between survivors and non- survivors. In Cox multivariate regression 
analysis for all cause mortality only NYHA class and DM remained significant. Kaplan 
Meier analysis showed that diabetics had the worst survival and non-diabetics with 
glucose < 110 mg/dl had the best survival. Nondiabetics with impaired fasting 
glucose had intermediate survival. Analysis for cardiac death/hospitalization for heart 
failure showed similar results. 
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Conclusion 
 
In male patients with CAD and impaired LV function DM and fasting glucose are 
strongly predictive of poor outcome. Diabetics have the worst prognosis but 
nondiabetics with impaired fasting glucose also are at higher risk compared to 
nondiabetics with low fasting blood glucose. 
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INTRODUCTION 
 
Diabetes mellitus (DM) occupies a prominent notorious role among the risk factors 
for heart disease.  Many diabetics develop coronary artery disease (CAD) and DM is 
also linked to heart failure. Using data from the SOLVD trials and registry Schindler 
and coworkers showed that DM is an independent predictor of morbidity and 
mortality both in patients with symptomatic heart failure and in patients with 
asymptomatic left ventricular dysfunction. (1) Dries and coworkers demonstrated in 
the same SOLVD population that there is a differential impact of DM on mortality and 
heart failure progression according to the etiology of heart failure suggesting an 
interaction between diabetes and ischemic heart disease. (2) This was confirmed 
more recently by de Groote et al; their results suggest that DM is particularly 
deleterious in heart failure patients with an impaired function and ischemic 
cardiomyopathy. (3)  
The current American Diabetes Association criteria define diabetes mellitus from 
fasting blood glucose levels ≥ 126 mg/dL. Levels between 110 and 125 mg/dL were 
designated impaired fasting glucose. (4) Fisman et al showed in a population of  
nondiabetic patients with documented coronary artery disease that there was a 
substantially increased mortality rate among patients with impaired fasting glucose 
levels.  (5) In the present study  we evaluated the prognostic value of DM and fasting 
blood glucose levels among nondiabetics in a well definied population of male elderly 
adult patients with coronary artery disease and poor left ventricular systolic function.  
The study population was followed for a median period of 2.7 years and the following 
endpoints were taken into account: total mortality, cardiac death and hospitalization 
for heart failure. 
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METHODS 
 
Study design 
 
All male patients with CAD were selected from a prospective database comprizing 
2150 patients referred for a 2 day stress-rest gated myocardial single photon 
emission computed tomographic (SPECT) imaging study in the period ranging from 
October 1998 till December 2001. Diagnosis of CAD was based on a history of 
myocardial infarction, percutaneous coronary interventions (PCI), coronary artery 
bypass grafting (CABG) or angiographically significant CAD (at least one coronary 
artery with ≥ 75 % stenosis). In addition we further selected males with scintigraphic 
evidence of poor left ventricular systolic function: left ventricular ejection fraction 
(LVEF) ≤ 40 % as determined by 3D gated SPECT. Day to day variability of this 
technique in our hospital was < 5 % (6). Patients had to be stable [New York Heart 
Association (NYHA) class I-III] for the last three months.  
 
Study protocol 
 
Patients were informed to abstain from caffeine and nicotin containing products at 
least 24 h before testing and to visit the laboratory for exercise physiology after 
overnight fasting. 
 
Blood sample 
A venous blood sample was collected. Serum glucose was assayed by a standard 
hexokinase enzymatic method. For serum creatinine, a rate blanked kinetic Jaffé 
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method was used. Total serum cholesterol was assayed by the enzymatic 
colorimetric CHOD-PAP method of Allain et al. Serum High Density Lipoprotein 
(HDL) - cholesterol was determined by the homogenous enzymatic colorimetric 
method. For serum triglycerides the esterase PAP kinetic colorimetric reaction 
without glycerol correction was used. Low Density Lipoprotein (LDL) - cholesterol 
was calculated using the classical Friedewald formula. All serum parameters were 
determined at 37°C on a Modular system (Roche). All tests were performed 
according to an ISO 17025 Beltest accreditation.  
 
Two days stress-rest Tetrofosmin gated SPECT study 
Before starting the stress test length and weight of the patients were determined and 
body mass index (BMI) was calculated. After resting for 5 minutes arterial blood 
pressure was measured at the right brachial artery with a mercury 
sphygmomanometer. Stress and rest studies were performed in a 2-days protocol as 
decribed previously (6).  Bicycle stress testing was used in patients able to perform 
maximal physical stress (n=97, 61 %). When a patient was not able to perform 
maximal bicycle stress, an additional intravenous infusion of dipyridamole was given 
(n=45, 28 %). In patients unable to perform physical stress, only intravenous 
dipyridamole stress testing was used (n=18, 11 %).  Technetium-99m tetrofosmin 
was injected at peak stress. Imaging was started 15-30 minutes after injection at 
peak stress and 30-60 minutes after injection in the resting state. Gated images were 
processed to obtain LVEF. 
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Patient categories 
 
Patients were classified as diabetic if they were being treated with oral 
hypoglycaemic drugs or insulin and/or if they had a previous history of DM, 
documented on their medical chart and/or if they had elevated (≥126 mg/dL) fasting 
blood glucose. The others were considered nondiabetic and were devided into two 
groups: nondiabetics with fasting glucose < 110 mg /dL and nondiabetics with fasting 
glucose between 110 and 125 mg/dL (impaired fasting glucose).   Among the 
nondiabetics we identified individuals with the metabolic syndrome if they met with 
three out of five modified National Cholesterol Education Panel’s Adult Treatment 
Panel III criteria: 1) blood pressure ≥ 130 mmHg systolic and/or ≥ 85 mmHg diastolic, 
2) fasting glucose ≥ 110 mg/dL, 3) triglycerides ≥ 150 mg/dL, 4)  HDL-cholesterol < 
40 mg/dL  5) BMI ≥  27 kg/m². (7) BMI was used instead of a waist circumference 
>102 cm (for men) since these data were not available in our database. The use of 
BMI in stead of waist circumference has recently been adopted by Ridker et al (8) in 
an analysis of the Women’s Health Study and by Sattar et al in the West of Scotland 
Coronary Prevention Study (9). 
 
Follow-up 
 
Demographic data at study entrance were collected by history taking and physical 
examination on the day of the stress testing. Follow-up data were collected in 2003. 
One of the investigators (ODW), blinded to the exposure status, contacted patients’ 
general practitioners and reviewed hospital records. A standard questionnaire was 
used for follow-up interviews. The following events were taken into account: all cause 
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mortality, cardiac death and hospitalisation for heart failure. Cardiac death was 
defined as death caused by acute myocardial infarction, refractory congestive heart 
failure, clinically important cardiac arrhythmias and sudden death without another 
explanation. Follow-up was limited to 36 months. The study was approved by the 
local Ethics Committee of the Ghent University Hospital. 
 
Statistical analysis 
 
All statistical analyses were performed using SPSS 11.5 statistical software (SPSS 
Inc., Chicago, USA).  Data are shown as mean ± standard deviation (SD) or number 
(%). Unpaired Student t test was used to compare continuous variables and the 
Fisher Exact test was used to compare categorical variables. Cumulative survival 
rates as function over time were obtained by the Kaplan-Meier method. Differences 
in survival were analysed by log-rank testing.  Predictors of mortality were tested by 
univariate analysis. Significant parameters were entered into a stepwise multivariate 
Cox proportional hazards regression model.  Significance level was set at < 0.05. 
 
RESULTS 
 
Study population 
 
From the 2150 subjects 160 male patients with a history of CAD and a LVEF ≤ 40% 
could be selected. Mean age was 65 ± 9 years with a mean LVEF of 29 ± 8 %.  At 
the time of myocardial SPECT imaging 73 % of these patients had a history of prior 
myocardial infarction,  23 % a history of PCI and 33% previously underwent  CABG. 
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Clinical characteristics according to the metabolic status of the patients 
 
In table 1 the patients are presented according to one of the following groups: 
nondiabetics with fasting glucose < 110 mg/dL, nondiabetics with fasting glucose 
between 110 and 125 mg/dL (impaired fasting glucose) and diabetics. Age and LVEF 
did not differ between the groups. As expected highly significant differences were 
observed for fasting blood glucose levels between the 3 groups. Patients with 
impaired fasting glucose and DM had a higher BMI and were more symptomatic 
(according to NYHA class) than nondiabetics with glucose levels below 110 mg/dL. 
Revascularisation rates, either by PCI or CABG were comparable between groups. 
No significant differences were observed regarding blood pressure levels, lipid 
values, renal function and smoking habits. Drug treatment was comparable between 
the three groups. Among the patients without diabetes and low fasting glucose levels 
18 individuals (17%) had metabolic syndrome; among those with impaired fasting 
glucose 8 patients (44%) had metabolic syndrome (p<0.001). 
 
Prognostic significance of diabetes mellitus and impaired fasting glucose in 
patients with coronary artery disease and poor left ventricular function 
 
We prospectively followed all 160 subjects during a median period of 32.4 months 
(range 0.7 – 36 months).  During follow-up 25 patients died of which 15 deaths were 
considered cardiac and 8 patients were hospitalized for heart failure. Total mortality 
rate at the end of the study was 10/107 (9%, 4 cardiac deaths) in the normoglycemic 
patients, 4/18 (22%, 3 cardiac deaths) in the patients with impaired fasting glucose  
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Table 1  Clinical characteristics  
 
 Non-diabetics
Fasting 
glucose < 110 
mg/dL 
Impaired 
fasting 
glucose 110 – 
125 mg/dL 
Diabetics p value 
(ANOVA) 
N 
Age (years) 
BMI (kg/m²) 
LVEF (%) 
NYHA class 
Smoking 
 
Atrial fib 
Heart rate 
(beats/min) 
SBP (mmHg) 
DBP (mmHg) 
 
PCI 
CABG 
 
Glucose (mg/dL) 
Creatinine (mg/dL) 
Total-chol (mg/dL) 
HDL-chol (mg/dL) 
LDL-chol (mg/dL) 
Triglycerides 
(mg/dL) 
 
Antiplatelet agents 
B blockers 
ACE/AT2 blockers 
Digoxin 
Diuretics 
Calciumantagonist 
Statins 
Fibrates 
107 (67%) 
65 ± 10 
26 ± 4 
30 ± 7 
1.2 ± 0.5 
25 (25%) 
 
4 (4%) 
65 ± 14 
 
133 ± 20 
80 ± 10 
 
26 (24%) 
39 (36%) 
 
86 ± 12 
1.2 ± 0.8 
201 ± 36 
45 ± 14 
132 ± 31 
124 ± 59 
 
 
78 (73%) 
60 (58%) 
74 (71%) 
10 (10%) 
24 (23%) 
10 (10%) 
26 (25%) 
7 (7%) 
18 (11%) 
66 ± 7 
28 ± 5 
27 ± 9 
1.7 ± 1 
5 (28%) 
 
2 (11%) 
72 ± 15 
 
132 ± 19 
81 ± 7 
 
4 (22%) 
7 (39%) 
 
117 ± 5 
1.2 ± 0.3 
210 ± 52 
43 ± 12 
137 ± 43 
139 ± 62 
 
 
11 (61%) 
8 (53%) 
12 (80%) 
4 (27%) 
5 (33%) 
3 (20%) 
3 (20%) 
0 (0%) 
35 (22%) 
66 ± 7 
28 ± 5 
29 ± 7 
1.5 ± 0.8 
8 (28%) 
 
5 (14%) 
70 ± 14 
 
130 ± 12 
79 ± 12 
 
5 (14%) 
15 (43%) 
 
148 ± 69 
1.4 ± 0.9 
196 ± 44 
42 ± 12 
124 ± 42 
150 ± 70 
 
 
24 (69%) 
15 (43%) 
29 (83%) 
8 (23%) 
14 (40%) 
5 (14%) 
8 (23%) 
2 (6%) 
 
NS 
p< 0.05 
NS 
p< 0.001 
NS 
 
NS 
NS 
 
NS 
NS 
 
NS 
NS 
 
p< 0.0001 
NS 
NS 
NS 
NS 
NS 
 
 
NS 
NS 
NS 
p=0.05 
NS 
NS 
NS 
NS 
 
Abbreviations: BMI: body mass index, LVEF: left ventricular ejection fraction, 
NYHA: New York Heart Association, fib: fibrillation, SBP: systolic blood pressure, 
DBP: diastolic blood pressure, MI: myocardial infarction, PCI: percutaneous coronary 
angioplasty, CABG: coronary artery bypass grafting, chol: cholesterol, HDL: high 
density lipoprotein, LDL: low density lipoprotein, Antiplatelet agents (aspirin and/or 
ticlopidine and/or clopidogrel) B: beta, ACE: angiotensin converting enzyme, AT2: 
angiotensin 2 receptor, NS: non significant 
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and 11/35 (31%, 8 cardiac deaths) in the diabetics (overall p = 0.005 for all cause 
mortality and p = 0.002 for cardiac death). Hospitalization rates for heart failure in the 
three glucose groups were 4, 8 and 9 % respectively. 
 
Univariate analysis for all cause mortality 
Table 2 compares characteristics between survivors and non-survivors. Univariate 
associated with death were presence of atrial fibrillation, higher NYHA classification, 
fasting blood glucose levels and DM.   
 
 
Multivariate predictors of all cause mortality 
In a multivariate Cox proportional hazard model (chi square 18, p<0.0001) NYHA 
class  (Wald Statistic 6.4, p = 0.01) and DM (Wald Statistic 5.3,  p=0.02) were 
independent clinical predictors of all cause mortality. 
 
Kaplan- Meier survival curves 
Figure 1 shows survival curves for the studied population. Patients with DM have a 
worse survival compared to nondiabetics. Nondiabetics with impaired fasting glucose 
have an intermediar survival curve. In Figure 2 the combined end point of cardiac 
death and hospitalization for heart failure is depicted. Again diabetics had more 
events, nondiabetics with low fasting glucose had the lowest number of events and 
nondiabetics with impaired fasting glucose had an intermediar event rate.  
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Table 2 
Univariate analysis for all cause mortality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NA 
0.164 
0.949 
0.138 
p<0.01 
0.805 
p<0.01 
p<0.05 
0.984 
0.616 
 
0.297 
0.511 
 
p<0.05 
0.183 
0.678 
0.139 
0.965 
0.887 
 
0.08 
0.191 
0.288 
0.103 
0.255 
0.409 
0.358 
0.184 
25 
67 ± 9 
26.3 ± 5.6 
27 ±  6 
1.6±1 
7 (28%) 
11 (44%) 
6 (24%) 
132 ± 17 
79 ± 9 
 
3 (12%) 
11 (44%) 
 
119 ± 54 
1.33 ± 0.52 
204 ± 38 
47 ± 12 
131 ± 33 
130 ± 58 
 
14 (56%) 
10 (40%) 
20 (80%) 
6 (24%) 
9 (36%) 
4 (16%) 
4 (16%) 
0 (0%) 
135 
65 ± 9 
26.4 ± 4.2 
30 ± 8 
1.2±0.5 
31 (23%) 
24 (18%) 
10 (7%) 
132 ± 19 
80 ± 11 
 
32 (24%) 
50 (37%) 
 
100 ± 39 
1.25 ± 0.72 
201 ± 40 
43 ± 13 
131 ± 35 
132 ± 63 
 
99 (73%) 
73 (54%) 
95 (70%) 
16 (12%) 
34 (25%) 
14 (10%) 
33 (24%) 
9 (7%) 
N 
Age (years) 
BMI (kg/m²) 
LVEF (%) 
NYHA class  
Smoking 
Diabetes 
Atrial fib  
SBP (mmHg) 
DBP (mmHg) 
 
PCI 
CABG 
  
Glucose (mg/dl) 
Creatinine (mg/dl) 
Total chol (mg/dl) 
HDL-chol (mg/dl) 
LDL-chol (mg/dl) 
Triglycerides (mg/dl) 
 
Antiplatelet agents 
Beta blockers 
ACE/ATII antagonists 
Digoxin 
Diuretics 
Calcium antagonist 
Statins 
Fibrates 
 
p-value Deaths Survivors  
Abbreviations: BMI: body mass index, LVEF: left ventricular ejection fraction, 
NYHA: New York Heart Association, fib: fibrillation, SBP: systolic blood pressure, 
DBP: diastolic blood pressure, PCI: percutaneous coronary intervention, CABG: 
coronary artery bypass grafting, chol: cholesterol, HDL: high density lipoprotein, LDL: 
low density lipoprotein, B: beta, ACE: angiotensin converting enzyme, AT2: 
angiotensin 2 receptor 
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Figure 1 and 2 
 
Kaplan-Meier curves for all cause mortality (Fig 1) and the combined end point of 
cardiac death (death caused by acute myocardial infarction, refractory congestive 
heart failure, clinically important cardiac arrhythmias and sudden death without 
another explanation) and hospitalization for heart failure (Fig 2) in male patients 
with coronary artery disease and poor left ventricular function according to 3 
categories: nondiabetics with fasting blood glucose < 110 mg/dL, nondiabetics with 
impaired fasting glucose (fasting blood glucose between 110 and 125 mg/dL) and 
diabetic patients. 
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DISCUSSION 
 
In a well defined population of male CAD patients with impaired left ventricular 
systolic function DM and fasting blood glucose are predictors of poor outcome. 
Patients with DM had the worst prognosis but nondiabetics with impaired fasting 
glucose also had significantly more events than nondiabetics with low fasting blood 
glucose. 
 
It is well known that patients with CAD and an impaired left ventricular systolic 
function have in general a poor prognosis. (10) This was not different in the present 
study. After a median follow-up of 2.7 years 25 out of the 160 male elderly CAD 
patients died. A mortality rate of 16% despite the fact that most of these men were 
asymptomatic: 121 were in NYHA class I.  
 
Schindler et al demonstrated that patients in the SOLVD Treatment Trial (including 
patients with LVEF ≤ 35% and clinical evidence of heart failure) had higher morbidity 
and mortality rates if they had DM. (1) Also patients with a LVEF ≤ 35% in the 
SOLVD Prevention Trial but without a history of overt heart failure did worse if DM 
was present. (1) Although their observations is based on a large dataset, important 
information is lacking namely fasting blood glucose levels. The diagnosis of DM in 
the SOLVD  was based on self-report by the patient or documentation in the patient’s 
medical records. In the present study treatment with oral antidiabetics or insulin 
and/or fasting glucose ≥ 126 mg/dL (as recommended by the American Diabetes 
Association) were also taken into account to diagnose more correctly DM.  
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Dries et al retrospectively analyzed the patients in the SOLVD Prevention and 
Treatment Trials and showed that DM was strongly associated with an increased risk 
for all cause mortality in patients with ischemic cardiomyopathy, but not in patients 
with nonischemic cardiomyopathy suggesting that DM and ischemic heart disease 
interact to accelerate the progression of myocardial dysfunction. (2) They also 
demonstrated that previous surgical revascularization identified patients within the 
cohort with CAD and DM with improved prognosis. Based on these finding they 
concluded that the potential for revascularization may be particularly important in 
patients with ischemic cardiomyopathy and DM. Revascularisation procedures have 
shown to improve prognosis in patients with CAD and a depressed LV function. (11) 
Although the present study is to small to draw conclusions concerning the effect of 
revascularization on mortality in patients with impaired fasting glucose  one could 
speculate about the role of early revascularization in these patients since their risk is 
increased just as in patients with DM.  
 
More recently de Groote et al confirmed the findings from the SOLVD trial by 
studying 1246 patients with impaired left ventricular function. (3) They showed that 
the prognostic impact of diabetes mellitus is markedly influenced by the underlying 
aetiology and is particular deleterious in those with ischaemic cardiomyopathy. De 
Groote et al  had a better characterisation of diabetic status because they included 
fasting blood glucose values ≥ 126 mg/dL. The recent definition of DM using the 
threshold of 126 mg/dL was not based on either the risk for cardiovascular disease or 
for all-cause mortality. (4) So there is no reason to believe that the glucose-
cardiovascular relationship should not extend below the diabetes thresholds. 
Impaired fasting glucose, definied as a fasting blood glucose between 110 and 125 
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mg/dL by the American Diabetes Association is regarded by some as a prediabetic 
state. Fisman et al studied almost 12 000 patients with documented coronary artery 
disease screened for participation but not included in the Benzafibrate Infarction 
Prevention (BIP) study. Patients were devided into 3 groups on the basis of their 
fasting blood glucose concentrations at screening: (1) nondiabetic patients (glucose 
up to 109 mg/dL), (2) patients with impaired fasting glucose and (3) undiagnosed 
diabetic patients (glucose ≥ 126 mg/dL).  Mean follow-up was 6.2 to 9.0 years. All 
cause mortality was 14.3 % in nondiabetics, 20.1 % in patients with impaired fasting 
glucose and 24.3 % in undiagnosed subjects (P<0.001). Impaired fasting glucose 
was identified as an independent predictor of increased all-cause and ischemic heart 
disease mortality with hazard ratios of 1.39 and 1.29 respectively. Fisman’s study 
differs with the present study by the fact that patients with known DM (including 
pharmacologically treated patients) were excluded. Moreover no information was 
available in Fisman’s study regarding the left ventricular systolic function. 
 
The present study specifically investigates the prognostic role of DM but also of 
impaired fasting glucose levels in CAD patients with poor left ventricular function. As 
expected diabetics had most events but the event rate was also higher in 
nondiabetics with fasting glucose levels between 110 and 125 mg/dL. The worse 
prognosis in nondiabetics with impaired fasting glucose compared to nondiabetics 
with normal fasting glucose might be explained by a higher prevalence of the 
metabolic syndrome (44% versus 17%) among these patients; a logic consequence 
of the definition of metabolic syndrome since one of the conditions is fasting blood 
glucose ≥ 110 mg/dl. The metabolic syndrome was reintroduced in 1988 by Reaven 
as a link between insulin resistance, hypertension, dislipidemia and DM (12).   In the 
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past, many authors highlighted the prognostic importance of MS in the setting of 
primary prevention. However the number of papers addressing the prognostic 
significance of MS in secondary setting are scarce.  Anderson et al studied a large 
population of over 3000 subjects (65 % of them had advanced CAD as proven by 
coronary angiography) and observed a very high prevalence of 64 % with metabolic 
syndrome (13). They also investigated the predictive value of metabolic syndrome for 
incident death or non-fatal myocardial infarction and found that metabolic syndrome 
had no prognostic implications. However, when fasting glucose was assessed 
individually, a worse outcome was observed for patients with glucose levels ≥ 110 
mg/dL. The patients they studied had preserved left ventricular systolic function 
(averaging 61%) whereas we studied patiens with a poor LV systolic function.   
 
A single measurement of fasting blood glucose among men with CAD and poor 
systolic function provides important prognostic information. This finding suggests that 
CAD patients with impaired function should  ondergo screening for impaired fasting 
glucose. Whether a strategy of screening followed by aggressive treatment of both 
DM and impaired fasting glucose will result in better outcome deserves further 
investigation.  
 
 
STUDY LIMITATIONS 
 
Our study population was exclusive male and extrapolation of the findings to female 
patients should be performed with caution. Subjects were recruited from all patients 
referred to a large teaching hospital for myocardial perfusion imaging and exercise 
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testing. This could imply a certain degree of selection bias. Information on the 
duration of diabetes or on diabetic control (such as HbA1c) was not available. Blood 
glucose levels were determined only once; the American Diabetes Association 
requires elevated fasting glucose levels on at least two separate occasions to identify 
diabetics and patients with impaired fasting glucose. Even with this limitation a single, 
simple and inexpensive fasting blood glucose measurement provides important 
prognostic information in the studied population.  
 
CONCLUSION 
 
In male patients with CAD and impaired LV function DM and fasting glucose are 
strongly predictive of poor outcome. Patients with DM have the worst prognosis but 
nondiabetics with impaired fasting glucose also have a higher event rate compared to 
nondiabetics with low fasting glucose levels.  
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ABSTRACT 
 
Background 
 
Several studies have shown that longitudinal systolic function and left ventricular (LV) 
filling pressures, as assessed with tissue Doppler imaging (TDI), predict exercise 
capacity. 
 
Aim 
 
To evaluate whether natruretic peptides and inflammatory parameters can 
independently predict peak oxygen consumption (VO2max) on top of TDI derived 
markers. 
 
Methods 
 
We evaluated 142 patients (age 70±6 years, 77% men) with known or suspected 
coronary artery disease (CAD) and a preserved left ventricular ejection fraction 
(≥50%). All patients underwent bicycle-spiroergometry and NT-proBNP levels were 
determined. Cytokines (Interleukin-6, soluble TNF-receptors 1 & 2) and hsCRP were 
measured as inflammatory markers. TDI was applied to evaluate LV longitudinal 
myocardial velocities (Sm) and early mitral annulus velocities (E’). Ratio of early 
transmitral flow (E) to E’ was assessed as marker of LV filling. ANOVA, comparing 
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VO2max quartiles, was used to determine univariate predictors and linear regression 
to determine multivariate VO2max predictors. 
Results 
 
Average VO2max was 18.5±5.7 ml/kg/min (range 6-36.6). Compared to the highest 
quartile, patients with low VO2max were more frequently female (p<0.0001). NT-
proBNP and cytokine levels were significantly higher in the lower VO2max categories. 
Longitudinal myocardial velocities increased and E/E’ decreased along with 
increasing VO2max. In multivariate linear regression analysis VO2max was 
independently predicted by gender, glucose, Sm, E/E’ and cytokine levels.  
 
Conclusion 
 
VO2max in patients with known or suspected CAD and preserved systolic function 
was independently predicted by inflammatory makers on top of tissue Doppler 
derived systolic and diastolic function. 
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INTRODUCTION 
 
Maximum oxygen uptake at peak exercise (VO2max) is widely used to assess 
exercise capacity and provides prognostic information. (1,2) The exact mechanisms 
of exercise intolerance however are not fully understood. Attempts to correlate 
exercise capacity with traditional systolic function markers such as left ventricular 
(LV) ejection fraction (EF)  could only demonstrate weak correlations.  Simple 
diastolic function parameters (transmitral flow pattern) are more strongly correlating 
with exercise capacity than LVEF. (3-6)  
 Application of tissue Doppler imaging (TDI) has introduced novel non-invasive 
markers for both systolic and diastolic function including filling pressures. (7) Several 
of these parameters predict exercise capacity. A tool to estimate LV filling pressure is 
the ratio of early transmitral flow E to early diastolic velocity of the mitral annulus E’. 
(8,9) E/E’ is inversely correlated to exercise capacity. (10,11)  Longitudinal 
myocardial velocities, a more sensitive method to determine LV systolic function, also 
predict exercise capacity.  (12, 13) 
 Although both systolic and diastolic function are intrinsically related to 
VO2max, studies focusing only on echocardiographic parameters do not take into 
consideration other processes influencing exercise capacity such as natriuretic 
peptides and inflammation. The aim of the present study was to evaluate whether 
information on N-terminal pro-B type Natriuretic Peptide (NT-proBNP) and 
inflammatory markers (including CRP and cytokines) can independently predict 
exercise capacity on top of information on longitudinal systolic function and LV filling 
in patients with known or suspected CAD and preserved LV systolic function.  
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METHODS 
 
Patient population 
 
We evaluated 196 consecutive patients, age ≥ 60 years, with known or suspected 
CAD, referred for bicycle spiroergometry combined with 2 day stress-rest gated 
Single Photon Emission Computed Tomography (SPECT). Patients with severe 
valvular disease or with a history of heart failure were excluded. Patients were 
evaluated remote (> 6 months) from myocardial infarction, percutaneous coronary 
angioplasty (PCI) and coronary artery bypass grafting (CABG). Subjects had to be 
free from infections, systemic diseases, malignancies, treatment with corticosteroids, 
anti-inflammatory agents or any other situation influencing the inflammatory system. 
Since it s well known that both inflammatory cytokines and neurohumoral levels are 
increased in patients with poor LV systolic function, 54 patients with an ejection 
fraction < 50% on gated SPECT were excluded. The final population comprised 142 
patients. 
 
Study protocol 
 
Day 1:  Exercise testing 
 
Patients visited the exercise physiology laboratory after overnight fasting. Body mass 
index (BMI) was calculated as weight/height².  After resting 5 minutes, arterial blood 
pressure was measured, in sitting position,  at the right brachial artery with a mercury 
sphygmomanometer and a 12 lead electrocardiogram was recorded.  Each subject 
underwent maximal bicycle exercise testing. Standardized protocols, depending on 
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patient condition, were used: starting at 50 watts increasing 25 watts every 2 minutes 
(46%), or starting at 50 watts increasing 10 watts every minute (28%) or starting at 
25 watts increasing 10 watts every minute (23%).  Most of the patients were familiar 
with the procedure and were encouraged to exercise to exhaustion. Patients wore a 
tightly fitting facemask connected to an Oxycon Pro spirometer (Jaeger - Viasys 
Healthcare, Hoechberg, Germany). Oxygen consumption (VO2), carbon dioxide 
production (VCO2) and minute ventilation (VE) were measured on a breath-by-breath 
basis. A 12-lead ECG was continuously recorded and the heart rate was followed. 
Blood pressure was measured at each stage and at peak exercise. Subjects were 
exercised to their self-determined maximal capacity or until the physician stopped the 
test because of chest pain or dizziness, potentially dangerous arrhythmias or ST-
segment deviations, or marked systolic hypotension or hypertension. A respiratory 
exchange ratio  (RER; VCO2/VO2) > 1 was taken to indicate maximal effort. Peak 
VO2 was defined as the highest VO2 obtained at the end of the test, and was 
expressed in ml.min-1.kg-1. A 99m-technetium labelled perfusion agent (MIBI or 
tetrofosmin) was injected at peak stress. Perfusion imaging was started 15-30 
minutes later using a triple-headed camera (Picker Prism 3000, Marconi, Philips, 
Cleveland, Ohio, USA).  
 
Day 2: blood sampling and transthoracic echocardiography 
 
After overnight fasting patients came to the laboratory for venous blood sampling.  
Routine measurements (blood cell count, creatinine and glucose) were performed 
according to an ISO 17025 Beltest accreditation. Glomerular filtration rate (GFR) was 
calculated using a validated equation. (14) Serum was frozen at -80°C for further 
analysis. Patients were injected with a perfusion agent and resting myocardial 
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perfusion imaging was started 30-60 minutes later. Gated images were processed 
using Quantified Gated SPECT software to obtain resting LVEF.  
The same day patients underwent echocardiography with a VIVID 7 scanner 
(GE Vingmed Ultrasound, Horten, Norway). Sample volume of the pulsed wave 
Doppler was placed between the tips of the mitral leaflets in apical 4-chamber view. 
Early (E) and late (A) transmitral flow velocities, ratio of early to peak late velocities 
(E/A) and deceleration time (DT) of E velocity were obtained. Pulsed wave tissue 
Doppler was performed by activating this function in the same platform. Sample 
volume was located at the septal side of the mitral annulus. Early (E’) mitral annulus 
velocities and ratio of E/E’ were obtained. Colour tissue Doppler data were acquired 
in the apical 4 and 2 chamber views; sector width was adjusted to obtain frame rates 
> 100 frames per second. Three loops were digitally stored for off-line velocity 
analysis (Echopac for PC, GE Vingmed Ultrasound). Peak long-axis systolic (Sm), 
early diastolic (Em) and late diastolic velocities (Am) within the septal, lateral, inferior 
and anterior walls were obtained at the basal segment and averaged.   
 
Laboratory analysis 
 
Serum concentration of NT-proBNP was measured on an Elecsys 2010 apparatus 
(Roche Diagnostics, Mannheim, Germany) with an automated 
electrochemiluminescence sandwich immunoassay. Serum CRP concentrations 
were measured by a high-sensitivity, particle-enhanced immunoturbidimetric method 
on an Integra 400 analyser (Roche Diagnostics). Total imprecision in our laboratory 
was < 3 %. Soluble tumour necrosis factor receptors I and II: sTNFr 1 and sTNFr 2 
were measured with ELISA kits from BioSource (CA, USA) with sensitivities of 0.05 
and 0.1 ng/mL, respectively. Interleukin 6 (IL-6) was measured with a high sensitivity 
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ELISA kit from R&D (R&D Systems Europe, Abingdon, Oxon, UK) in which the total 
amount of IL-6 is  measured, thus bound and free fraction. Sensitivity is 0.1 pg/mL.   
 
Scoring of Perfusion Imaging 
 
Myocardial perfusion was scored semiquantitatively in a 17-segment model as 
described previously. (15) The summed stress score (SSS) and summed rest score 
(SRS) can be considered global perfusion scores of the LV myocardium during stress 
and resting conditions. The summed difference score (SSS-SRS) reflects the amount 
of myocardial ischemia with higher scores indicating worse perfusion. 
 
Statistical analysis 
 
Data were analyzed with a statistical software program (SPSS 11.5.1, SPSS Inc, 
Chicago, Illinois (USA)). Continuous variables are presented as mean ± standard 
deviation. Categorical variables are presented as absolute number and percentage. 
Patients were divided in 4 groups according to VO2max quartiles. Analysis of 
Variance (ANOVA) and chi square analysis were used when appropriate. The 
significance level p was set at 0.05. NT-proBNP, hsCRP, IL-6, sTNFr 1 & 2 were not 
normally distributed and underwent logarithmic transformation. Linear regression 
analysis was applied for multivariate analysis. 
 
Ethics 
The protocol was approved by the ethical committee of the University Hospital Ghent 
and each patient signed an informed consent form before participating. 
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RESULTS 
 
Basic characteristics and univariate determinants of VO2max 
 
In Table 1 basic characteristics are reported. Patients with lower exercise capacity 
had higher BMI, were more likely female, had higher NYHA class and had more 
frequently hypertension and diabetes mellitus. Exercise hemodynamic variables are 
listed in Table 2. Patients with the lowest exercise capacity reached lower heart-rates 
at peak exercise. Resting ejection fraction did not differ significantly between the 
VO2max quartiles. Analysis of myocardial perfusion showed no significant differences 
between the 4 groups regarding amount of myocardial ischemia. Diastolic function 
parameters, estimated LV filling and longitudinal myocardial velocities are presented 
in Table 3.  Patients in the lowest VO2max category had higher E velocities and lower 
E’ velocities resulting in higher E/E’ values.  Patients with lower systolic and diastolic 
longitudinal myocardial velocities reached lower VO2max. Biochemical univariate 
predictors of VO2max are presented in Table 4.  Lower VO2max was associated with 
higher NT-proBNP levels.  Leukocytes and inflammatory markers such as IL-6, 
sTNFr 1 and 2 were significantly increased in patients with the lowest VO2max.   
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Table 1: Baseline characteristics  
Quartiles of VO2 max  
1st quartile 
6-14.5 
ml/kg/min 
n = 35 
2nd quartile
14.6-17.9 
ml/kg/min 
n = 36  
3th quartile 
18.0-21.9 
ml/kg/min 
n = 35  
4th quartile 
22.0-36.6 
ml/kg/min 
n = 36  
 
p 
(ANOVA) 
Age (years) 71 ± 6 72 ± 7 70 ± 5 68 ± 5 NS 
Male gender 19/35 (54%) 25/36 (69%) 30/35 (96%) 35/36 (97%) < 0.0001 
BMI (kg/m²) 30 ± 5 27 ± 5 27 ± 3 26 ± 3 < 0.0001 
NYHA 1.3 ± 0.6 1.1 ± 0.8 1.1 ± 0.5 0.8 ± 0.6  0.001 
History of CAD 31/35 (89%) 26/36 (72%) 31/35 (89%) 27/36 (75%) NS 
Myocardial infarction 10/35 (29%) 15/36 (42%) 12/35 (34%) 12/36 (33%) NS 
PCI 14/35 (40%) 10/36 (28%) 16/36 (44%) 10/36 (28%) NS 
CABG 18/35 (51%) 13/36 (36%) 14/35 (40%) 14/36 (39%) NS 
Smoking 2/35 (6%) 4/36 (11%) 5/35 (14%) 2/36 (6%) NS 
Hypertension 25/35 (71%) 26/36 (72%) 26/35 (74%) 15/36 (42%) 0.010 
Diabetes mellitus 17/35 (49%) 11/35 (31%) 4/35 (11%) 2/36 (6%) < 0.0001 
Hypercholesterolemia 30/35 (86%) 28/36 (78%) 34/35 (97%) 29/36 (81%) NS 
Familial cardiac history 16/35 (46%) 11/36 (31%) 11/35 (31%) 18/36 (50%) NS 
CARDIAC DRUGS      
Aspirin 23/35 (66%) 25/36 (69%) 27/35 (77%) 26/36 (72%) NS 
Beta-blockers 29/35 (83%) 17/36 (47%) 25/35 (71%) 21/36 (58%) 0.011 
Digoxine 1/35 (3%) 0/36 (0%) 1/35 (3%) 1/36 (3%) NS 
ACE-I 17/35 (49%) 12/36 (33%) 10/35 (29%) 7/36 (19%) NS 
AT-II blockers 6/35 (17%) 8/36 (22%) 5/35 (22%) 4/36 (11%) NS 
Calcium antagonists 10/35 (29%) 10/36 (28%) 15/35 (43%) 3/36 (8%) 0.012 
Diuretics 13/35 (37%) 3/36 (8%) 6/35 (17%) 2/36 (6%) 0.002 
Spironolactone 2/35 (6%) 1/36 (3%) 0/35 (0%) 0/36 (0%) NS 
Nitrates 12/35 (34%) 10/36 (28%) 10/35 (29%) 7/36 (19%) NS 
Statins 20/35 (57%) 21/36 (58%) 19/35 (54%) 22/36 (61%) NS 
Fibrates 4/35 (11%) 1/36 (3%) 4/35 (11%) 1/36 (3%) NS 
Abbreviations: LV: left ventricular, BMI: body mass index, LVEF: left ventricular ejection fraction 
NYHA: New York Heart Association, CAD: coronary artery disease PCI: percutaneous coronary 
angioplasty, CABG: coronary artery bypass grafting, CHF: congestive heart failure, ACE-I: angiotensin 
converting enzyme inhibitors, AT-II blockers: angiotensin II receptor blockers  
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Table 2: Exercise testing results and myocardial perfusion imaging 
Quartiles of VO2 max  
1st quartile 
 
2nd quartile
  
3th quartile 
  
4th quartile 
  
 
p 
(ANOVA)
Heart-rate at rest (bpm) 65 ± 14 63 ± 12 60 ± 10 62 ± 10 NS 
SBP at rest (mmHg) 151 ± 27 153 ± 24 157 ± 22 144 ± 24 NS 
DBP at rest (mmHg) 82 ± 15 79 ± 12 79 ± 10 76 ± 12 NS 
Heart-rate at peak (bpm) 106 ± 19 117 ± 23 118 ± 20 135 ± 20 < 0.0001 
SBP at peak (mmHg) 194 ± 31 190 ± 31 189 ± 23 197 ± 24 NS 
DBP at peak (mmHg) 97 ± 16 90 ± 14 92 ± 9 90 ± 14 NS 
Watt at peak exercise 85 ± 27 97 ± 25 121 ± 23 156 ± 37 < 0.0001 
RER 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.1 ± 0.1 NS 
VO2 max (ml/kg/min) 11.8 ± 2.2 16.2 ± 0.9 19.7 ± 1.2 26.2 ± 3.7  
EF rest (%) 65 ± 9 65 ± 10 64 ± 9 61 ± 6 NS 
Summed Stress Score 4.4 ± 6.4 3.5 ± 4.8  3.7 ± 4.8 3.6 ± 4.9 NS 
Summed Rest Score 2.6 ± 3.7 2.6 ± 3.8 2.9 ± 5.2 2.3 ± 4.2 NS 
Summed Difference Score 1.3 ± 3.9 0.9 ± 3.8 0.8 ± 2.8 1.3 ± 2.2 NS 
 
Abbreviations: bpm: beats per minute, SBP: systolic blood pressure, DBP: diastolic blood pressure, 
RER: respiratory exchange ratio, VO2max: maximal oxygen uptake at peak exercise, EF: ejection 
fraction 
 
Multivariate determinants of VO2max. 
From the list of significant univariate predictors, the following (patho)physiological 
variables were selected to enter in a multivariate linear regression model predicting 
VO2max:  gender,  fasting glucose, Log(NT-proBNP), E/E’ (representing diastolic 
function), Sm (representing systolic function) and IL-6 (representing inflammation).  
Model fit: R² 0.34 (p<0.0001). The following variables independently predicted 
VO2max: gender (β=4.5 p<0.0001), fasting glucose (β=-3.2, p=0.04), E/E’ (β=-0.2, 
p=0.04), Sm (β=1.0, p=0.03) and Log(IL-6) (β=-3.8, p=0.004). If IL-6 was replaced by 
sTNFr 1 or 2 than these were also independent predictors of VO2max. Adding to the 
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model additional basic characteristics that differed between the exercise capacity 
groups such as diabetes mellitus, hypertension and BMI resulted in a highly 
significant model: R2 0.46 (p<0.0001). The following variables independently 
predicted VO2max: gender (β=3.7 p<0.0001), BMI (β=-0.5 p<0.0001), E/E’ (β=-0.21 
p=0.03), Sm (β=1.3 p=0.003), Log(IL-6) (β=-3.2 p=0.01). 
 
Table 3: Diastolic function, left ventricular filling pressures and longitudinal 
myocardial velocities 
Quartiles of VO2 max  
1st quartile 2nd quartile 3th quartile 4th quartile  
 
p (ANOVA)
E 80.6 ± 22.4 71.3 ± 15.3 74.1 ± 16.6 68.7 ± 17.3 0.04 
A 78.3 ± 20.1 82.5 ± 21.8 72.9 ± 13.8 69.9 ± 18.0 0.03 
DT 217 ± 55 202 ± 40 203 ± 43 211 ± 57 NS 
E/A 1.1 ± 0.5 0.9 ± 0.4 1.0 ± 0.3 1.0 ± 0.3 NS 
E’ 6.4 ± 1.7 6.5 ± 1.9 7.1 ± 2.0 7.4 ± 1.9 NS 
A’ 8.1 ± 2.4 9.2 ± 2.8 9.2 ± 2.4 9.0 ± 1.9 NS 
E/E’ 13.4 ± 4.9 11.8 ± 3.9 11.1 ± 3.4 10.0 ± 3.8 0.005 
Sm (cm/s) 4.7 ± 1.0 5.0 ± 0.9 5.2 ± 1.1 5.5 ± 0.8 0.004 
Em (cm/s) 5.2 ± 1.6 4.9 ± 1.5 5.6 ± 1.2 6.4 ± 1.5 < 0.0001 
Am (cm/s) 5.6 ± 1.8 6.6 ± 1.7 6.3 ± 1.2 6.7 ± 1.5 0.019 
 
Abbreviations: E & A: early and late transmitral flow velocity, DT: deceleration time, E’ & A’: early and 
late diastolic (medial) mitral annulus velocity; Sm: average systolic, Em: average early diastolic, Am: 
average late diastolic myocardial velocity of the basal septal, lateral, inferior and anterior wall 
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Table 4: Laboratory results 
 
Quartiles of VO2 max  
1st quartile 2nd quartile 3th quartile 4th quartile  
 
p (ANOVA)
Hematocrit (%) 42.6 ± 3.9 42.3 ± 2.9 43.4 ± 2.9 43.7 ± 2.6 NS 
Leukocytes  (10 E³/µl) 6.9 ± 2.1 6.0 ± 1.2 6.3 ± 1.3 5.8 ± 1.6 0.014 
Creatinine (mg/dL) 0.98 ± 0.24 0.97 ± 0.20 1.04 ± 0.19 1.04 ± 0.20 NS 
GFR (ml/min/1.73m²) 74 ± 16 77 ± 16 75 ± 13 78 ± 18 NS 
Glucose (g/dL) 1.17 ± 0.33 1.11 ± 0.36 1.03 ± 0.16 0.95 ± 0.13 0.005 
Log (hsCRP) 0.32 ± 0.45 0.36 ± 0.40 0.29 ± 0.34 0.25 ± 0.55 NS 
Log (NT-proBNP) 2.44 ± 0.44 2.23 ± 0.37 2.22 ± 0.33 2.10 ± 0.37 0.004 
Log (IL-6) 0.43 ± 0.31 0.34 ± 0.30 0.29 ± 0.32 0.23 ± 0.32 0.044 
Log (sTNFr 1) 0.51 ±0.16 0.46 ± 0.12 0.41 ± 0.87 0.40 ± 0.12 0.001 
Log (sTNFr 2) 0.99 ± 0.16 0.93 ± 0.14 0.88 ± 0.10 0.88 ± 0.14 0.003 
 
Abbreviations: GFR: glomerular filtration rate, hsCRP: high sensitive C reactive protein , NT-proBNP: 
N-terminal pro-B-type Natriuretic Peptide, IL-6: Interleukin-6, sTNFr: soluble Tumour Necrosis Factor 
receptor. 
 
DISCUSSION 
 
Exercise capacity is generated through complex interaction between the 
cardiovascular, respiratory and muscular system.  Physiologic conditions (e.g. aging)  
and  pathologic conditions affecting one or more of these systems can lead to 
impaired exercise capacity. The present study demonstrates among elderly patients 
with known or suspected CAD and preserved LV function, that VO2max is not only 
predicted by tissue Doppler parameters assessing filling pressures and longitudinal 
systolic function but also by inflammatory markers.  
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Diastolic function, LV filling pressures and longitudinal global systolic function 
as predictors of VO2max 
 
Although many patients with reduced  LV systolic function have impaired exercise 
capacity only weak correlations have been found between traditional markers of 
global (radial) LV systolic function and exercise parameters. Many reports however, 
including healthy individuals (3), CAD patients (6) and heart failure patients (4,5), 
have been published emphasizing the role of diastolic function as an important 
determinant of exercise intolerance.   
Some authors also studied the relation between exercise capacity and 
estimated LV filling pressure using TDI. Skaluba et al analyzed 121 patients with 
suspected CAD and normal EF, referred for exercise stress testing. (10) They found 
E/E’ to be the strongest independent predictor of reduced exercise tolerance.  A 
limitation was the indirect evaluation of exercise capacity with metabolic equivalents 
rather than with spirometry. Studies suggesting a better correlation of diastolic than 
systolic function with exercise capacity may reflect the insensitivity and load-
dependence of EF. Smart et al sought the correlation of more sensitive methods of 
quantifying systolic and diastolic function and filling pressures. (11) They analyzed 95 
patients with congestive heart failure (80% CAD, EF 31±10%) and found that peak 
VO2 did not only correlate with diastolic function and E/E’ but also with systolic 
velocities. Witte and co-workers used TDI to study longitudinal ventricular function in 
153 patients with chronic heart failure (LVEF<45%) and 87 age and sex matched 
controls and also found close correlations between systolic myocardial motion and 
VO2max. (12)  Skaluba et al investigated the relative contributions of LV systolic and 
diastolic function to maximal exercise capacity in 110 subjects referred for exercise 
testing. (13) Mitral annular velocities in systole and diastole each correlated 
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moderately with exercise tolerance. Patients with preserved LV function and reduced 
exercise capacity had lower systolic and diastolic mitral annular velocities. This 
suggests, but does not prove, that the longitudinal components of LV contraction and 
relaxation may be a physiologically important determinant of exercise capacity. 
Traditional measures of systolic function focus mainly on radial shortening and are 
insensitive to changes in longitudinal contractile function.  
 
The present study is in agreement with these previous studies and emphasizes the 
role of both diastolic and systolic function in the prediction of exercise capacity. Even 
in patients with a preserved LV function TDI detected small differences in longitudinal 
systolic velocities affecting exercise capacity. The previous studies were limited to 
evaluating only echocardiographic predictors of exercise capacity; the present study 
adds information on NT-proBNP and the inflammatory system. 
 
VO2max and NT-proBNP 
 
Several authors have studied heart failure patients with impaired systolic function and 
report that brain natriuretic peptide levels are related to peak VO2. (16, 17, 18, 19). 
Conraads et al demonstrated that combined endurance/resistance exercise training 
in patients with stable heart failure and LV dysfunction improved peak VO2 and 
reduced NT-proBNP concentrations. (20) Although baseline NT-proBNP levels 
correlated significantly with VO2max the observed decrease of NT-proBNP after 4 
months training was not related to the increase of VO2max. The authors suggest that 
the increased exercise capacity is the result of peripheral adaptations such as a 
decrease in left ventricular afterload.  
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In the present study patients with lower VO2max had higher NT-proBNP levels. In 
multivariate analysis however NT-proBNP levels did not independently predict 
exercise capacity in a model including E/E’. This could be related to the fact that 
levels of NT-proBNP are determined by increased LV wall stress which is in turn 
related to LV filling pressures and LV function.  
 
VO2max and inflammation 
 
Data on the relationship between exercise capacity and inflammatory markers, 
especially circulating, are scarce. Rahimi et al studied 209 patients with established 
CAD and found an inverse correlation between hsCRP and an estimation of exercise 
capacity. (21)  In the present study hsCRP levels were not significantly different 
between the VO2max quartiles.  Proinflammatory cytokines however were 
significantly higher in patients with low exercise capacity and they independently 
predicted VO2max in multivariate analysis. Lommi et al studied 58 patients, 44 had 
heart failure, and found inverse relations between 6 minutes walking distance and 
sTNFr 2 and IL-6. (22) A potential explanation for the relationship between 
proinflammatory cytokines and exercise capacity is their involvement in the 
pathogenesis of skeletal muscle pathology causing deconditioning.  Larsen et al 
studied 15 men (LVEF 33±5 %, VO2max < 20 ml/kg/min) and evaluated the effect of 
3 month aerobic exercise training on muscle fibre distribution, muscle characteristics 
and the relationship between muscle changes and cytokine levels. (23) Some of the 
changes in muscle morphometry were weakly correlated to IL-6, suggesting a link 
between cytokines and skeletal muscle pathology. Conraads and co-workers 
evaluated cytokines in 23 heart failure patients (EF 27%, 52% CAD) at baseline and 
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after 4 months exercise training. (24) They found significant correlations between 
peak VO2 and TNFα and sTNFr 2.  Moreover the training program improved peak 
VO2 and diminished cytokines among the CAD patients.  These authors suggest that 
the anti-inflammatory effect of exercise training could reverse the detrimental 
consequences of heart failure induced muscular adaptations.  Whether the link 
between elevated cytokines and lower exercise capacity in the present study are 
muscular adaptations is far from proven but is an attractive hypothesis. 
 
LIMITATIONS 
A minority of the patients had clinical, electrocardiographic or scintigraphic signs of 
myocardial ischemia during exercise testing. Ischemia could have influenced 
exercise results but quantitative perfusion analysis showed no relevant differences 
regarding reversible myocardial ischemia between the VO2max quartiles. Pulmonary 
and muscular function was not evaluated but patients with severe chronic obstructive 
pulmonary disease and patients with orthopaedic problems limiting exercise were not 
included. Patients were on optimal medical treatment; ACE-inhibitors, AT-II-receptor 
blockers and aldosterone antagonists could have influenced the neurohumoral axis; 
also statin treatment could have influenced inflammatory status. Blood samples were 
taken on day 2; exercise testing was done one day 1; some studies reported 
elevation of NT-proBNP as a result of exercise induced ischemia, however the 
duration of this possible effect has not been evaluated. 
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CONCLUSION 
 
In patients with known or suspected CAD, VO2max was  independently determined 
by inflammatory markers on top of tissue Doppler derived cardiac factors assessing 
LV filling and longitudinal global systolic function. 
 
ACKNOWLEDGEMENTS 
 
Roche Diagnostics provided NT-proBNP reagent as an unrestricted grant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 182 
VO2MAX: ROLE OF INFLAMMATION & TDI DERIVED CARDIAC FUNCTION IN CAD PTS 
_________________________________________________________________ 
REFERENCES 
 
1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of 
peak oxygen consumption for optimal timing of cardiac transplantation in 
ambulatory patients with heart failure. Circulation 1991;83:778-786. 
2. Corra U, Mezzani A, Bosimini E, Giannuzzi P. Cardiopulmonary exercise testing 
and prognosis in chronic heart failure. A prognosticating algorithm for the 
individual patient. Chest 2004; 126:942-950. 
3. Okura H, Inoue H, Tomon M, Nishiyama S, Yoshikawa T, Yoshida K, Yoshikawa 
J. Impact of Doppler-derived left ventricular diastolic performance on exercise 
capacity in normal individuals. Am Heart J 2000; 139: 716-722. 
4. Parthenakis F, Kanoupakis E, Kochiadakis G, Skalidis E, Mezilis N, Simantirakis 
E, Kanakari M, Vardos P. Left ventricular diastolic filling pattern predicts 
cardiopulmonary determinants of functional capacity in patients with congestive 
heart failure. Am Heart J 2000; 140: 338-344. 
5. Patrianakos A, Parthenakis F, Papadimitriou E, Diakakis G, Tzerakis P, Nikitovic 
D, Vardas P. Restrictive filling pattern is associated with increased humoral 
activation and impaired exercise capacity in dilated cardiomyopathy. Eur J Heart 
Fail 2004; 6: 735-743.  
6. Sakate Y, Yoshiyama M, Hirata K, Fujita H, Takeuchi K, Tachibana K, Fujii T, 
Yoshikawa J Relationship between Doppler-derived left ventricular diastolic 
function and exercise capacity in patients with myocardial infarction. Jpn Circ J 
2001; 65: 627-631.  
7. Oh J. Echocardiography as a noninvasive Swan-Ganz Catheter. Circulation 2005; 
111: 3192-3194. 
8. Nagueh S,  Middleton F, Kopelen H, Zoghbi W, Quinones M. Doppler tissue 
imaging: a noninvasive technique for evaluation of left ventricular relaxation and 
estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533. 
9. Ommen S, Nishimura R, Appleton C et al. Clinical utility of Doppler 
echocardiography and tissue Doppler imaging in the estimation of left ventricular 
filling pressures : a comparitive simultaneous Doppler-catheterization study. 
Circulation 2000;102;1788-1794. 
10. Skaluba S, Litwin S. Mechanisms of exercise intolerance. Insights from Tissue 
Doppler Imaging. Circulation 2004; 109: 972-977. 
11. Smart N, Haluska B, Leano R, Case C, Mottram P, Marwick T. Determinants of 
functional capacity in patients with chronic heart failure: Role of filling pressure 
and systolic and diastolic function. Am Heart J 2005; 149:152-8 
12. Witte K, Nikitin N, De Silva R, Cleland J, Clark A. Exercise capacity and cardiac 
function assessed by tissue Doppler imaging in chronic heart failure. Heart 2004; 
90: 1144-1150 
13. Skaluba S, Bray B, Litwin S. Close coupling of systolic and diastolic function: 
combined assessment provides superior prediction of exercise capacity. J Card 
Fail 2005; 711: 516-522 
14. Anavekar N, McMurray J, Velazquez E, Solomon S, Kober L, Rouleau JL, White 
H, Nordlander R, Maggioni A, Dickstein K, Zelenskofske S, Leimberger J, Califf R, 
Pfeffer M. Relation between renal dysfunction and cardiovascular outcomes after 
myocardial infarction. N Engl J Med 2004; 351: 1285-1295. 
15. De Winter O, Velghe A, Van de Veire N, De Bondt P, De Buyzere M, Van De 
Wiele C, De Backer G, Gillebert T, Dierckx R, De Sutter J. Incremental prognostic 
 183
CHAPTER 3.2 
___________________________________________________________________ 
value of combined perfusion and function assessment during myocardial gated 
SPECT in patients aged 75 years or older. J Nucl Cardiol 2005; 12:662-670. 
16. Williams SG, Ng LL, O’Brien RJ, Taylor S, Li Y-F, Tan LB. Comparison of plasma 
N-brain natriuretic peptide, peak oxygen consumption and left ventricular ejection 
fraction for severity of chronic heart failure. Am J Cardiol 2004; 93: 1560-1561 
17. Williams SG, Ng LL, O’Brien RJ, Taylor S, Wright DJ, LI YF, Tan LB. 
Complementary roles of simple variables, NYHA and N-BNP in indicating aerobic 
capacity and severity of heart failure. Int J Cardiol 2005; 102: 279-286 
18. Krüger S, Graf J, Merx M, Stickel T, Kunz D, Hanrath P, Janssens U. Brain 
natriuretic peptide levels during dynamic exercise in patients with chronic heart 
failure Int J Cardiol 2004; 95: 49-54 
19. Passino C, Poletti R, Bramantini F, Prontera C, Clerico A, Emdin M. Neuro-
hormonal activation predicts ventilatory response to exercise and functional 
capacity in patients waith heart failure. Eur J Heart Fail 2005, in press 
20. Conraads V, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, 
Possemiers N, Wuyts FL, Vrints C. Combined endurance/resistance training 
reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 
25: 1797-1905 
21. Rahimi K, Secknus M-A, Adam M, Hayerizadeh B, Fiedler M, Thierry J, Schuler 
G. Correlation of exercise capacity with high-sensitivite C-reactive protein in 
patienst with stable coronary artery disease. Am Heart J 2005; 150: 1282-1289. 
22. Lommi J, Pulkki K, Koskinen P, Naveri H, Leimonen H, Harkonen M, Kupari M. 
Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine 
concentrations in congestive heart failure. Eur Heart J 1997; 18: 1620-1625 
23. Larsen A, Lindal S, Aukrust P, Toft I, Aarsland T, Dickstein K. Effect of exercise 
training on skeletal muscle fibre characteristics in men with chronic heart failure. 
Correlation between skeletal muscle alterations, cytokines and exercise capacity. 
Int J Cardiol 2002; 83: 25-32. 
24. Conraads V, Beckers P, Bosmans J, De Clerck LS, Stevens WJ, Vrints CJ, 
Brutsaert DL. Combined endurance/resistance training reduces plasma TNF-
alpha receptor levels in patients with chronic heart failure and coronary artery 
disease. Eur Heart J 2002; 23: 1854-1860. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 184 
  
 
 
 
 
General Discussion and Future Perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
___________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 186 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
_________________________________________________________________ 
GENERAL DISCUSSION 
 
 
This thesis focuses on the growing patient population of coronary artery (CAD) 
disease patients with heart failure. Many of these patients survived a myocardial 
infarction and gradually developed signs and symptoms of heart failure. As it involves 
an elderly population, often with comorbidities such as diabetes mellitus, pulmonary 
disease, neurologic deficits, musculoskeletal conditions, it is important to rely on 
noninvasive techniques for diagnosis, prognostification, therapy choice and follow-up. 
 
Parts 1 and 2 were devoted to the clinical applications of noninvasive imaging 
techniques. In Part 1 echocardiography was used for diagnostic purposes, in Part 2 
we discussed the role of echocardiography, scintigraphy and Multi-slice Computed 
Tomography in the selection of patients for biventricular pacing. In Part 3 the role of 
prognosticators such as fasting blood glucose and exercise testing combined with 
spirometry was emphasized. 
 
In Part 1 we studied the role of echocardiography as a means to estimate filling 
pressures noninvasively. Since the original validation in the mid eighties, the peak 
systolic pressure gradient across a regurgitant tricuspid valve has been increasingly 
used to estimate right ventricular systolic pressure. More recently, since the 
introduction of Tissue Doppler Imaging (TDI), the ratio of transmitral early peak 
velocity (E) over early diastolic mitral annulus velocity (E’) was validated as an 
estimation of left ventricular (LV) end-diastolic pressure. Alhough both parameters 
are being used extensively in clinical practice, published data on reference values 
incorporating the influence of aging were scarce. Therefore, in Chapter 1.1, we 
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studied the effects of aging on the transtricuspid Doppler gradient and on the E/E’ 
ratio in 249 normotensive healthy individuals. We found that both the transtricuspid 
gradient and the E/E’ ratio increased with aging. Moreover linear regression analysis 
showed that E/E’ was an independent predictor of the transtricuspid gradient. Aging 
is accompanied by an increased vascular loading on the heart, causing a change in 
LV geometry, an increase in LV mass, slowed ventricular and myocardial relaxation, 
altered diastolic tone and altered passive myocardial properties. (1) These alterations 
lead to increased diastolic filling pressures elicited by stress and exercise. (2) When 
disease and age advance, elevated diastolic filling pressures will even be observed 
in the resting state. These changes, together with pulmonary alterations, could be 
responsible for the equivalent increase of right ventricular systolic pressure at older 
age. The results of our analysis support the need for additional studies in healthy 
individuals in order to establish age specific reference values. Especially in the old 
and very old, other (higher) cut-off values should probably be used to identify 
individuals with pathologically elevated right and left ventricular filling pressures. In 
Chapter 1.2 we studied the effects of age, gender and LV hypertrophy on E/E’ in 
normals and in patients with LV hypertrophy due to hypertension. Age was the 
strongest determinant of E’ and E/E’ suggesting that both in normals and patients 
with LV hypertrophy age dependent cut-off values should be taken into consideration. 
In normals there was also a relationship between gender and E/E’; women had 
higher values than men across all age groups but the differences were small. The 
effect of LV mass was only modest after correction for age and gender. Both 
Chapters 1.1 and Chapter 1.2 strongly support the need for age dependent reference 
values. Using a dichotomic cut-off value for the E/E’ ratio was a valid initial step, but 
not designed to be used in a growing population of older individuals. 
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After having established reference values, we applied non-invasive estimation of LV 
filling pressures in a clinical setting. In Chapter 1.3, we applied the E/E’ ratio in a 
population of patients with established coronary artery disease and ischemic mitral 
regurgitation. This form of mitral regurgitation is not caused by a structural defect of 
the valve itself but by changes in ventricular structure and function related to 
ischemia and remodeling. It is well known that patients with a more severe degree of 
ischemic mitral regurgitation have a worse prognosis. We observed a high 
prevalence of significant mitral regurgitation, especially in CAD patients with a low LV 
ejection fraction. We were able to show that patients with the highest degree of mitral 
regurgitation and the lowest ejection fraction had the highest E/E’ values. The higher 
filling pressures in these patients might be associated with a worse prognosis. 
Further studies are needed to clarify this issue. 
   
Table: E/E’ values according to age categories based on Chapers 1.1, 1.2, 1.3 
 E/E’  
 
Age category 
Normals Hypertension 
+ LV hypertrophy
CAD patients 
< 45 years 7.9 ± 2.0 9.3 ± 2.3 9.5 ± 2.4 
45 – 54 years 9.0 ± 2.3 10.5 ± 2.2 11.7 ± 4.0 
55 -64 years 10.4 ± 3.2 11.1 ± 3.1 12.6 ± 4.3 
65 -74 years 10.5 ± 3.2 12.6 ± 3.9 13.6 ± 4.6 
> 74 years 10.9 ± 2.0 13.6 ± 3.9 14.2 ± 4.4 
 
 
Despite advances in pharmacological treatment, some heart failure patients with 
ischemic cardiomyopathy remain highly symptomatic. In selected patients Cardiac 
Resynchronization Therapy (CRT) will improve symptoms, favour reverse 
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remodelling and reduce cardiac events. If classic selection criteria (NYHA III-IV, 
broad QRS, poor LV function) are used than up to 30% of the patients with a 
biventricular pacemaker do not respond favourably. In Part 2 we applied several 
noninvasive imaging modalities to help identifying potential responders. In Chapter 
2.1, using TDI we investigated potential differences between patients with an 
ischemic and patients with a nonischemic cardiomyopathy. Mechanical activation 
times were longer in patients with an idiopathic cardiomyopathy. The area of latest 
mechanical activation in patients with an ischemic cardiomyopathy was most 
frequently located in the lateral wall whereas in ischemic patients the location was 
more spread. Our results were recently confirmed by a Magnetic Resonance Imaging 
study. (3) These findings underscore the importance of an individual approach for 
every patient. Accepting a “standard” posterolateral LV lead position in every single 
patient will not automatically result in optimal pacing in some CAD patients.  
 
Not all heart failure patients have an impaired systolic function. In Chapter 2.2 we 
report on the prevalence of mechanical dyssynchrony in heart failure patients with a 
preserved LV function. We found that the prevalence of mechanical dyssynchrony in 
these patients is generally low. However, in the subgroup of heart failure patients 
with a preserved LV function and a wide QRS, the prevalence of mechanical 
dyssynchrony was as high as in patients with a broad QRS and poor LV function. 
Further studies are needed to investigate the potential role of biventricular pacing in 
heart failure patients with a preserved LV systolic function. 
 
In Chapter 2.3 we used a scintigraphic technique to describe the prevalence of 
nonviable tissue in CRT candidates and found that 30% of these patients have no 
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viable tissue in the inferolateral wall. Recently Bleeker et al found similar results, 
using Magnetic Resonance Imaging. (4) Since nonviable tissue is electromechanical 
nonfunctional, placement of the LV lead in this area could lead to ineffective pacing. 
Based on Chapters 2.1 and 2.3 we proposed a triad of questions that has to be 
answered before referring a highly symptomatic heart failure patient with ischemic 
cardiomyopathy and broad QRS for CRT implantation; First what is the area of latest 
mechanical activation? TDI will provide an answer. Second: does the area of latest 
mechanical activation contain viable tissue? Nuclear imaging techniques or MRI will 
answer this question. But even if the area of latest mechanical activation is viable 
than implantation of an LV lead will only be succesfull via the transvenous approach 
if this target area is drained by a suitable cardiac vein. So the third question to be 
answered is: what about cardiac venous anatomy? 
 
In Chapter 2.4 we provide an answer using another noninvasive imaging modality: 
Multislice Computed Tomography (MSCT). We demonstrated that patients with a 
history of a myocardial infarction were less likely to have a Left Marginal Vein. We 
also showed that 64 MSCT is an ideal tool to depict the cardiac veins noninvasively, 
at the outpatient clinic. If no suitable tributary of the Coronary Sinus is demonstrated 
with MSCT than a surgical approach could be more successful than the endocardial 
technique to insert the LV pacemaker lead. 
 
In Part 3 we switch from noninvasive evaluation with imaging modalities to 
nonivasive prognosticators such as fasting blood glucose and exercise testing 
combined with spiroergometry. Exercise testing can be used as a diagnostic tool to 
detect ischemia and arrhythmia but if combined with spirometry it also offers 
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important information on the patients’ functional status and prognosis. Moreover it is 
an objective tool to evaluate the effect of therapeutic interventions. 
 
In this part of the thesis we tried to gain insight in some of the determinants of 
exercise capacity as evaluated with spirometry in a clinical setting. It is widely 
accepted that patients with diabetes mellitus have a worse prognosis. In Chapter 3.1 
we showed that in patients with coronary artery disease, heart failure and a poor left 
ventricular ejection fraction, diabetes patients had indeed the worst prognosis but 
patients with fasting blood glucose levels between 110 and 126 mg/dl (impaired 
fasting glucose) also had a less favourable prognosis compared to patients with 
fasting blood glucose levels < 110 mg/dL. This underscores the recent observations 
that there is a spectrum of patients from normoglycaemic to diabetes mellitus 
patients and that the risk for cardiovascular events increases gradually along this 
spectrum along with the fasting blood glucose levels.  
 
Exercise performance is the result of interaction between the cardiovascular, 
pulmonary and musculoskeletal systems. Attemps to correlate the most widely used 
parameter of LV systolic function, LV ejection fraction, have found only weak 
correlations between VO2max and ejection fraction. More recently several authors 
have reported significant correlation between exercise capacity and more sensitive 
markers of LV systolic function reflecting longitudinal suction: TDI derived systolic 
velocities. Exercise capacity is also determined by diastolic parameters, including 
E/E’. In pathological conditions, neurohormones such as NTproBNP and 
inflammation could also have an effect on VO2max. In Chapter 3.2 we investigated 
the role of inflammatory markers and NTproBNP (on top of TDI derived markers of 
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systolic and diastolic function) on the exercise capacity of coronary artery disease 
patients with a preserved LV systolic function. Even in patients with a normal ejection 
fraction, small differences in longitudinal suction as evaluated with sensitive TDI 
techniques had an influence on exercise capacity. Longitudinal myocardial velocities, 
E/E’, fasting blood glucose and inflammation were all independently associated with 
VO2max in these patients.  
 
FUTURE PERSPECTIVES 
 
In an era of subspecialisation (5,6), increasing invasive cardiologic interventions and 
growing numbers of device implantations, the future ‘s looking bright for a novel 
subspeciality within cardiology: that of the noninvasive cardiology. (7) Emerging 
technologies such as high-end echocardiographic platforms (including tissue Doppler 
and 3D applications), gated SPECT, PET, multidetector row CT and MRI allow 
noninvasive evaluation of cardiac function and structure. The integration of these 
imaging modalities into clinical cardiologic practice requires specific training and  
close collaboration between cardiologists, radiologists and specialists in nuclear 
medicine. (8) The noninvasive cardiologist working in a large cardiovascular center 
will have to keep up the pace with several novel imaging modalities that will be 
introduced into clinical practice: 
- Multi-modality imaging and fusion imaging such as PET-CT and SPECT-CT allow a 
combined evaluation of structure and function. PET-CT for instance could be used in 
the selection of CRT patients to evaluate viability in the area of latest mechanical 
activation and to identify a suitable cardiac vein for LV lead implantation. SPECT-CT 
might facilitate the decision to treat a stenosis in a specific coronary artery if 
associated ischemia is demonstrated (9,10). 
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- Noninvasive targeted molecular imaging will allow us to directly track biochemical 
processes and signalling events that precede the pathophysiological changes of e.g. 
atherosclerosis. (11)  
- High- end echocardiographic platforms that have the size of a notebook are 
becoming commercially available. These small portable echomachines will have all 
features including Tissue Doppler Imaging. Measuring the E/E’ value in the 
emergency department, outpatient clinic or at the ward will be just as easy as using a 
sthethoscope. (12) 
- Three-dimensional echocardiography will improve the accuracy to calculate left and 
right atrial and ventricular dimensions, mass and ejection fraction. (13)  
- Contrast media, especially developed for cardiac purposes, will allow a more 
sensititive analysis of regional wall motion abnormalities, a reliable identification of 
intracardiac thrombi and evaluation of myocardial perfusion 
 
Combining cardiovascular imaging modalities with exercise testing will also be the 
responsibility of the noninvasive cardiologist. Some pathologic cardiovascular 
conditions are not present at rest but become detectable during stress. The most 
physiologic way of stressing the heart is exercise. Bicycle or treadmill testing 
combined with gated SPECT is being used routinely in many centers to increase 
sensitivity and specificity of standard exercise testing to detect ischemia. Recently 
semi-supine exercise echocardiography has also gained interest, especially for the 
evaluation of dynamic mitral regurgitation in patients with coronary artery disease. 
(14) Other indications of semisupine exercise echocardiography might include other 
valvular lesions and hypertrophic cardiomyopathy to evaluate dynamic 
intraventricular gradients. A recent publication validates the use of E/E’ to estimate 
 194 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
_________________________________________________________________ 
LV filling pressures during exercise. (15) Using spirometry in all patients referred for 
stress testing combined with imaging will provide new insights in the pathophysiology 
of exercise intolerance and introduce novel markers that allow a better 
prognostification of patients unable to reach a true maximal exercise.  
 
The real challenge for the clinical and noninvasive cardiologist will be about making 
the right choices. Working as a gatekeeper, it will be his responsibility to select the 
most appropriate technique to unravel a patients’ problem and to propose a valid 
treatment option, within the technological boundaries of a specific hospital setting. To 
achieve this goal he will combine “old fashion” clinical skills and knowledge on the 
latest state-of-the-art noninvasive evolutions. Finally, it will require a lot of flexibility 
and creativity to reach these goals within a cost-effective manner. 
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Aging is accompanied by structural and functional cardiac changes that are reflected 
by echocardiographic parameters. Left ventricular end-diastolic pressure, estimated 
with the E/E’ ratio and right ventricular systolic pressure, estimated with the 
transtricuspid regurgitation gradient, increase in older subjects. Age appears to be 
strongest determinant of E’ and E/E’ whereas the effects of gender and left 
ventricular hypertrophy are only moderate. These findings support the need for age 
specific reference values and cut-off values. In coronary artery disease patients, the 
E/E’ ratio is determined by the degree of left ventricular systolic dysfunction and by 
the severity of mitral regurgitation. Ischemic mitral regurgitation is frequently 
observed in patients with an ischemic cardiomyopathy; patients with poor LV systolic 
function and mitral regurgitation grade III-IV have the highest E/E’ value. 
 
If classic criteria (poor LV function, broad QRS, NYHA III-IV) are used to select heart 
failure patients for cardiac resynchronization therapy, than the success rate is only 
70%. The answers to a triad of additional questions, especially in patients with an 
ischemic cardiomyopathy, might increase the number of responders. First, using 
tissue Doppler imaging, the degree of intraventricular dyssynchrony and the region of 
latest mechanical activation has to be determined. In patients with an ischemic 
cardiomyopathy this area is not always the lateral wall as in patients with an 
idiopathic cardiomyopathy. Almost 50% of patients with an ischemic cardiomyopathy 
and broad QRS have significant intraventricular dyssynchrony but also half of the 
patients with preserved LV function and broad QRS have significant asynchrony. 
Second, viability of myocardial tissue has to be evaluated. Using SPECT, 30% 
nonviable tissue was observed in the inferolateral wall of CRT candidates with CAD. 
Third, when an area of latest mechanical activation containing viable tissue is 
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identified then transvenous positioning of the LV lead wil only be possible if a suitable 
cardiac vein is present. Multi-slice Computed Tomography allows noninvasive 
evaluation of the cardiac venous system. Knowledge on the cardiac veins is 
especially important in CAD patients with a history of myocardial infarction because 
patients with anterolateral infarctions are often missing the left marginal vein. 
 
Nondiabetic patients with an ischemic cardiomyopathy have a worse prognosis if 
their fasting blood glucose levels are between 110 and 126 mg/dL compared to 
normoglaecymic patients. In patients with a preserved LV systolic function, exercise 
capacity is not only predicted by fasting blood glucose but also by E/E’, longitudinal 
suction and biomarkers representing inflammation.  
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Verouderen gaat gepaard met structurele en functionele cardiale veranderingen die 
gereflecteerd worden door echocardiografische parameters. De linker ventriculaire 
(LV) einddiastolische druk, geschat met de E/E’ waarde, en de rechter ventriculaire 
systolische druk, geschat met de gradient over een lekkende tricuspidalisklep, 
nemen toe bij oudere individuen. Leeftijd blijkt de belangrijkste determinant te zijn 
van E’ en E/E’ terwijl de effecten van geslacht en linker ventrikelhypertrofie eerder 
bescheiden zijn. Deze bevindingen ondersteunen de noodzaak tot leeftijds-specifieke 
referentie-waarden en drempelwaarden. Bij patiënten met coronair lijden, wordt de 
E/E’ verhouding bepaald door de ernst van de linker ventriculaire dysfunctie en de 
ernst van de mitralisklepinsufficiëntie. Ischemische mitralisklepinsufficiëntie wordt 
frequent gevonden bij patiënten met een ischemische cardiomyopathie; patiënten 
met een slechte LV functie en mitralisklepinsufficiëntie graad 3-4 hebben de hoogste 
E/E’ waarde. 
 
Indien klassieke criteria (slechte LV functie, breed QRS, NYHA III-IV) worden 
gebruikt om hartfalen patiënten te selecteren voor cardiale resynchronisatietherapie 
dan is het slaagpercentage slechts 70%. De antwoorden op een drietal bijkomende 
vragen, voornamelijk bij patiënten met een ischemische cardiomyopathie, kunnen het 
aantal responders doen toenemen. Ten eerste kan gebruik makende van tissue 
Doppler imaging, de ernst van intraventriculaire dyssynchronie en de regio van 
laatste mechanische activatie worden bepaald. Bij patiënten met een ischemische 
cardiomypathie is dit niet altijd de laterale wand zoals bij patiënten met een 
idiopatische cardiomyopathie. Bijna 50% van de patiënten met een breed QRS 
hebben significante dyssynchronie maar ook de helft van de patiënten met bewaarde 
LV functie en breed QRS hebben significante asynchronie. Ten tweede dient de 
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viabiliteit van het myocard te worden geëvalueerd. Gebruik makende van SPECT, 
werd 30% niet-viabel weefsel geobserveerd in de inferolaterale wand van CRT 
kandidaten met coronair lijden. Ten derde, wanneer een viabel gebied dat laatst 
wordt geactiveerd is geidentificeerd dan zal transveneuze plaatsing van een LV 
draad enkel mogelijk zijn indien een geschikte cardiale vene aanwezig is. Multi-slice 
Computed Tomography laat een niet-invasieve evaluatie toe van het cardiaal veneus 
systeem. Kennis van de cardiale venen is voornamelijk belangrijk bij coronaire 
patiënten met een voorgeschiedenis van acuut myocardinfarct omdat bij patiënten 
met anterolaterale infarcten de linker marginale vene vaak ontbreekt.  
 
Niet-diabetische patiënten met een ischemische cardiomyopathie en een nuchtere 
bloedsuikerspiegel tussen 110 en 126 mg/dL hebben een slechtere prognose dan 
normoglycemische patiënten. Bij patiënten met een bewaarde LV systolische functie 
wordt de inspanningscapaciteit niet alleen bepaald door de bloedsuiker spiegel maar 
ook door E/E’, longitudinale suctie en inflammatie markers in het bloed. 
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